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1 Introduction 
 
Phthalocyanines (Pc’s) are macrocyclic compounds with wide applications in 
various fields. Metal (PcM) and metal free phthalocyanines (PcH2) are used as 
dyes and pigments in textile and dyeing industries. More recently phthalocyanines 
find a large number of applications in various fields of materials science. This will 
be discussed later on page 9. 
 
1.1 Historical background 
 
The compound that was later named as phthalocyanine was first observed in 1907 
as highly dark colored insoluble byproduct during the preparation of 2-
cyanobenzamide.[1] In laboratory for the first time a copper phthalocyanine was 
prepared in 23 % yield by reacting 1,2-dibromobenzene with copper (I) cyanide in 
pyridine.[2] However these new compounds did not find much significance until 
1928 when accidental appearance of a blue-green material was observed at the 
Grangemouth plant of Scottish dyes. During the synthesis of phthalimide from 
phthalic anhydride, the glass lined steel vessel had cracked resulting in the 
formation of a blue-green material.[3,4] Preliminary studies at Scottish Dyes 
revealed that the iron-containing by-product may acquire potential applications as 
pigments because it is exceptionally stable and insoluble in common organic 
solvents. Later on Scottish Dyes were acquired by ICI in 1928. Due to the 
business interests ICI started investigations about the 
preparation and structural evaluation of these novel 
blue colored compounds. The structure of this newly 
formed substance was extensively investigated by 
Linstead at Imperial College London, who later 
published a series of papers on the synthesis and 
structural investigations.[5-10] He was the first one who 
used the name phthalocyanine, deriving the name 
from the Greek words naphtha (rock oil) and cyanine (blue). In the subsequent 
years he developed procedures for the synthesis of metal and metal free Pc’s. 
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Figure 1: Structure of PcM.
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Structure of a typical metal phthalocyanine (PcM) with IUPAC nomenclature is 
shown in figure 1. The positions 1, 4, 8, 11, 15, 18, 22 and 25 are usually referred 
as α-positions whereas, 2, 3, 9, 10, 16, 17, 23, and 24 are called as β-positions. 
The substituents located at α-positions are named as α-substituents, while those 
located at β-positions are regarded as β-substituents. 
Nowadays Pc’s are most familiar organic compounds with a vast variety of 
applications. A square planar phthalocyanine ring has coordination number of four, 
can tightly bind almost all metals. Metals having coordination number higher than 
four can bond with a variety of axial ligands which enables the Pc ring to be used 
in the extension and formation of polymers. 
 
1.2 Phthalocyanines and related macrocycles  
 
Phthalocyanines although not found in nature have resemblance with some 
naturally occurring substances such as haemoglobin, vitamin B12 and chlorophyll. 
Porphyrins (P) and porphyrazines (Pz) are among the other substances which are 
structurally related with phthalocyanines (see figure 2). 
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Figure 2: Structures of vitamin B12, naphthalocyanine (NcM), porphyrazine (PzM) and 
porphyrin (PM). 
 
Phthalocyanines are further modified on the periphery to form naphthalocyanines 
(Nc’s), anthracenocyanines (Ac’s) as well as mixed structures containing 
phthalocyanine and naphthalocyanine subunits. 
 
1.3 Phthalocyanine and naphthalocyanine precursors 
 
Various 1,2-disubstituted benzene precursors, e.g. phthalic anhydride, 
phthalimide, phthalamide, o-cyanobenzamide and phthalonitrile, are used to 
synthesize metal free and metal phthalocyanines as shown in figure 3. Among 
them phthalonitriles are the most widely used starting materials for the synthesis 
of metal and metal free phthalocyanines. However these precursors are not 
discrete as one type of precursor is often an intermediate in the 
cyclotetramerization reaction of other. For example phthalonitrile is formed as an 
intermediate during cyclotetramerization of 1,2-dibromobenzene with copper (I) 
cyanide. Similarly diiminoisoindoline is formed during tetramerization of 
phthalonitrile induced by ammonia under more forcing conditions. Phthalonitriles 
can be synthesized from other phthalic acid derivatives by a step wise progression 
from the dicarboxylic acid through to the anhydride , imide and diamide and finally 
to the desired phthalonitrile.[13] An excellent example of this was employed in the 
synthesis of 4,5-dichlorophthalonitrile from the inexpensive commercially available 
1,2-dichloro-3,4-benzenedicarboxylic acid (figure 4).[14] 
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Figure 3: General methods for the synthesis of metal phthalocyanine (PcM). 
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Figure 4: Synthesis of 4,5-dichlorophthalonitrile. 
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A highly popular method of synthesizing phthalonitriles is by a cyano-
dehalogenation reaction known as the Rosenmund-von Braun reaction.[15] In this 
method aryl halides are converted into the corresponding aryl nitriles using 
cuprous cyanide in refluxing DMF. Although it is known that aryl iodides react 40-
100 times[16] more readily than aryl bromides, phthalonitrile synthesis is usually 
accomplished using the corresponding aryl bromides. This is due to the ready 
availability of brominated precursors (see figure 5). 
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Figure 5: General synthesis of 4,5-disubstituted phthalonitriles (X = O or N). 
 
Another more simple approach for the preparation of mono or disubstituted 
phthalonitriles, is the modification of preexisting phthalonitrile molecules.[13] A 
number of substituted phthalonitriles bearing chemically versatile functional groups 
such as NO2, OH and halides etc., are commercially available. Others can be 
easily synthesized from inexpensive commercially available starting materials 
using one of the classic methods discussed above. 
Phthalocyanines and metal phthalocyanines may also be synthesized by the 
modification of already formed metal free or metal phthalocyanines. This involves 
the reactions of substituents present on the peripheral ring of already formed 
phthalocyanines.[13] 
Peripherally substituted Pc’s are generally synthesized by corresponding 
substituted phthalonitriles as starting material. In contrast to octasubstituted 
systems tetrasubstituted Pc’s are obtained as a mixture of four constitutional 
isomers, by tetramerization of monosubstituted phthalonitriles or their derivatives. 
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Attempts to separate these constitutional isomers were carried out with tetra-tert-
butyl substituted 1,2-naphthalocyanine [1,2-NcFe(C6H11NC)2.].[17] But only the C4h-
isomer could be separated from the three other ones. 
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Figure 6: Tetrasubstituted metal phthalocyanines. 
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Figure 7: Constitutional isomers of tetrasubstituted metal phthalocyanines. 
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Complete separation of a 1,4-tetrasubstituted Pc- the 1,4-tetrakis(2-
ethylhexyloxy)phthalocyaninatonickel(II) [1,4-(2-Et-C6H12O)PcNi], was first 
achieved by Hanack and coworkers using high performance liquid 
chromatography (HPLC).[18] The four isomers were also isolated in a preparative 
scale with medium pressure liquid chromatography (MPLC). The four isomers of 
2,3-tetra-tert-butylphthalocyaninatonickel [2,3-(t-Bu)4PcNi] were separated with 
MPLC on a silica gel column with toluene and n-hexane.[19] Attempts failed to 
separate 2,3-tetrasubstituted alkoxyphthalocyanine with nickel or hydrogen as the 
central atoms, on silica gel or using nitrophenyl phase. Using newly developed 
nitrophenylquinoline phase 1,4-tetrasubstituted Pc’s can be completely 
separated.[20] From all 2,3-substituted alkoxyphthalocyanines with more than 6 C-
atoms in the side chains or ring systems of the periphery the C4h- and D2h- 
isomers can be easily separated.[20] 
For the synthesis of naphthalocyanines, naphthalonitriles are the most commonly 
used precursors, due to their reactivity, ease of synthesis and possibility of 
numerous substituents at different positions of naphthalene ring. Likewise already 
formed naphthalocyanines may also be modified by the reactions of reactive 
substituents on the naphthalocyanine ring with other functional groups to form a 
diverse range of new naphthalocyanines.[21] 
 
1.4 Absorption spectra of phthalocyanines 
 
Purity and intensity of phthalocyanine’s color arises from an isolated and intense 
band (Q-band) at the red end of the visible spectrum of light, between 650 and 
720 nm approximately. A second band (B-band) appears between 300 and 400 
nm, being generally less intense (figure 8). In the spectra of metal phthalocyanine 
solutions, the intense Q-band arises from doubly degenerate π-π* transition 
between the A1g (a21u) ground state to the first excited singlet state, which has Eu 
(a11ue1g) symmetry. The second allowed π-π* transition (B-band) is caused by a 
transition between either an a2u or a b2u orbital to the eg orbital (LUMO).[22] 
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In the case of metal free phthalocyanines all states are non-degerated, due to the 
reduced D2h molecular symmetry. The Q-band is polarized in either the x or y 
direction and is therefore splitted in two bands. [23] 
300 400 500 600 700 800
0,0
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Figure 8: UV/vis spectrum of a typical phthalocyanine. 
 
Additional bands, which appear in the spectra of certain molecules can be 
assigned to metal-ligand or ligand-metal charge transfer or even to exciton 
coupling between the π-systems of dimeric complexes.[11] 
 
1.5 Solubility of phthalocyanines 
 
The solubility of phthalocyanines in common organic solvents can be increased by 
introduction of bulky or long chain substituents in the periphery of macrocycle 
(peripheral substitution) and/or, in case of possibility, by coordination of the central 
metal with additional axial ligands (axial substitution).[24] Substituents enable 
phthalocyanine solvation because they increase the distance between the stacked 
molecules.[11,25] The peripherally substituted phthalocyanines studied in more 
detail are the tetra and octasubstituted ones.[25] Generally, the solubility of 
tetrasubstituted phthalocyanines is higher than the octasubstituted analogues, 
mainly due to the fact that the tetrasubstituted phthalocyanines are prepared as a 
mixture of isomers and therefore, leading to a lower degree of order in the solid 
state, when compared to the symmetrically octasubstituted phthalocyanines 
(figure 9). 
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Figure 9: 1,4- and 2,3-octasubstituted phthalocyanines. 
 
1.6 Applications of phthalocyanines 
 
Phthalocyanines (Pc’s) have traditionally found use as dyes and pigments, 
however, now have been employed in a variety of high-tech fields, including 
semiconductor devices[26], photovoltaic solar cells[27], electrophotography[28], 
rectifying devices[29], molecular electronics[30], Langmuir-Blodgett films[31], 
electrochromism in display devices[32], low-dimentional metals[33], gas sensors[34], 
liquid crystals[35], nonlinear optics[36], photodynamic reagents for cancer therapy 
and other medical applications[37]. A few of the important applications of Pc’s will 
be discussed in detail. 
 
1.6.1 Phthalocyanine pigments and dyes 
 
Pthalocyanines found their first application as pigments, with the industrial 
discovery of phthalocyanines at Scottish Dyes Ltd. (see page 1) in 1928.[38] 
Copper phthalocyanine was first manufactured by Imperial Chemical Industries 
(ICI) in 1935 under trade name Monastral Blue.[39] Later on in 1936, IG 
Farbenindutrie began production of PcCu in Germany under trade name 
Heliogene Blue followed by Du Pont in 1937 in the United States. Todays 
phthalocyanines are predominantly (ca. 90%) used as pigments. These pigments 
are almost copper phthalocyanines, including the chloro and bromo derivatives.[40] 
Modification of nearly insoluble phthalocyanines by introduction of various 
substitutions at peripheral positions of Pc ring has led to the solublization of these 
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pigments leading to their use as dyes. The first phthalocyanine dye was sulfonated 
phthalocyanine. Since 1930 many other derivatives such as sulfonamides, 
aminomethyl, sulfur and azo dyes, and vinylsulfone and triazine reactive dyes 
have been patented. The colors of these dyes range from brilliant blue through 
turquoise to green. Phthalocyanine dyes are therefore used as direct, solvent and 
reactive dyes in dyeing of textiles, paper and leather and for the manufacture of 
high quality ink.[40] 
Recently Kodak has put new ink jet inks on the market in which the Aluminium 
phthalocyanine is employed as cyan colorant. This new cyan ink exhibits a very 
clean yellowish shade of blue.[41] Many phthalocyanines with different central 
metal atoms, which have been theoretically investigated, may become active 
members in this field of application in future. 
 
1.6.2 Phthalocyanines in nonlinear optics 
 
Another important application of Pc’s and Nc’s is the use of these compounds as 
optical limiters. Optical limiters are devices designed to have high transmittance 
for low level inputs (such as in images) while blocking the transmittance for high 
intensity laser beams. Among the phthalocyanine based nonlinear absorbers that 
have been used as optical limiting (OL) materials and approach the necessary 
characteristics for a practical device are (tert-butyl)4PcInX (A)[42] and (tert-
butyl)4PcTi[O2C6H2(CN)2] (B)[43]. 
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As far as dimeric Pc’s are concerned, the non linear optical (NLO) properties of μ-
oxo bridged Pc dimers with the general structure Pc(X)M-O-M(X)Pc [M = Fe, Ga 
and In (C), diisocyanobenzene (dib) (D) and 2,3,5,6 tetrafluorophenylene (TFP) 
(E), X= Cl and TFP][44], have been studied mostly by Hanack and coworkers. The 
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larger OL effect generated by the dimers PcInX-dib-XInPc as bridging ligand with 
respect to the bridged dimers PcIn-TFP-InPc. 
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A newly synthesized dimer with a direct M-M bond [t-Bu4PcM]2 2L, with M= In and 
L= tmed (tmed= N, N, N’, N’-tetramethylethylenediamine) (F) display OL properties 
with improved features with respect to the single Pc ring coordinated by one single 
metal atom.[45] Similarly, the Pc dimer with central Ti atoms bridged by 
tetrahydroxy-p-benzoquinone (G) also displays an OL effect with improved 
characteristics if compared with the parent monomer.[46] 
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1.6.3 Phthalocyanine semiconducting properties 
 
Hanack and his group has studied very much in detail the properties of 
phthalocyanines as semiconductors especially transition metal Pc’s with 
compounds of polymeric structures.[47] Formula H shows a typical example for a 
Pc transition metal polymer in which L (ligand) is an organic molecule e.g. 
pyrazine (pyz), cyano (CN) or tetrazine (tz). Compounds of this type exhibit 
semiconducting properties with out external doping. [47] 
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It is evident from table 1[25] that the polymerization of Pc through cyano and 
tetrazine bridging is particularly effective for the rising of conductivity in neutral 
Pc’s. The chemical nature of ligand L in stacked bridged polyphthalocyanines 
plays a significant role on the conductivity of the resulting bridged complexes 
[PcM(L)]n[47]. This is especially true when tz is the bridging ligand and possess an 
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electronically conjugated path. The reason for that has to be ascribed to the 
energy difference between the lowest unoccupied molecular orbital (LUMO) of the 
bridging ligand acting as an acceptor and the highest occupied molecular orbital 
(HOMO) of the metal-macrocycle complex acting as a donor. [48] 
 
Table 1: Conductivity values of undoped polymeric stacked phthalocyanines at room 
temperature.[25] 
Compound σ/S cm-1 
[2,3NcFe(tz)]n 3.0 x 10-1 
[2,3NcCo(CN)]n 1.0 x 10-1 
[PcFe(tz)]n 2.0 x 10-2 
[PcRu(tz)]n 2.0 x 10-2 
[(CH3)8PcFe(tz)]n 1.0 x 10-2 
[PcRu(tz)]n 1.0 x 10-2 
[PcFe(CN)]n 6.0 x 10-3 
[PcFe(pyz)]n 1.0 x 10-6 
[PcRu(pyz)]n 1.0 x 10-7 
 
The conductivity of stacked polymeric phthalocyanines can be further improved 
through doping processes[49], which lead to the increase of the charge carrier 
number as a consequence of the partial oxidation or reduction of the molecular 
entities constituting the polymeric complex. 
 
1.7 Naphthalocyanines 
 
Naphthalocyanines are analogs of phthalocyanines. Two types of 
naphthalocyanines are known to date. If 2,3-dicyanonaphthalene or its derivatives 
are used as starting materials, they are named as 2,3-naphthalocyanines (2,3-
Ncs) or simply Ncs. If 1,2-dicyanonaphthalene and its analogs are condensed, the 
resultant Ncs are termed as 1,2-Ncs (figure 10). 
 
  
 14 
N
N
N
N
N
N
N
N
M
2,3-NcM  
N
N
N
N
N
N
N
N
M
1,2-NcM
 
Figure 10: Types of metal naphthalocyanines (NcM’s). 
 
Concerning the π-systems, there is no isomer for 2,3-Nc, while there are four 
types of isomers (C4h, Cs, D2h and C2v) in the case of 1,2-Ncs (figure 11). In 1936 
Bradbrook and Linstead[50] first prepared 1,2-Ncs due to the inaccessibility of 2,3-
dicyanonaphthalene. Because of the presence of several isomers of 1,2-Ncs, the 
solubility is higher than for the unsubstituted phthalocyanines. 
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Figure 11: Constitutional isomers of 1,2-metal naphthalocyanines (1,2-NcM’s). 
 
In 1988, pentacarbonyliron was reacted with 1,2-dicyanonaphthalene in 
chloronaphthalene at 260 oC under nitrogen to produce black-green air stable 
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Fe(1,2-Nc) isomer.[51 When the mixture was left at room temperature or slightly 
warmed in chloroform, with isocyanides, it formed bis-isocyanide complexes.[52] 
The most simpler nonmetalated 2,3-Nc, was obtained by boiling 2,3-
dicyanonaphthalene and sodium isoamylate in amylalcohol, and subsequent 
replacement of two sodiums by two protons in 26% yield, and is insoluble in 
majority of solvents.[53] Mg and Fe (2,3-Ncs) were obtained by fusing the nitrile and 
the appropriate metal salt or metal dust with or without solvent. However when 
metal chlorides were used as templates with out any solvent, partial chlorination of 
Nc occurred.[53]  
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CHBr2
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70-80 oC
 
Figure 12: Synthesis of 6-tert-butyl-2,3-dicyanonaphthalene. 
 
6-tert-butyl-2,3-dicyanonaphthalene was synthesized (figure 12) from 4-tert-butyl-
o-xylene[54] via 1,2-bis(dibromomethyl)-4-tert-butylbenzene in usual manner. 
Because of the tert-butyl group, these compounds are soluble in many solvents, 
and accordingly could be purified using columns.[55] 
 
1.8 Photodynamic therapy (PDT) 
 
Photodynamic therapy (PDT) is a technique for the treatment of cancer cells. PDT 
uses drugs, called photosensitizers, visible light and oxygen. The photosensitizer 
is administered systemically in to the body or put on the skin in case of skin 
cancer. Over a certain interval of time the photosensitizer is preferentially 
absorbed by the cancer cells and reaches a favorable tumor/normal tissue ratio. 
  
 16 
Red light (~640 nm) is applied to the area to be treated with fiber optics. The light 
activates the drug to react with oxygen, which forms reactive singlet oxygen 
species that kill the cancer cells (figure 13).[56] 
Dye transport and tissue 
distribution
Differential clearance from
 tumor/normal tissue
Generation of reactive
 intermediates
Chemical reactions
Biological damage
Cell death,
tumor necrosis
Dye injection
Light
 
Figure 13: Schematic representation of photodynamic treatment. 
 
The interval of time between the application of photosensitizer and its activation by 
the light is called drug-to-light interval. It may range from a couple of hours to a 
couple of days and depends on the drug used.[57] 
 
1.8.1 History of PDT 
 
In 1900, Oscar Raab discovered that a combination of light and acridine dyes 
could kill a living organism (Paramecium). This is commonly considered as the 
start of PDT.[58] The first clinical trial of photodynamic therapy on skin tumors was 
carried out by von Tappeiner and Jesionek in 1903. These two researchers 
introduced the term photodynamic action in 1907.[58] However studies of PDT were 
not very successful until the mid century because of the use of inefficient 
photosensitizers. In 1955 Samuel Schwartz isolated a tumor localizing byproduct, 
a hematoporphyrin derivative (HpD) from hematoporphyrin isolated from blood. 
This product was used by Richaard Lipson in detecting tumor tissues by observing 
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the fluorescence of the HpD. His experiments opened the possibility of using HpD 
as a photosensitizer to treat cancer.[59] 
A major breakthrough was made in the 1970s by Thomas Dougherty, who showed 
that Schwartz’s HpD could be used as a photosensitizer in PDT. HpD had some 
advantages over previously used compounds, e.g., a relatively high 1O2 quantum 
yield, an absorption maximum in the red region and selectivity for tumor tissues. A 
purified product from HpD, Photofrin (figure 14), was produced in the mid 
1970s.[58] In 1993, Photofrin was approved for the treatment of bladder cancer in 
Canada.[60] Now it has been approved in more than 40 countries for various 
cancers and nearly 10,000 patients in the United States, Canada, Japan and 
European Union have been treated using Photofrin.[58] 
 
1.8.2 Second–Generation photosensitizers 
 
Porfimer sodium (Photofrin, figure 14) was the first photosensitizer which was 
licensed to treat the oesophagus, lung, stomach, cervix and bladder carcinomas 
and is refered as first generation photosensitizer. It is only moderately active in 
tissue because the wavelength of light needed for activation (630 nm) penetrates 
tissue only slightly and the absorption band at this wavelength is weak.[61] 
Considerable work has been carried out on second generation photosensitizers, 
and now three more drugs have been approved in various countries. Verteporfin 
(Visudyne, p. 19), and 5-aminolevolinic acid (ALA, Levulan, p. 18) were approved 
in 1999 whereas Foscan was approved in 2001.[62] 
 
1.8.3 Pros and cons of PDT 
 
PDT works well in treating various kinds of cancers and pre-cancers. It has certain 
advantages over the other therapeutic techniques, such as: It has no long-term 
side effects when used properly. It is less invasive than surgery. It can be targeted 
very precisely. It can be repeated many times at the same site if needed. 
On the other hand PDT has some limitations e.g. it can only treat the body parts 
where light can reach, so it is mainly used to treat skin cancers and tumors 
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present in the lining of internal organs. It can not be used to treat the cancers 
which have been spread over many organs. PDT can not be used in people who 
have a blood disease called acute intermittent porphyria or people who are allergic 
to porphyrins.[63] 
 
1.8.4 Approved drugs for PDT: Porfimer sodium (Photofrin) 
 
Porfimer sodium is the most widely used and studied photosensitizer. It is 
activated by red light from a laser to treat patients with cancer of the esophagus. It 
is also used for Bowen’s disease, basal cell carcinoma and some tumors of the 
vagina, vulva and cervix that can be reached by the activating light.[64] 
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Figure 14: Synthesis of Photofrin. 
 
5-Aminolevulinic acid (ALA or Levulan) 
 
5-Aminolevulinic acid (ALA) is applied directly on the 
skin. It is used to treat actinic keratosis, a skin condition 
that can become cancer, Bowen’s disease, superficial basal cell and squamous 
cell carcinoma. It is approved for use only on the face or scalp. A special blue 
light, rather than laser light, is used to activate this drug. 
H2N
O
O
OH
ALA
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Methyl ester of 5-aminolevulinic acid (MLA) was 
approved by the FDA in July 2004 for the treatment of 
non-hyperkeratotic actinic keratoses of the face and 
scalp.[65] 
 
Verteporfin (Visudyne) 
 
Verteporfin (VP) has been developed and used to 
treat age-related macular degeneration, a 
progressive eye problem that leads to blindness.[66] 
 
1.8.5 The future of photodynamic therapy 
 
Photodynamic therapy may be used to treat other cancers and diseases in the 
future. Current studies are testing the use of PDT for several types of cancer and 
pre-cancerous conditions, including cancers of the, skin, cervix, bladder, prostate, 
bile duct, pancreas, stomach, brain, head and neck.[59-62] 
 
1.8.6 Desired properties of photosensitizers for PDT 
 
Based on the extensive biological work done on 
photosensitizers, an ideal photosensitizer should posses the 
following properties: It should be chemically pure and 
maintain a constant composition during the treatment. Its 
photobleaching and dark toxicity should be minimal. It should 
have a high quantum yield of long lived triplet states and a 
strong absorption peak in the region of 600-800 nm.It should be able to treat 
tumors under the skin or in body tissues. Its tumor selectivity should be high. It 
should accumulate in the cancer cells more quickly and it should be removed from 
the body more quickly.[67] 
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A number of second generation photosensitizeers such as tetra(meta-
hydroxyphenyl)chlorin, Photochlor and mono-L-aspartyl chlorin e6, are currently 
being evaluated in PDT clinical trials.[68] 
Photochlor is under clinical trials for the treatment of tumors of esophagus, lungs, 
skin, mouth and throat. So far, studies have shown that the photosensitivity lasts 
for much shorter time because the drug is removed from the body much faster 
than Photofrin.[69] 
 
1.9 Phthalocyanines, cellular uptake and biodistribution 
 
The interest for phthalocyanines in PDT dates back to 1985 following the 
demonstration that some Pc’s can photosensitize inactivation of mammalian cells, 
by Ben-Hur and coworkers.[70] The ability of some Pc’s to act as second 
generation photosensitizers is due to a long wavelength band with large extinction 
coefficient. Presence of diamagnetic metals e.g. Zn, Al, Ga etc. in Pc core 
enhance the photo activity due to long lived triplet state, leading to the generation 
of higher concentration of singlet oxygen (1O2), with quantum yield of 0.18-0.62.[71] 
Moreover Pc’s show generally low dark toxicity and are easily obtainable in pure 
form.[56] 
It is noted that the aggregation of phthalocyanine molecules in aqueous medium 
leads to decrease in excited singlet state by internal conversion. This results in the 
reduction of triplet quantum yield and consequent decrease in the photosensitizing 
efficiency.[56] To date mono-, di-, tri-, or tetra-sulfonated derivatives (Pc’Sn) of zinc 
and chloro aluminium phthalocyanines have been most commonly studied 
photosensitizers, but increasing attention is given to an axially substituted silicon 
phthalocyanine called as Pc 4 (p. 23).[72] 
Intracellular localization of photosensitizer is affected by non lethal light doses. 
Thus PcAlS3 and PcAlS4 (where S = OSO2H) localized initially in extracellular 
organelles of cells, were translocated from lysosomes to the whole cytoplasm with 
a small fraction localizing into the cell’s nuclei, with irradiation of small doses of 
light. At low concentration of sensitizer no dye translocation occurred.[73] Similarly 
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in V79 cells, PcAlS2 or PcAlS4 initially stain the lysosomes but following the 
exposure to harmless doses of light a similar redistribution in the cells occurred.[74] 
The association of photosensitizer with blood serum components is critical to the 
degree of uptake and cellular distribution. The effect of human serum on 
photodynamic activity of PcZn was observed on V79 Chinese Hamster cells. High 
density lipoproteins present in the serum increase the uptake of PcZn by 23%, 
when compared to the incubation of PcZn with the same cells in serum free 
medium, whereas low density lipoproteins and globulins decrease the dye 
uptake.[75] 
Analysis of tumor growth indicates that malignancies have a high demand for 
cholesterol. Thus PcGe bearing two axially ligated cholesterol moieties, injected 
into mice bearing an intramuscularly implanted MS-2 fibrosarcoma, is 
quantitatively transferred and localized in the tumor tissue with good efficiency.[76] 
Pharmacokinetic studies have pointed out that the hydrophobic Pc’s become 
largely associated with serum lipoproteins and can be administered in association 
with liposome as delivery system. In liposomal formulation it is important that PcZn 
should be in monomeric and not in aggregated form.[77] 
A different approach to tumor affinity is the covalent binding of the sensitizer to 
monoclonal antibodies directed against antigens present at the surface of 
malignant cells. This selective phototoxicity has been achieved in vitro by targeting 
PcAlSn with monoclonal antibodies directed against a human bladder carcinoma 
cell line [78] 
The details of chemical structure ‘in and around’ the phthalocyanine macrocycle, 
are determinants of biodistribution. Thus differences in tissue localization were 
observed in a series of Pc’s chelated with either Al or Zn and sulfonated to 
different degrees, as studied in vivo in rats. Al dyes showed highest fluorescence 
signal and seemed superior tumor localizers over Zn dyes. Increasing peripheral 
sulfonate groups favor tumor localization. Overall the ratios tumor/normal tissue 
distribution decrease in the following order: PcAlS4≥ PcAlS2> PcZnS4> PcZnS2> 
PcAlS1> PcZnS1.[79] 
In addition to the chemical structure of the sensitizer, the biodistribution and 
cellular uptake depends on the specifics of the biological tissue. The comparative 
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distribution of PcAlS4 and PcAlS2 administered in rat was higher in colon and 
colon wall structures, in murine fibrosarcoma, in bladder and bladder carcinoma. 
The duodenal concentration of PcAlS2 was much higher than stomach and 
pancreas observed after 24 h administration in Chinese Hamster.[80] 
 
1.10 Photodynamic activity 
 
Once localized in the biological tissues and activated by light, the sensitizer 
initiates a cytotoxic chain of events whose details are not yet completely clear. The 
presence of molecular oxygen is determinant in photo toxicity of Pc’s and the 
photosensitized oxidation is the accepted basis for photodynamic action.[81] 
Photosensitizer
Light
Activated 
photosensitizer
Substrate
Type II Reaction
1O2
O2
Products of 
oxidation
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Radicals
Radical ions
Substrate1O2
Products of 
oxidation
 
Figure 15: Type I and Type II reaction in photodynamic therapy. 
 
It is widely accepted that the PDT process goes through two pathways. Both begin 
with the absorption of light. The light excites the photosensitizer from its ground 
state to its excited singlet state. The excited photosensitizer decays back to its 
ground state in many ways. If it decays directly to the ground state, the absorbed 
energy is released in the form of light resulting into fluorescence. Photosensitizer 
may undergo intersystem crossing (ISC) to its excited triplet state. Two types of 
reactions may occur when photosensitizer releases energy while going back from 
excited triplet state to the ground state. Type I reaction may occur, if excited 
photosednsitizer reacts with the oxygen in the cells to form hydroxyl (.OH) or 
superoxide (.O2-) radicals which damage or destroy the cells. Type II reaction 
occurs when it transfers its energy to nearby oxygen to produce singlet oxygen 
(1O2) which is the most toxic among the reactive oxygen species. Type I reactions 
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generally predominate at low oxygen concentrations and high photosensitizer 
concentrations, while Type II reactions predominate at high oxygen 
concentrations. Biological studies have shown that Type II reactions are dominant 
in normal PDT conditions.[81] 
 
1.11 Phthalocyanines/naphthalocyanines and PDT 
 
A silicon phthalocyanine, Pc 4, shown in figure 16 has attracted considerable 
interest as a PDT agent since it was reported for this use in 1993.[82] Biological 
studies have shown that Pc 4 has good phototoxicity against V79 Chinese 
Hamster cells, MCF-7v cells and MCF-7c3 cells,[83] human erythrocyte ghosts and 
liver microsomes in vitro and mouse tumors in vivo[84]. This photosensitizer 
contains an aminosiloxy and a hydroxyl ligand on axial positions of the silicon 
central metal. It has strong absorption in red (∼670 nm), minimum tendency to 
produce cutaneous photosensitivity after 
PDT treatment.[85] 
In addition to porphyrins and Pc’s also 
naphthalocyanines (Nc’s) have been used 
as photosensitizers in PDT. Nc’s are of 
particular interest due to their absorption 
maxima in the range of 750 to 800 nm, 
where light penetration through skin and 
tissues is approximately twice for that of Pc’s at 630 nm.[86] This would allow 
treatment of larger and more deeply lying tumors.[87] Several peripherally 
substituted metal naphthalocyanines have been synthesized and studied for their 
use in PDT by various research groups.[88] 
A silicon naphthalocyanine bearing two methoxyethylenglycol axial ligands 
(NcSi1) to the centrally coordinated metal ion (figure 17) was assayed for the 
phototherapeutic activity against Lewis lung carcinoma or B16 pigmented 
melanoma in mice. Photodynamic therapy after 24 h of NcSi1 injection causes an 
efficient tumour response for Lewis lung carcinoma while the pigmented 
melanoma shows only a minor response regarding the rate of tumour growth. The 
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Figure 16: Structure of Pc 4.
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pharmacokinetic behavior and phototherapeutic effectiveness of bis(di-
isobutyloctadecylsiloxy)silicon naphthalocyanine (NcSi2, figure 17) incorporated 
into liposome have been studied in Balb/c mice bearing an MS-2 fibrosarcoma, 
shows that it is a highly effective photosensitizer for PDT of tumors.[89] 
Bis(tert-butyldimethylsiloxy, NcSi3), bis(dimethylhexylsiloxy, NcSi4), bis(tri-n-
hexylsiloxy, NcSi5), and bis(dimethyloctadecylsioxy, NcSi6)silicon 
naphthalocyanines (figure 17) were prepared via substitution of the bis(hydroxy) 
precursor with the corresponding chlorosilane ligands. They were evaluated as 
potential photosensitizers for the photodynamic therapy (PDT) of cancer in vitro 
against V-79 cells and in vivo against the EMT-6 tumor in Balb/c mice. In vitro all 
four dyes showed limited phototoxicity combined with substantial dark toxicity. 
Surprisingly, in vivo all dyes induced tumor regression in at least 50% of mice 
whereas NcSi4 gave a complete tumor response in 80% of mice without apparent 
systemic toxicity at doses as high as 10 pm/kg.[90] 
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NcSi4 = OSi(CH3)2C(CH2)4CH3
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Figure 17: Bis axially substituted silicon naphthalocyanines. 
 
Four zinc naphthalocyanines, unsubstituted (NcZn1), tetraacetylamido substituted 
(NcZn2) tetraamino substituted (NcZn3) and tetramethoxy substituted (NcZn4), 
as shown in figure 18, incorporated into 
liposome have been injected to male 
C57/Black mice bearing a transplanted 
Lewis lung carcinoma. The 
pharmacokinetic investigations show that 
three of the four NcZn’s, are good tumor 
localizers in Lewis lung carcinoma except 
tetramino substituted NcZn3. The lowest 
tumor concentration as well as the lowest phototherapeutic effect was also 
established with tetraamino substituted NcZn3. PDT of rhabdomyosarcoma was 
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Figure 18: Tetrasubstituted zinc naphthalocyanines.
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carried out using liposome-delivered NcZn’s. The best effect was found after PDT 
with tetraacetylamido substituted NcZn2 where 50% of the treated animals were 
cured.[91] 
 
1.12 Glycosylation  
 
The preparation of complex carbohydrates has emerged as a major focus in 
synthetic organic chemistry due to many important roles of this class of molecules 
in biology.[92] The most important reaction in the chemical synthesis of 
carbohydrates is the formation of glycosidic bond which is primary means of 
controlled assembly of comlex oligosaccharides and glycoconjugates from 
monosaccharide precursors. A general description of glycosidic bond formation is 
given in the figure 19.[93] The process starts with a carbohydrate coupling partner 
which is subjected to initial derivatization whereby the anomeric substituent is 
transformed into a good leaving group (LG). The resulting intermediate is isolated 
and anomeric leaving group is activated with an appropriate glycosylation 
promoter or catalyst. This process usually takes place in the presence of a 
nucleophilic glycosyl donor (aglycon), which undergoes displacement of leaving 
group to form the anomeric bond in the product glycoside.[93] 
 
O
OH
(RO)n
O
LG
(RO)n
O
Nu
(RO)n
NuH
 
Figure 19: General description of glycosidic bond formation. 
 
The first synthesis of glycosidic linkage was the coupling of peracetylated glucosyl 
chloride to potassium phenolate in ethanol, which was reported by Michael in 
1879.[94] Since then, carbohydrate synthesis has evolved into a thriving field with 
an abundance of methods for the formation of the glycosidic linkage. The most 
common donors and their interconversions are summarized in figure 20.[95] 
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Figure 20: Examples of donor interconversions. 
 
Glycosidic bonds can be formed either through an SN2 type mechanism, usually 
under basic conditions with glycosyl halides, or through an SN1 type mechanism 
under acidic conditions. The stereochemical outcome of Lewis acid-promoted 
glycosylations is influenced by several factors. The anomeric effect generally 
directs the aglycon to the thermodynamically preferred axial orientation. However, 
participating groups (e.g., esters) at C2 can interact with the intermediate 
oxacarbenium ion to form a cyclic dioxolenium ion. The dioxolenium ion is 
subsequently opened by the acceptor in an SN2 manner, which results in a 1,2-
trans-glycosidic bond.[96] 
 
1.12.1 Use of glycosyl acetates 
 
Glycosyl acetates can be activated by Lewis as well as Brønsted acids (Helferich 
conditions) and used as donors in aromatic O-glycosylations (scheme 1). The 
strength of glycosyl acetates as donors in glycoside synthesis lies in their 
simplicity, i.e. the peracetylated compounds are inexpensive and either 
commercially available or easily synthesized in one step from the corresponding 
free sugars. The yields of aromatic O-glycosylation using anomeric acetates are 
usually lower compared to trichloroacetimidates. One reason is the anomerization 
of both the starting material and the product. For example, in a few hours using 3 
equiv of BF3·Et2O peracetylated β-glucose pentaacetate anomerized to α-glucose 
pentaacetate, which was shown to be inert.[97] 
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Typical aromatic β-glycosylations are performed in dichloromethane as solvent 
with equimolar amounts of BF3·Et2O and reactants for 1–24 h at room temperature 
(scheme 1). SnCl4, p-toluenesulfonic acid and other Lewis acids have also been 
used, but most often with substantially lower yields.[98] 
 
O
OAc
AcO
O
OPh
AcODCM, RT, 24h
BF3
.OEt2, Phenol
 
Scheme 1: General BF3·Et2O catalyzed aromatic O-glycosylation. 
 
The yields and reaction rates are clearly dependent on the nucleophilicity of the 
phenol; electron donating groups (e.g., alkoxy) usually give better yields. 
Generally, substituents in the ortho-position tend to give lower yields irrespective 
of the electronic properties (scheme 2).[99] 
 
O
OAc
AcO
O
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AcODCM, RT, 48h
BF3
.OEt2, Phenol
R1
R2a: R1= OMe, R2= H
b: R1= H, R2= OMe  
Scheme 2: Examples of BF3·Et2O catalyzed aromatic O-glycosylation. 
 
Anomeric trifluoroacetates have been used for the synthesis of a number of 
aromatic glycosides.[100] The trifluoroacetate was activated either by BF3·Et2O or 
trimethylsilyltriflate (TMSOTf) and gave good yields (85–90%) using activated 
aromatic aglycons. Deactivated aromatic acceptors gave lower yields using 
BF3·Et2O, but the yields could be improved using TMSOTf (scheme 3). The 
drawback of this method is the multi-step synthesis of donor. Perbenzoylated 
glucose has also been used as donor and gave an excellent yield of α-glucoside 
upon prolonged reaction times (scheme 3).[101] There are also examples of the use 
of other anomeric benzoates.[102] 
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Scheme 3: Reagents and conditions: (a) p-nitrophenol, BF3.Et2O, CH2Cl2, -20 oC, 50 min, 
62% (b) p-nitrophenol, TMSOTf, CH2Cl2, 20 oC, 50 min, 80% (c) phenol, BF3.OEt2, CH2Cl2, 
50 oC, 48 h. 
 
1.12.2 Use of glycosyl halides 
 
Glycosyl halides are by far the most used carbohydrate donors for aromatic O-
glycosylation. Of these, the vast majority are glycosyl bromides. Glycosyl 
bromides are generally more reactive compared to glycosyl chlorides, yet not as 
unstable as the corresponding iodides. There are very few examples of aromatic 
O-glycosylations using glycosyl iodides.[103] 
Generally, the glycosyl halides give less than 60% yield of the product but their 
strength lies in their simplicity and well-known procedures; they are especially 
useful for glycosylation under basic conditions. Glycosyl bromides are usually 
isolated as the thermodynamically favored α-anomer and glycosylation generally 
results in the inversion of stereochemistry. 
In these reactions, the glycosyl bromide is dissolved in dichloromethane or 
chloroform and a water/methanol solution of the base (NaOH, K2CO3 or LiOH) is 
added together with a suitable phase transfer catalyst (PTC) such as 
tetrabutylammonium salts or crown ethers. A few typical examples are shown in 
Scheme 4. The synthetically challenging compound S1 was prepared using the 
corresponding protected glucosyl bromide under PTC conditions, which gave 
better results compared to both acetate and trichloroacetimidate donors.[104] 
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Scheme 4: Reagents and conditions: (a) appropriate phenol, K2CO3, CHCl3, BnEt3NCl, rt, 2 d 
(b) appropriate phenol, n-Bu4NBr, CHCl3, NaOH 60 oC, 6 h (c) appropriate phenol, n-Bu4NBr, 
CH2Cl2, NaOH rt, 45 min. 
 
An anionic exchange resin was used for the formation of nitrophenoxides and 
subsequent glycosylation, which provided the products in yields from 40% up to 
98% as shown in scheme 5.[105] The use of DMF as a solvent resulted in increased 
formation of 2-substituted glycols, which are produced by elimination. Apparently, 
due to less β-elimination, galactose generally seems to give better yields 
compared to glucose as illustrated in schemes 5.[106] 
O
Br
O O
R1
R2
R3
OAcOAc
AcO
AcO
OAc
OAc
AcO
AcO
O
Br
O O
R1
R2
R3
OAc
AcO
AcO
OAc
AcO
AcO
AcO AcO
a
a
a: R1=NO2, R2=R3=H
b: R1=R3=H, R2=NO2
c: R1=R2=H, R3=NO2
 
Scheme 5: Reagents and conditions: (a) appropriate phenol bound to Amberlyst A-26, 2-
propanol, rt, 8 h. 
Another general observation is that aromatic residues with electron-withdrawing 
groups tend to give better yields, possibly due to easier deprotonation and 
subsequent phase transfer. A few examples are given in scheme 6.[107] 
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O
Br
O O
R
OAcOAc
AcO
AcO
OAc
OAc
AcO
AcO
a a: R=NO2b: R=Br
c: R=H
d: R=Me
e: R=OMe
 
Scheme 6: Reagents and conditions: (a) appropriate phenol, NaOH, CHCl3, BnEt3NBr, 60 
oC, 3 h. 
PTC conditions have also been used in a solid phase approach.[108] Apart from 
Michael type reactions, glycosyl halides can be activated using the Koenigs–Knorr 
procedure, i.e., the use of silver salts (e.g., Ag2CO3,[109] AgOTf[104] or Ag2O[110]) or 
mercury salts.[104] Typical solvents are CH2Cl2,[104] quinoline[110] and pyridine.[110] 
Glycosyl fluorides are relatively stable (both α and β), which facilitates synthesis 
and purification but hampers their use as donors in glycosylation reactions. For 
aromatic O-glycosylations, the use of BF3·Et2O is most common and typical 
reaction conditions are given in scheme 7. 
The addition of a hindered base (1,1,3,3 tetramethylguanidine) resulted in 
excellent β-selectivity,[111] and also lowered the amount of C-glycosides 
formed.[112] Another promoter system that gives good yield is Cp2HfCl2/AgClO4.[113] 
Finally, glycosyl fluorides have been used in Michael type reactions using sodium 
phenolate in ethanol–CH2Cl2.[114] 
O
F
OAc
AcO
AcO
AcO
O
OAc
AcO
AcO
AcO
Oa or b
 
Scheme 7: Reagents and conditions: (a) 1-naphthol, BF3·Et2O, CH3CN, rt, 3 h (b) 1-naphthol, 
BF3·OEt2, 1,1,3,3-tetramethylguanidine, CH3CN, rt, 3 h. 
 
1.12.3 Use of glycosyl trichloroacetimidates 
 
Anomerically pure trichloroacetimidates can be synthesized from the 
corresponding hemiacetal by treatment with trichloroacetonitrile in CH2Cl2 and a 
suitable base (K2CO3 for β-imidate, NaH for α imidate or DBU for an anomeric 
mixture).[104,115] 
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O
AcO O
Cl3C
NH
O
AcO
OPhBF3
.OEt2, Phenol
DCM, -40 oC, 3-12h
 
Figure 21: General trichloroacetimidate reaction. 
 
Typical aromatic β-glycosylations using trichloroacetimidates are performed in 
CH2Cl2 as solvent, using a sub-stoichiometric amount of the promoter, usually 
BF3·Et2O. There are also examples of reactions run in dichloroethane,[116] 
acetonitrile[117] or diethylether.[118] BF3·Et2O is the far most common promoter 
(>90%) but there are examples of other promoters such as TMSOTf,[117,119] 
AgOTf[120] and even LiClO4 (which was used as a nearly neutral system).[117] 
Normal temperatures are between - 40 oC up to room temperature but there are 
examples of reactions run at -78 oC[121] and in CH2Cl2 at reflux.[122] Even if the 
reaction is likely complete in a few minutes, typical reaction times are 3-12 h. 
Some examples of compounds synthesized using the trichloroacetimidate 
methodology is shown in figure 22.[123] Among other imidates used for glycoside 
synthesis was an N-methylacetimidate[124] used for aromatic O-glycosylation. 
Another example is the use of an N-phenyltrifluoroacetimidate for the synthesis of 
flavonoid 7-O-glucosides.[125] 
OAcO
OAc
AcO
AcO
O
OAc
(CH2)9SO(CH2)3C2F5
OAcO
AcO
AcO
OAc
O O O
NHCOPh
OBnO
OBn
BnO
BnO
O
COOMe
OAc
OAcO
MeOOC
AcO
AcO
O
N
O
F
AcO
I
 
Figure 22: Examples of compounds synthesized using the trichloroacetimidate methodology. 
 
1.12.4 Use of thioglycosides and related compounds 
Thioglycosides are relatively stable carbohydrate derivatives that can be activated 
by thiophilic reagents, usually iodonium species generated from, for example, N-
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iodosuccinimide and triflic acid (NIS/TfOH, figure 23). There are also anomeric 
sulfoxides as well as a few examples of glycosylselenides and -tellurides used for 
aromatic O-glycosylation. Generally, the thioglycosides give lower yields 
compared to other donors. 
O
SRAcO
O
OPhAcO
NIS/TfOH, Phenol
DCM, -40oC, 30 min.  
Figure 23: General thioglycoside reaction. 
 
Despite the fact that thioglycosides are the most popular donors in carbohydrate 
synthesis (approx 50% of all donors used in carbohydrate synthesis in the year 
2000 were thioglycosides),[126] they are not frequently used for aromatic O-
glycosylation. The major reason is probably incompatibilities between the 
promoter systems used for thioglycoside activation and the aromatic residues. In 
particular, activated aromatic compounds are prone to react with iodonium ions, 
an observation that has been used for the synthesis of iodoarenes.[127] The 
aromatic residues that have been glycosylated using thioglycosides are usually 
relatively simple phenols and the yields are moderate to good. A few examples are 
given in scheme 8. 
O
SPh
OAc
AcO
MeO
O
O
OAc
AcO
MeO
I
OTBDPS
OMe
OMe
O
BnO
O
SPh
OAc
AcO
AcO
SEt
OBn
OBn
O
BnO
OBn
OBn
Cl
NO2
O
O
OAc
AcO
AcO
CHO
a
b
c
 
Scheme 8: Reagents and conditions: (a) appropriate phenol, NIS, TMSOTf, CH2Cl2, 4A˚ MS, 
0 oC, 2 h (b) appropriate phenol, NIS, TMSOTf, CH2Cl2, - 42 oC, 30 min (c) appropriate 
phenol, NIS, TfOH, CH2Cl2. 
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The difficulties using thioglycosides for aromatic O-glycosylation stimulated the 
development of a new promoter system, that is, N-(phenylthio)-ε-caprolactam S2, 
which was used to synthesize compound S3 in 85% yield (Scheme 9).[128] 
O
OBn OTBDPS
AIIO
OBz
STol
O
OBn OTBDPS
AIIO
OBz
O
OMe
MeO
S3S
N
O
S2  
Scheme 9: Appropriate phenol, 60, MS AW-300, Tf2O, CH2Cl2, - 45 oC to rt, 1 h. 
 
Glycosyl sulfoxides were introduced for glycosylation of unreactive substrates, 
such as phenols, in 1989.[129] Thioglycosides can easily be oxidized to sulfoxides, 
which can be used as donors by activation with triflic anhydride (Tf2O). 
Interestingly, the α/β-ratios can be controlled by careful choice of protecting 
groups and solvent as shown in scheme 10. 
O
OBn
BnO
BnO
OBn
S
O
Ph
O
OBn
BnO
BnO
OBn
O
O
OPiv
PivO
PivO
OPiv
S
O
Ph
O
OPiv
PivO
PivO
OPiv
O
a
b
 
Scheme 10: Reagents and conditions: (a) appropriate phenol, Tf2O, 2,6-di-t-butyl-4-
methylpyridine, toluene, - 78 oC (b) appropriate phenol, Tf2O, 2,6-di-t-butyl-4-methylpyridine, 
CH2Cl2, - 78 oC. 
 
Subsequently, the methodology was used for glycosylation of 2,6-
dimethoxyphenol, activated as the tributyltin derivative, in an excellent 92% 
yield.[130] One problem associated with the use of Tf2O for activation was 
interference with amides, but this could be suppressed by pretreatment with 
BF3·OEt2.[131] The analogous sulfimides, formed from the thioglycoside by reaction 
with chloramines T, can also be used for glycosylation, upon activation with 
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Cu(OTf)2/CuO.[132] Sulfimides have been used for glycosylation of p-
methoxyphenol in excellent yields (scheme 11). 
O
OAc
AcO
AcO
OAc
S
NTS
Et
O
OAc
AcO
AcO
OAc
O
OMe
a
 
Scheme 11: Reagents and conditions: (a) p-methoxyphenol, Cu(OTf)2, CuO, 4A˚ MS, 
CH2Cl2, rt, 2.5 h. 
 
1.12.5 Other methods for aromatic O-glycosylation 
 
Carbohydrate derivatives unsubstituted at the anomeric centre can be used 
directly, either by in situ activation or by using the carbohydrate as the nucleophile. 
Other possibilities are glycals and anomeric phosphates; Fischer glycosylation is 
usually not viable. 
 
1.12.5.1 Mitsunobu reaction 
 
Carbohydrate hemiacetals can be activated in situ by using Mitsunobu conditions. 
The sugar hemiacetal and a suitable phenol are stirred with triphenylphosphine 
and diethyl azadicarboxylate (DEAD) to give aromatic glycosides. Perbenzylated 
2-naphthyl glucoside S4[133] and α-L-arabinopyranoside S5[134] were thus 
synthesized according to scheme 12. 
O
OAc
AcO
OAc
OH
O
OAcOAc
AcO
OAc
Ob
OAc
O
OBnOBn
BnO
OBn
O
O
OBn
BnO
OBn
OBn
OH
a
S4
S5  
Scheme 12: Reagents and conditions: (a) 2-naphthol, PPh3, DEAD, THF, 0  oC to rt, 12 h (b) 
2-naphthol, PPh3, DEAD, toluene, 0 oC, 2.75 h. 
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Mitsunobu conditions were also used for glycosylation of calixarenes in 
toluene.[135] The reaction of calix[4]-arene with 1.1 equivalent of 2,3:5,6-di-O-
isopropylidene-α-D-mannofuranose using 1.5 equivalent of DEAD and PPh3 in 
toluene gave monoglycosylated compound S6 in 71% yield (scheme 13). 
Bisglycosylation using tetraacetyl α/β-D-glucopyranose (2.2 equiv) gave 50% yield 
of a mixture of the α, α - and α, β -diglucopyranosides. 
O OO
OH
O OO
O
OH
3
S6
a
 
Scheme 13. Reagents and conditions: (a) calix[4]arene, PPh3, DEAD, toluene, 70 oC, 30 
min. 
 
Finally, Mitsunobu glycosylation was evaluated using several different phenols, 
where the acidity of the phenols was varied using electron donating or withdrawing 
substituents in the para-position (scheme 14).[136] The yields were clearly 
dependent on the acidity of the phenols, that is, the least acidic compounds gave 
low yields. 
O
MeOOC
AcO
AcO
AcO
OH
O
MeOOC
AcO
AcO
AcO
O
RR= NO2, Br, H, Me, OMe
a
 
Scheme 14: Reagents and conditions: (a) appropriate phenol, PPh3, DEAD, THF, rt, 24 h. 
 
1.12.5.2 Nucleophilic aromatic substitution 
 
Carbohydrate hemiacetals can also be used as the nucleophile in aromatic 
substitutions using activated fluoroarenes. Unprotected glucose and nine other 
unprotected mono and disaccharides were reacted with 1-fluoro-2,4-
dinitrobenzene in saturated aqueous NaHCO3 solution to give the corresponding 
β-glycosides in 15–30% yield.[137] The low yields can be explained by the 
formation of both α - and β -pyranosides as well as furanosides, but the simplicity 
makes the method valuable. Reaction with acetylated compound S7, using 1,4-
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diazabicyclo- [2,2,2]octane (DABCO) as base, gave 80% yield of S8 which could 
be converted to the α-anomer with K2CO3 in DMF.[138] 
Glycosides of methyl 2-hydroxy-3,5-dinitrobenzoate (DISAL, e.g., compound S9) 
are used for glycosylation under neutral or mildly basic conditions. These 
glycosides are synthesized from methyl 2-fluoro-3,5-dinitrobenzoate under basic 
conditions as exemplified by compound S9 (scheme 15).[139] The anomeric ratio of 
the product was directed by the anomeric ratio of the starting material, that is, the 
pure α -hemiacetal gave an 8.4:1 α:β ratio. 
O
AcO
AcO
AcO
OH
O
AcO
AcO
AcO
O
NO2
OAc OAc NO2
O
BnO
BnO
BnO
OH
O
BnO
BnO
BnO
O
NO2
OBn OBn COOMe
O2N
S7 S8
S9
a
b
 
Scheme 15: Reagents and conditions: (a) 1-fluoro-2,4-dinitrobenzene, DABCO, DMF, rt, 90 
min (b) methyl 2-fluoro-3,5-dinitrobenzoate, Li2CO3, DMAP, CH2Cl2, rt, 0.5 h. 
 
1.12.5.3 Use of glycals 
 
An unusual aromatic O-glycosylation was performed by Helferich et al. where 
glucal S10 was reacted with 9,10- phenanthrenequinone in a UV-promoted [4+2] 
cycloaddition to give compound S11 in 50% yield (scheme 16).[140] S11 was then 
subsequently opened by ozonolysis to remove the aromatic moiety. 
O
OAc
AcO
AcO
O
OAc
AcO
AcO
O
O
S10
S11  
Scheme 16: Reagents and conditions: (a) 9,10-phenanthrenequinone, hν, benzene. 
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Glucals can also be oxidized to the corresponding α-1,2-anhydroglucoside by 
treatment with 3,3-dimethyldioxirane. The anhydrosugar can then react with 
nucleophiles such as phenols (scheme 17).[141] Danishefskyet al. noted that 
anhydroglucoside S12 reacted slowly with phenol under Lewis acidic conditions 
(ZnCl2) to give a 1.8:1 ratio of α- and β-phenylglucoside S13. However, reaction 
with potassium phenolate gave a clean conversion to the β -glucoside without any 
trace of the α-anomer.[141] Glycal derivatives with good leaving groups at the allylic 
position are readily converted into aryl 2,3-unsaturated aldosides by heating with 
phenols.[142] 
O
OBn
BnO
BnO
O
OBn
BnO
BnO
O
O
OBn
BnO
BnO
HO
O
a
b
S12
S13
 
Scheme 17: Reagents and conditions: (a) 3,3-dimethyldioxirane, acetone, CH2Cl2, 0 oC, 10 
min (b) phenol, K2CO3, 18-crown-6, acetone, reflux, 4 h. 
 
1.12.5.4 Use of glycosyl phosphates 
 
Anomeric phosphates were introduced as synthetic carbohydrate donors by 
Ikegami and co-workers,[143] and compound S14 was synthesized in an excellent 
92% yield (scheme 18). It was later shown that O-glycosides were formed in good 
yields (79%) in 15 min but then rearranged to C-glycosides on prolonged reaction 
times (3 h, scheme 19).[144] Anomeric dimethylphosphinothioates gave aromatic 
glycosides in moderate yields (79%, α:β 65:35 for p-methoxyphenol) upon 
activation by silver perchlorate.[145] 
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O
OBz
BzO
BzO
OBz
O
P
PhO
OPh
O
O
OBz
BzO
BzO
OBz
O
H
H
H
H
O
S14
 
Scheme 18: Reagents and conditions: 
Phenol, TMSOTf, 1,1,3,3-tetramethylurea, 
CH2Cl2, rt, 1h. 
O
OBn
BnO
BnO
OBn
P
PhO
OPh
O
O
O
OBn
BnO
BnO
OBn
O
O
OBn
BnO
BnO
OBn
HO
 
Scheme 19: Reagents and conditions: 2-
naphthol, TMSOTf, CH2Cl2, 0 oC. 
 
1.12.5.5 Glycosylation by biotransformation 
 
Despite the natural abundance of aromatic glycosides, there are few examples of 
biotransformations for glycosylation of phenolic compounds. Kieslich et al. 
published glucosylations of a number of aromatic compounds, exemplified by the 
reaction with Sporotrichum sulfurescens, which gave 4-O-methylated glucoside 
S15, and Rhizopus colinii, which gave S16 (scheme 20).[146] 
HO
HO
HO
OO
OH
RO
HO
OH
          R 
S15 = H 
S16 = Me
 
Scheme 20: Reagents and conditions: (a) Sporotrichum sulfurescens, 60 h (b) Rhizopus 
colinii, 90 h. The medium contained 3% glucose. 
 
Recently, capsaicin was glucosylated to give compound S17 in 50% yield by 
Phytolacca americana (scheme 21).[147] There are several examples of 
glycosylations using UDP activated glucose[148] or glucuronic acid.[149] A wide 
range of phenols were tested for UDP-glucose dependent glycosylation by 
Rauvolfia arbutin synthase and gave yields from 0.8% up to 100%.[148] Other 
sugars (e.g., L-noviose) can also be used by specific enzymes (e.g., L-noviosyl 
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transferase).[150] Recently, use of nucleotide diphosphosugars (NDP-sugars) was 
presented for glycorandomization using a large set of carbohydrates and four 
aromatic aglycons,[151] and a similar approach was used for randomization of 
vancomycin.[152] 
HO
MeO
H
N
O
O
MeO
H
N
O
O
OH
HO
HO
OH
S17
 
Scheme 21: Reagents and conditions: (a) Phytolacca americana, 25 oC, 3 days. The 
medium contained 3% sucrose. 
 
1.13 Glycosylated phthalonitriles and naphthalonitriles 
 
Phthalocyanines can be synthesized from a variety of starting materials such as 
treatment of o-dibromoarenes and its derivatives with CuCN in boiling DMF 
furnishes CuPc, whereas phthalic acid, phthalic anhydride, phthalimide, 
phthalamide and cyanobenzamide and their derivatives can be converted to metal 
and metal free phthalocyanies using several possibilities (p. 3,4).[13-15,153] Each 
individual precursor however possesses certain limit of advantages and 
disadvantages associated with it. Among all the known phthalocyanine precursors 
phthalonitriles are the most widely used starting materials for the synthesis of 
metal as well as metal free Pc’s. Owing to their high reactivity and possibility in the 
ease of modification and substitution on the aromatic ring which results into the 
formation of many derivative of phthalonitriles, these precursors furnish 
corresponding phthalocyanines in relatively high yield.[13] 
Selective glycosidic bond formation in order to gain chemically well defined 
oligosaccharides and glycoconjugates is probably the most significant challenge of 
carbohydrate chemistry today. Although great achievements in the development of 
versatile and efficient glycosylation and building block strategies have been made 
during the last years, there is still need for more efficient procedures to prepare 
glycoconjugates.  
Glycosylated phthalonitriles are not very common in literature. The first example of 
glycosylated phthalonitriles comes from Hanack-Ziegler and coworkers.[154] These 
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phthalonitriles (figure 24) were synthesized by nitrite substitution in 4-
nitrophthalonitrile when it was reacted with anomerically deprotected glucose in 
DMF or DMSO, while NaH or K2CO3 was used as base. SNAr displacement of 
nitro group in 4-nitrophthalonitrile proved to be an efficient method leading to 
monoglycosylated phthalonitrile product in high yield at ambient reaction 
conditions. The reaction was further studied with different glycons protected with 
benzyl (Bn), benzoyl (Bz) or acetyl (Ac) groups while anomeric carbon was 
attached with OH or SH groups as shown in figure 24.[155] All sugar substrates 
were successfully conjugated to form glycosylated phthalonitriles in good to 
excellent yields. 
O
OR2
R3O
R2O
R1
XH
O
OR2
R3O
R2O
R1
CN
CNCN
CN
O2N
1,3a R1= OBn, R2,R3= Bn, X= O
1,3b R1= OBz, R2,R3= Bz, X= O
1,3c R1= OAc, R2,R3= Ac, X= O
1,3d R1= OAc, R2,R3= Ac, X= S
1,3e R1= NPhth, R2,R3= Ac, X= O
1,3f R1= OBz, R2= OBz, R3= ß-BzGal, X= S
X
+
 
Figure 24: Synthesis of glycosylated phthalonitriles. 
 
The above described method has been successfully used by other research 
groups to synthesize glycophthalonitriles by using 3- or 4-nitrophthalonitriles. 
Substitutions of nitrite in these phthalonitriles with a number of glycons containing 
OH groups at different positions of sugar moiety leads to satisfactory yields of 
corresponding substituted products. From experimental data it is known that the 
yields in case of reacting the same substrate with 3-nitrophthalonitrile is lesser 
than that of 4-nitrophthalonitrile. A number of glycosylated phthalonitriles 
synthesized so far have been shown in figure 25.[156] 
CN
CN
R2
R1
ROH
CN
CN
R4
R3
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Figure 25: 3- or 4-glycosylated phthalonitriles synthesized from 3- or 4-nitrophthalonitrile. 
 
In contrast to the monoglycosylated phthalonitriles, the diglycosylated 
phthalonitriles are not very common in literature. An example of 3,6-diglucosylated 
phthalonitrile linked through polyethylene glycol, has been synthesized by 
nucleophilic substitution of tosylated polyethyleneglycol substituted glucose with 
3,6-dihydroxyphthalonitrile as shown in figure 26.[156] 
O O
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Figure 26: Synthesis of 3,6-diglycosylated phthalonitrile. 
 
3,4,5,6-Tetrafluorophthalonitrile (figure 27), a commercially available reagent, has 
been used to synthesize a tetragalactose phthalonitrile which was subsequently 
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cyclized in mixed condensation with phthalonitrile to form an asymmetrical zinc (II) 
phthalocyanine.[157] 
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Figure 27: Synthesis of 3,4,5,6-tetragalactosephthalonitrile. 
 
1.14 Glycosylated phthalocyanines, synthesis and photodynamic 
studies. 
 
Pthalocyanines have emerged as a promising class of second generation 
photosensitizers for PDT, owing to their strong and long wavelength absorptions, 
high efficiency at generating reactive oxygen species (ROS) and ease of chemical 
modification.[158] Over the last decade, a substantial number of phthalocyanine 
based photosensitizers have been prepared and evaluated for their photodynamic 
activity, with the focus on silicon, zinc and aluminium analogues. To date, several 
phthalocyanine systems such as the silicon(IV) phthalocyanine PC4 (see p. 23) 
and a liposomal preparation of zinc(II) phthalocyanine have been in clinical trials. 
Photosense, which is a mixture of sulfonated aluminium(III) phthalocyanines, is 
clinically used in Russia for the treatment of a number of cancers.[158] 
One of the major challengers in PDT is to develop selective photsensitizers which 
can preferentially accumulate in malignant tissues relative to normal tissues. 
Various approaches have been explored to enhance the photosensitizer 
concentrations in target tissues, which include encapsulation of sensitizer in 
colloidal carriers such as liposomes and polymeric micelles[159], and conjugation to 
tumor specific carrier molecules such as antibodies, synthetic peptides, epidermal 
growth factor and adenoviruses.[160] 
  
 43 
Carbohydrates are also promising candidates for bioconjugation to 
photosensitizers to achieve targeted PDT. It has been known that cancer cells 
have increased level of glucose uptake and glycolysis in order to provide sufficient 
metabolic energy to sustain their proliferation.[161] By taking advantage of this, 
glycoconjugation of various sensitizers such as porphyrins,[162] chlorines,[163] 
pyropheophorbides[164] and hypocrillins[165] have been carried out with a view to 
enhance their PDT efficacy. 
In contrast to carbohydrate-porphyrin conjugates, glycoconjugated 
phthalocyanines are extremely rare despite their great potential in PDT. First 
example of anomerically glucosylated zinc(II) phthalocyanine was synthesized in 
our group by cyclotetramerization of 4-(2,3,4,6-tetra-o-acetyl-α/β-D-
glucose)phthalonitrile in boiling n-butanol/DMAE (2:1) containing zinc acetate and 
subsequent deacetylation of glucose moities under Zemplen’s conditions.[154] 
A series of tetraglycosylated zinc(II) phthalocyanines containing galactose, 
thioglucose, lactose, thiolactose and cellobiose as carbohydrate moieties, were 
further synthesized by using the same method.[166] Later on several other 
researchers synthesized a number of glycoconjugated silicon(IV)[167] and 
zinc(II)[156,157] phthalocyanines and studied their effectiveness in PDT. 
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Figure 28: First example of glycosylated zinc(II) phthalocyanine. 
 
Symmetrically as well as asymmetrically substituted zinc(II) phthalocyanines 
containing a variety of sugar moieties on the periphery of Pc ring have been 
prepared and a few of them have been examined for their in vitro phototoxicity 
using different cancer cell lines. A water soluble asymmetrical phthalocyanine 
starting from condensation of tetrakis(1,2:3,4-di-O-isopropylidene-α-D-
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galactopyranos-6-yl)phthalonitrile with phthalonitrile in refluxing 
dimethylaminoethanol (DMAE) for 12h yielded 30% zinc(II) phthalocyanine 
followed by deprotection of isopropylidene groups with trifluoroacetic acid (TFA) in 
H2O was synthesized and characterized (figure 29).[157]  
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Figure 29: A water soluble asymmetrical zinc(II) phthalocyanine. 
 
Similarly asymmetrical zinc(II) phthalocyanines-β-cyclodextrin dyads were 
prepared via a cross condensation of a 4-(β-cyclodextrin)phthalonitrile with 
phthalonitrile and 4,5-dibutoxyphthalonitrile as shown in figure 30.[156] 
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Figure 30: Asymmetrical zinc(II)phthalocyanines-β-cyclodextrin dyads. 
 
A number of tetraglycosylated zinc(II) phthalocyanines substituted with glucose, 
galactose or glycerol subunits (figure 31) at peripheral positions of Pc ring have 
been synthesized by other authors and studied for their PDT applications.  
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Figure 31: Tetraglycosylated zinc(II) phthalocyanines substituted at α or β position. 
 
Photocytotoxicity of these PcZn’s against HT29 human colon adenocarcinoma and 
HepG2 human hepatocarcinoma cell lines revealed the effect of the position of 
substituents on the Pc ring. Monoglycosylated PcZn’s substituted at either α- or β- 
position of Pc ring were found to be more cytotoxic in nature as compared to the 
tetra-α-glycosylated PcZn’s. Whereas tetra-β-substituted analogues were found to 
be inactive, indicating their negligible cellular uptake due to high aggregation 
tendency of these Pcs in the cellular medium. Galactose substituted PcZn’s were 
more effeicient in the generation of reactive oxygen species in comparison with 
tetraglucosylated zinc phthalocyanines.[156] 
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Figure 32: Synthesis of octasubstituted galactose zinc(II) phthalocyanine. 
 
Comparison of aggregation behavior of tetra-α-glycerol zinc phthalocyanine with 
its β-analogue resulted in higher aggregation tendency of later in water rendering it 
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ineffective against HT29 human adenocarcinoma cells even at higher 
concentrations of 100 μM. Terta-α-glycerol substituted zinc phthalocyanine 
however was being less aggregated attained LD90 value of 35 μM.Only one 
example of octasubstituted galactose zinc(II) phthalocyanine has been found so 
far in literature, which is prepared according to the figure 32.[156] 
Photodynamic activities of a series of silicon(IV) phthalocyanines with different 
axial substituents including the 1,3-bis(dimethlamino)-2-propoxy group, 
isopropylidene protected galactose (figure 33) and glucose and polyethylene 
glycol have been investigated against HT29 and T84 human colon 
adenocarcinoma cells. While these compounds are not cytotoxic in the absence of 
light, they exhibit high photocytotoxicities wit IC50 values as low as 17 nM. The 
most potent compound having a 1,3-bis(dimethylamino)-2-propoxy group and a 
methoxy (figure 33) as the axial substituents, has high and selective affinity to the 
mitochondria of HT29 cells, as revealed by fluorescence microscopy.[167] 
Effect of peripheral chloro substitution on the photophysical properties of axially 
substituted glucose and galactose silicon(IV) phthalocyanines have been studied. 
The non, mono, and dichlorinated phthalocyanines (figure 33) formulated with 
Cremophor EL are all photodynamically active against HT29 human colon 
adenocarcinoma and HepG2 human hepatocarcinoma cells with IC50 values 
ranging from 0.03 to 0.1.05 μM. The photocytotoxicity as well as the efficiency to 
generate interacellular reactive oxygen species decrease along this series 
because of the increase in aggregation tendency upon chloro substitution.[167] 
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Figure 33: Silicon(IV) phthalocyanines with different axial substituents. 
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2 Aim of the work 
 
Aim of the present work is to synthesize glycosylated zinc(II) phthalocyanines and 
naphthalocyanines for PDT investigations. Since there are several structural 
varieties which can be explored in case of sugar substituted phthalocyanines and 
naphthalocyanines, until a very effective structure could be found for PDT 
applications. Therefore we planned to go through the systematic study for the 
synthesis of sugar substituted PcZn’s and NcZn’s. To start with simple structures 
we initially planned to synthesize tetrasubstituted PcZn’s in which sugar moieties 
such as glucose, galactose, maltose, thioglucose and thiogalactose, are attached 
at 1 position of the Pc macrocycle, in order to achieve the structural modification of 
already described tetraglycosylated PcZn’s containing sugar susbtituents at 2 
position of phthalocyanine ring. We further aimed to develop the methods for the 
synthesis of octaglycosylated zinc(II) phthalocyanines and tetraglucosylated 
zinc(II) naphthalocyanines targeted to the following structures. 
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In case of PcZn’s several acetyl protected sugar moieties (X = O, S) e.g. glucose, 
galactose, lactose, cellobiose and maltose were chosen to synthesize 
corresponding acetyl protected octaglycosylated PcZn’s. Deprotection of the 
acetyl groups in these Pc’s should lead to water soluble systems. 
An essential part was to find a new method to prepare substituted phthalonitriles 
which are the most important starting materials for the preparation of substituted 
Pc’s. 
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3 Results and Discussion 
 
3.1 A new method for the preparation of phthalonitriles 
 
Phthalonitriles are the most important starting materials for preparation of metal-
free and metal phthalocyanines.[11,12,25] A common pathway for the preparation of 
phthalonitriles proceeds by the cyano-dehalogenation process known as 
Rosenmund–von Braun reaction.[153] Starting from 1,2-dibromobenzenes and 
reacting them with cuprous cyanide, in refluxing DM .F, this reaction often 
proceeds unsatisfactorily concerning the yields. The harsh reaction conditions and 
subsequent oxidation of nitrile–cuprous halide, for example, with NH4OH/air or O2, 
FeCl3 and HCl, prohibit the presence of many functional groups.[153,168] The use of 
cuprous cyanide also generally leads to the formation of the corresponding copper 
phthalocyanine as a byproduct. 
Earlier, Hanack and coworkers proposed an easier method to prepare substituted 
phthalonitriles from substituted catechols via their corresponding aryl bistriflates. 
The displacement of the triflate groups in catechol triflates by cyanide ions 
proceeded in high yields using zinc cyanide and 
tris(dibenzylideneacetone)dipalladium [Pd2(dba)3] and 1,1’-
bis(diphenylphosphino)ferrocene (DPPF) as catalyst.[169] The mild conditions 
tolerate numerous functional groups and represent an improvement to the 
Rosenmund–von Braun reaction for the synthesis of phthalonitriles.  
Transition metal catalyzed cyanation of halobenzenes is an alternate to 
Rosenmund–von Braun reaction for the preparation of substituted benzonitriles. 
Most common catalysts for exchange of halobenzenes or triflates with cyanide are 
transition metal complexes of the platinum group, especially palladium or nickel 
complexes.[170] In general the cyanation of bromo- and iodobenzenes has been 
performed in the presence of an excess of cyanide sources like sodium, 
potassium, or zinc cyanide and potassium hexacyanoferrate(II) in dipolar aprotic 
solvents like DMF, DMAC, or NMP at 100-160 °C. Various sources for palladium   
such as PdCl2, Pd/C, Pd(OAc)2 and Pd2(dba)3 have been employed successfully 
to convert the halobenzenes into the corresponding benzonitriles.[171] 
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As an other alternative to Rosenmund–von Braun reaction and our earlier triflate 
method for the preparation of substituted phthalonitriles we now introduce 
palladium-catalyzed cyanation of mono- and disubstituted o-dibromobenzenes 
with Pd2(dba)3 and DPPF as the catalyst system (figure 34) in dimethylacetamide 
(DMAC) as solvent with Zn(CN)2 as cyanating agent at a temperature of 100-120 
°C (Table 1). 
Br
Br
R CN
CN
R
DPPF, Pd2(dba)3, Zn(CN)2
PMHS, DMAC, 100-120oC
 
Figure 34: Synthesis of phthalonitriles using a palladium catalyst. 
 
The reaction can be performed without an inert atmosphere, which is otherwise a 
necessary condition for other palladium-catalyzed reactions. The use of inert gas 
was avoided by using a small amount of polymethylhydrosiloxane (PMHS).[172] 
Moreover, we did not find any traces of corresponding phthalocyanine byproduct. 
The reaction also is easier to perform as our earlier described route via 
catecholtriflates. Tris(dibenzylideneacetone) dipalladium, DPPF and Zn(CN)2 was 
used earlier with some iodo- and bromobenzenes as well as aryltriflates which 
react with formation of the corresponding benzonitriles.[173] To the best of our 
knowledge, however, this catalyst system has not been applied for the synthesis 
of phthalonitriles starting with o-dibromobenzenes. 
The exchange of the bromo atoms in o-dibromobenzenes against CN groups 
depends upon the substituents in the para position of the bromo atoms in the 
benzene ring: o-dibromobenzene (1a) itself and the dibromobenzenes 2a– 6a[174] 
with electron-donating substituents in these positions in comparatively short 
reaction times are converted into the corresponding phthalonitriles 1b–6b in yields 
between 80 and 96% (Table 2). This is also true for 3,4-dibromoaniline (7a) and 
3,4-dibromoacetanilide (8a). As expected, 3,4-dibromophenol (10a) is also easily 
converted into the corresponding phthalonitrile 9b; the same applies to the 
protected tert-butyl(3,4-dibromophenoxy)dimethylsilane (9a) leading to 4-
hydroxyphthalonitrile (9b). The latter is probably formed after an initial 
deprotection of 9a to form 10a, which is subsequently converted into 4-
hydroxyphthalonitrile (9b). 
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Table 2: Palladium-catalyzed cyanation of various o-dibromobenzenes. 
Substrate Product Temp 
(oC) 
Time 
(h) 
Yield 
(%) 
1a Br
Br  
1b CN
CN 
100 3 86 
2a 
Br
Br  
2b 
CN
CN 
120 2 80 
3a Br
Br  
3b CN
CN 
110 2 96 
4a Br
Br
MeO
 
4b CN
CN
MeO
 
110 1.5 95 
5a Br
Br
MeO
MeO  
5b CN
CN
MeO
MeO  
120 2.5 90 
6a Br
Br
O
O
 
6b CN
CN
O
O
 
120 2 80 
7a Br
Br
H2N
 
7b CN
CN
H2N
 
110 2 91 
8a Br
Br
AcHN
 
8b CN
CN
AcHN
 
100 1.5 97 
9a Br
Br
TBDMSO
 
9b CN
CN
HO
 
100 2 90 
10a Br
Br
HO
 
10b CN
CN
HO
 
110 1.5 89 
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Substrate Product Temp 
(oC) 
Time 
(h) 
Yield 
(%) 
11a Br
Br
Br
Br  
11b CN
CN
NC
NC  
100 8 72 
12a Br
Br
F
 
12b CN
CN
F
 
100 2 87 
13a Br
Br
F
F  
13b CN
CN
F
F  
100 3 92 
14a Br
Br
O2N
H2N  
14b CN
CN
O2N
H2N  
120 6 62 
15a Br
Br
O2N
O2N  
15b CN
CN
O2N
O2N  
100-
120 
3-5 - 
16a Br
Br
NC
NC  
16b CN
CN
NC
NC  
100 4 73 
17a Br
Br
HO
HO  
17b CN
CN
HO
HO  
100-
120 
3-5 - 
18a 
N
Br
Br  
18b 
N
CN
CN 
100 4 78 
19a Br
Br
O
O
 
19b CN
CN
O
O
 
110 1 93 
 
Also bromine and fluorine in para position to the reacting bromide as in 1,2,4,5-
tetrabromobenzene (11a), 1,2-dibromo-4-fluorobenzene (12a), and 1,2-dibromo-
4,5-difluorobenzene (13a) allow an easy exchange of the bromine atoms against 
CN groups. Fluoro atoms are stable against an exchange reaction with the 
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catalyst system. The specific influence of the para substituents on the reactivity of 
the bromo atoms can be seen especially clearly with 4,5-dibromo-2-nitroaniline 
(14a):[175] only the bromo atom in the para position to the electron-donating NH2 
group is exchanged against the CN group, the strong electron- attracting NO2 
group (σp-NO2 = 0.778) in para position to the second bromo atom prevents its 
exchange. This is supported by the results with 1,2-dibromo-4,5-dinitrobenzene 
(15a)[176] which does not react with formation of the corresponding 
dinitrophthalonitrile 15b. 
Contrary to 1,2-dibromo-4,5-dinitrobenzene (15a), 4,5-dibromophthalonitrile 
(16a)[177] also with two but lesser electron-attracting CN groups (σp-CN = 0.628) in 
para position to the bromine atoms reacts with formation of 1,2,4,5-
tetracyanobenzene (11b) although in somewhat lower yields. In spite of the fact 
that 3,4-dibromophenol (10a) was converted in high yields into the 4-
hydroxyphthalonitrile (9b), 4,5-dibromocatechol (17a) even after a longer reaction 
time could not be reacted to form 4,5-dihydroxyphthalonitrile (17b). This is 
probably due to a partial decomposition of the catalyst because of its reaction with 
catechol 17a. 2,3-Dibromopyridine (18a) also reacts under the applied conditions 
with formation of 2,3-dicyanopyridine (18b) in good yield. Only one 
dibromonaphthalene was investigated: 6,7-dibromo-2,2-dimethylnaphtho[2,3-
d][1,3]dioxole (19a) was converted in a yield of 93% into the corresponding 
naphthalonitrile 19b within one hour at 110 °C. 
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A structural variety of metal phthalocyanines is essential for their applications in 
PDT. Tetra substituted sugar Pc’s at positions 1(α) or 2(β) of Pc ring are possible. 
Similarly sugar moieties can be substituted at 1(α) and 1’(α’) or 2(β) and 2’(β’) 
positions of the Pc macrocycle to get the octasubstituted sugar phthalocyanines. 
Tetraglycosylated Pc’s at positions 2(β) of phthalocyanine ring substituted with 
different sugar moieties have already been synthesized by Hanack-Ziegler and 
coworkers. Now we have planned to synthesize tetra- and octasubstituted sugar 
Pc’s containing sugar moieties at positions 1(α) resulting in tetraglycosylated Pc’s 
and 2(β) and 2’(β’) for the formation of octaglycosylated phthalocyanines. Other 
structural modifications in sugar substituted Pc’s are also possible e.g. 
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Concerning central metal atoms, Zn, Al and In etc. are important and have been 
investigated for their singlet oxygen generation abilities. To start with we have 
chosen Zn as metal ion because of its relatively low toxicity and known singlet 
oxygen generation efficiency. As sugar substituents glucose, galactose, maltose, 
cellobiose and lactose containing O or S atom at anomeric position have been 
selected. 
 
3.2 Synthesis and characterization of 1,8(11),15(18),22(25)-
tetraglycosylated zinc(II) phthalocyanines 
 
3.2.1 Synthesis of tetraglycosylated phthalonitriles 22a-22e 
 
The syntheses of the anomerically glycosylated phthalonitriles 22a-22e (scheme 
22) were carried out by our previously described method[155], through nitrite 
displacement in 3-nitrophthalonitrile (20) with anomerically deprotected glycoses 
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21a-21e. The phthalonitriles 22a-22e with sugar substituents such as glucose 
(22a), galactose (22b), maltose (22c), thioglucose (22d) and thiogalactose (22e), 
were purified by column chromatography using toluene and acetone as eluent to 
furnish white solid in 77-97% yield. Characterization of the glycosylated 
phthalonitriles 22a-22e was carried out with NMR, HRMS(FT-ICR) and elemental 
analysis.  
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Scheme 22: Synthesis of 3-glycosylated phthalonitriles. Reagents and conditions K2CO3, 
DMF, rt, 24h. 
 
1H NMR spectra of these compounds 22a-22e show two distinct regions of signals 
associated with aromatic region of phthalonitriles as well as the signals originating 
from sugar substituents. A representative spectrum of phthalonitrile 22b is shown 
in figure 35. Phthalonitriles 22a-22c containing oxygen atom at anomeric position 
has been assigned α-configuration due to the doublets at 5.83 ppm (J= 3.8Hz) and 
5.88 ppm (J= 3.8Hz) for 22a and 22b respectively, indicative of the presence of 
αH-1 and multiplet at 5.74-5.69 ppm assigned to αH-1 and αH-1’ for compound 
22c. It is further confirmed by 13C NMR spectra of compounds of 22a-22c, which 
show signals at 96.6, 97.6 and 96.0 ppm respectively, assigned to αC-1 of the 
sugar moities of these phthalonitriles. However phthalonitriles 22d and 22e, like 
their respective sugar precursors 21d and 21e, are β-anomers which is obvious 
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from their 13C NMR spectra containing signals at 84.8 and 85.7 which is typical 
signal for βC-1 of the sugar molecules. 
(ppm)
12345678
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Figure 35: 1H NMR spectrum of phthalonitrile 22b measured in CDCl3. 
 
3.2.2 Synthesis of 1,8(11),15(18),22(25)-tetraglycosylated zinc(II) 
phthalocyanines (scheme 23) 
 
Syntheses of PcZn’s 23a-23e turned out to be difficult. Many conventional 
methods were tried until we found a successful route for the syntheses of Pc’s 
23a-23e. First of all phthalonitrile 22a was subjected to acetyl deprotection in 
sugar part by Zemplen’s method [178]. The deprotected phthalonitrile 22a was now 
treated with Zn(OAc)2 2H2O in DMAE at various temperatures ranging from 110-
135 oC, which resulted only in tarry material from decomposition of the starting 
material. Changing solvent from DMAE to DMF did not improve the method. 
Now instead of 22a, the thioglucosylated phthalonitrile 22d was used assuming a 
higher reactivity for tetramerization. Deprotection of the acetyl groups in 22d under 
Zemplen’s conditions [178] followed by evaporation of the solvent, the obtained 
compound was heated at 110 oC in DMF. After sometime the solution turned 
green, zinc acetate was added and the mixture was further heated at the same 
temperature for 12 h. The cooled solution was poured in small amount of water 
and recrystallized from excess acetone to afford PcZn 23d in 27% yield. However 
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this method only worked for the phthalonitriles containing the thiosugars 22d and 
22e. 
Recently, hexamethyldisilazane (HMDS) is found to be an excellent reagent for 
use in the formation of PcM’s from phthalonitriles or phthalimides.HMDS in 
combination with other promoters such as ammonium sulphate or p-
toluenesulfonic acid activates the cyano group of phthalonitrile for intramolecular 
cyclization to give the diiminoisoindoline derivative. This activated HMDS also 
promotes further intermolecular reactions.[179] The possible mechanism is shown 
in figure 36. 
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Figure 36: Mechanism for the formation of phthalocyanine catalyzed by HMDS. 
 
In next attempt phthalonitrile 22a was treated with HMDS, p-toluenesulfonic acid 
(p-TsOH) and Zn(OAc)2 2H2O in DMF at 110-115 oC overnight, leading to the 
conversion of the phthalonitrile 22a into the coresspoing PcZn 23a, however the 
yield was low. 
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Scheme 23: Synthesis of 1,8(11),15(18),22(25)-tetraglycosylated zinc(II) phthalocyanines. 
Reagents and conditions: (i) TMSOTf, HMDS, DMF, Zn(OAc)2.2H2O, 115-120 oC, 15h (ii) 
MeOH, DMSO, NaOMe, rt, 15h. 
In order to improve the yield p-TsOH was replaced by trimethylsilyltriflate 
(TMSOTf), which proved to be successful. Finally all the individual phthalonitriles 
22a-22e were heated with HMDS, TMSOTf, Zn(OAc)2 2H2O and DMF sealed in a 
glass tube, at 115-120 oC to form the corresponding PcZn’s 4a-4e in good yield. 
Purification of the formed Pc’s 23a-23e was carried out by column 
chromatography to obtain the Pc’s 23a-23e which were further recrystallized from 
DCM and hexane. 
Phthalocyanines 23a-23e were characterized by UV/vis, NMR and MALDI-TOF 
data. UV/vis spectra of PcZn’s 23a-23e measured in dichloromethane, show 
intense Q-bands and B-bands which are typical for phthalocyanines. Q-bands of 
Pc’s 23d and 23e are red shifted at 727 nm as compared to anomerically oxygen 
containing Pc’s 23a-23c showing Q-bands at 691, 689 and 693 nm respectively. 
1H NMR signals for compounds 23a-23e although, are broad and not clearly 
  
 58 
defined, however contain signals from sugar as well aromatic phthalocyanine ring, 
in the regions comparable to the parent phthalonitriles 22a-22e. 
Deprotection of acetyl groups in Pc’s 23a-23e was accomplished by catalytic 
amount of NaOMe in methanol/DMSO mixture at room temperature to form the 
PcZn’s 24a-24e in good yields. Pc’s 24a-24e were purified by repeated 
recrystallization from water and acetone and further purified by reverse phase 
HPLC. Pc’s 24a-24e are completely water soluble. For the characterization 
deprotected systems 24a-24e, UV/vis, NMR and MALDI-TOF were used. Red shift 
of 10-15 nm was observed in Q-bands of unprotected Pc’s 24a-24c, at 
wavelengths 702, 704 and 703 respectively, as compared to the acetyl protected 
systems 23a-23c. Whereas in case of sulfur containing phthalocyanines 24d and 
24e, the Q-bands appeared at 710 and 712 nm respectively, showing a blue shift 
of ~15 nm compared to the coressponding acetyl protected PcZn’s 23d and 23e. 
1H NMR spectrum of an unprotected PcZn 24b is shown in figure 37. whereas a 
representative MALDI-TOF spectrum of compound 24d is shown in figure 38. 
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Figure 37: 1H NMR spectrum of PcZn 24b. 
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Figure 38: MALDI-TOF spectrum of compound 24d. 
 
3.3 Synthesis of 2,3,9,10,16,17,23,24-octaglycosylated phthalocyanines  
 
Two types of octaglycosylated PcZn’s have been synthesized and characterized. 
1. Octagalactose PcZn in which the sugar part is attached to the Pc macrocycle 
through its position 6 (scheme 25, p. 63). 
2. The octaglycosylated zinc(II) phthalocyanines in which different sugar 
substituents such as glucose, galactose, maltose, lactose and cellobiose are 
attached with Pc macrocycle through anomeric position (scheme 27, p.69). 
 
3.3.1 Synthesis of 2,3,9,10,16,17,23,24-octagalactose zinc(II) 
phthalocyanines 
 
For the synthesis of 2,3,9,10,16,17,23,24-octagalactose zinc(II) phthalocyanines 
we chose 1,2:3,4-di-O-isopropylidene-α-D-glalactopyranose (25) which is easily 
available from galactose,[180] and which was planned to be attached to the 
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macrocycle via its position 6. In our earlier reported tetraglycosylated Pc’s, the 
sugar moieties were anomerically attached to the Pc macrocycle (see p. 46). 
Here, however, we changed the attachment mode of the galactose residue from 
the anomeric position to position 6 because we anticipated that a better 
recognition by the cancer cells in PDT can be achieved this way. 
 
3.3.1.1 Synthesis of 4,5-di(1,2:3,4-di-O-isopropylidene-α-D-
glalactopyranosyl)-phthalonitrile (27) 
 
As starting material for the synthesis of octaglactose PcZn, coressponding 
phthalonitrile i.e 4,5-di(1,2:3,4-di-O-isopropylidene-α-D-glalactopyranosyl)-
phthalonitrile (27) was needed (scheme 24). Previously, glycosylated 
phthalonitriles were prepared from 4-nitrophthalonitrile by nucleophilic 
displacement of nitrite with a partially protected glycopyranose.[154,155] However, 
attempts to synthesize 4,5-dinitrophthalonitrile starting from 1,2-dibromo-4,5-
dinitrobenzene under Rosenmund-von-Braun reaction conditions were 
unsuccessful. 4-Bromo-5-nitrophthalonitrile (26a) which was previously used for 
the preparation of 4,5-disubstituted phthalonitriles also could not be efficiently 
disubstituted with 25.[181] Reaction of 25 with 26a using K2CO3 or NaH in DMF 
predominately resulted in the substitution of bromo group. The disubstituted 
product 27 was only formed in a small amount (scheme 24). Therefore, diacetone 
galactose 25 was instead reacted with 4,5-difluorophthalonitrile (2a).[182] Under 
optimized conditions (dimethyl acetamide or DMF, NaH, 35-40 °C, 48 h), the SNAr 
reaction proceeded smoothly and gave the bis-galactosylated phthalonitrile 27 in a 
virtually quantitative yield. 
O
OO
O
O OH CN
CN
R2
R1
+
CN
CN
O
OO
O
O O
OO
O
O
O
O
25 26a R
1=Br, R2=NO2
26b R1=R2=F 27
DMF/DMAC, NaH
35-40 oC, 48 h
 
Scheme 24: Synthesis of 4,5-di(1,2:3,4-di-O-isopropylidene-α-D-glalactopyranosyl)-
phthalonitrile (27).  
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3.3.1.2 Synthesis of [2,3,9,10,16,17,23,24-octakis(1,2:3,4-di-O-
isopropylidene-α-D-galactopyranos-6-yl)phthalocyaninato]zinc(II) (29) 
 
Next, attempts to cyclize compound 27 under various conditions which had been 
previously found suitable[154] failed. Heating 27 in various solvents in the presence 
of Zn(OAc)2 or ZnCl2 did not alter the starting material. Therefore, phthalonitrile 27 
was first converted into the isoindoline 28 by bubbling gaseous NH3 through a 
refluxing solution of 27 in THF/MeOH (1:1). Thus obtained crude isoindoline 28 
(95%) was pure enough for the subsequent cyclization step. Refluxing a solution 
of 28 and Zn(AcO)2.2H2O in DMAE for 24 h and purification of the obtained 
product by chromatography afforded Pc 29 in 29% yield as a green amorphous 
solid (Method A, experimental section). Alternatively, heating 28 and 
Zn(AcO)2.2H2O without a solvent in a sealed glass tube for 15 h also yielded 29 in 
30% yield (Method B, experimental section). Since compound 29 is sensitive to 
light, all experimental manipulations were performed in the dark. The NMR spectra 
of 29 showed only one doublet for H-1 of the 8 galactose moieties. This indicates 
that the galactoses in 28 are not sterically hindered and can freely rotate at room 
temperature. 
 
3.3.1.3 Synthesis of [2,3,9,10,16,17,24,25-octakis(α/ß-D-galactopyranos-6-
yl)phthalocyaninato]zinc(II) (30) 
 
Deprotection of the 16 isopropylidene groups was achieved by treating 29 with 
aqueous trifluoroacetic acid (TFA). Final purification by reverse phase HPLC 
afforded the fully deprotected octasubstituted Pc 30 in 81% yield. The obtained Pc 
30 is highly soluble in water, DMSO and DMF and is insoluble in common organic 
solvents such as DCM, ethyleacetate and acetone. 
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Scheme 25: Synthesis of octasubstituted galactose zinc(II) phthalocyanines, 29 and 30. 
Reagents and conditions: (i) THF/MeOH, NH3, NaOCH3, 0°C-rt, 1h, reflux, 1h, 95% (ii) 
DMAE, Zn(AcO)2.2H2O, 24h, reflux, 29% (iii) TFA/H2O, rt, 4h, 81% 30. 
 
PcZn 30 was characterized by NMR, UV/vis and MALDI-TOF spectroscopic data. 
1H NMR spectrum of compound 30 measured in DMSO is shown in figure 37. The 
spectrum shows a singlet at 8.99 ppm for aromatic Pc macrocycle while 
deprotection of all isopropylidene groups is evident from the absence of methyl 
signals at 2.00 ppm. Signals from galactose moieties are broad and can not be 
clearly defined. MALDI-TOF spectrum was in agreement with the structure of 
compound 30. 
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Figure 37: 1H NMR spectrum of octasubstituted PcZn 30 measured in DMSO-d6. 
 
3.3.2 Syntheses of 4,5-diglycosylated phthalonitriles 32a-32i (table 3) 
 
For the syntheses of the octaglycosylated phthalocyanines 33a–33i and 34a–34i, 
in which sugar molecules are anomerically attached with Pc macrocycle, we 
needed 4,5-diglycosylated phthalonitriles 32a-32i. 
As the first step for the synthesis of the 4,5-diglycosylated phthalonitriles, 4-
bromo-5-nitrophthalonitrile (26a) was reacted with anomerically deprotected 
glucose 31a (scheme 26). Mostly the monoglucosylated product was formed in 
poor yield, only traces of diglucosylated phthalonitrile 32a could be found. In the 
monoglucosylated product only Br was replaced by the sugar molecule in 26a 
while the NO2 group remained intact. Therefore 4,5-difluorophthalonitrile (26b) 
instead was reacted with the sugar molecules, assuming that F would be easier to 
exchange by the nucleophilic anomeric OH of the sugar than Br or NO2 
respectively in the bromo-nitrophthalonitrile 26a. 
Reaction of 4,5-difluorophthalonitrile (26b) with anomerically deprotected glucose 
31a (see table 3) in dimethylacetamide (DMAC) with NaH at room temperature 
even after long reaction time lead to diglucosylated phthalonitrile 32a only in poor 
yield. The major product again was the monoglucosylated phthalonitrile. The use 
of other solvents like DMF or DMSO did not improve the yield of 32a. Increasing 
the temperature to 40 oC with DMAC as solvent decreased the reaction time but 
led to the same product ratio between mono- and diglucosylated phthalonitriles. 
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Table 3: 4,5-Diglycosylated phthalonitriles and corresponding zinc(II) phthalocyanines. 
Sugar 4,5-Diglycosylated 
phthalonitrile 
Yield (%) 
32 33 34 
O
AcO
AcO
OAc
AcO
OH 
31a 
O
AcO
AcO
AcO
O
AcO
AcO
OAc
CN
CNO
O
AcO
AcO
 
32a 
64 75 94 
O
AcO
AcO
OAc
SHAcO
 
31b 
 
O
AcO
AcO
AcO
O
AcO
AcO
OAc
CN
CNS
SAcO
AcO
 
32b 
65 - 19 
O
AcO
AcO
OAcOAc
OH 
31c 
 
O
AcO
AcO
OAc
O
AcO
AcO
OAc
CN
CNO
O
AcO
AcO
 
32c 
72 70 91 
O
AcO
AcO
OAcOAc
SH
 
31d 
 
O
AcO
AcO
OAc
O
AcO
AcO
OAc
CN
CNS
S
AcO
AcO
 
32d 
80 70 89 
O
AcO
AcO
OAc
OH
OO
AcO
AcO
OAcOAc
 
31e 
 
O
AcO
AcO
AcO
O
AcO
AcO
OAc
CN
CNO
O
O
O
O
AcO
AcO
OAcAcO
O
AcO
AcO
OAcAcO
 
32e 
56 62 93 
O
AcO
AcO
OAc
SHO
O
AcO
AcO
OAcOAc
 
31f 
O
AcO
AcO
AcO
O
AcO
AcO
OAc
CN
CNS
SO
O
O
AcO
AcO
OAcAcO
O
AcO
AcO
OAcAcO
 
32f 
55 70 87 
O
AcO
AcO
OAc
OH
OO
AcO
AcO
OAc
AcO
 
31g 
O
AcO
AcO
AcO
O
AcO
AcO
OAc
CN
CNO
O
O
O
O
AcO
AcO
OAc
AcO
O
AcO
AcO
AcO
AcO
 
32g 
74 55 90 
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Sugar 4,5-Diglycosylated 
phthalonitrile 
Yield (%) 
32 33 34 
O
AcO
AcO
OAc
SHO
O
AcO
AcO
OAc
AcO
 
31h 
O
AcO
AcO
AcO
O
AcO
AcO
OAc
CN
CNS
SO
O
O
AcO
AcO
OAc
AcO
O
AcO
AcO
AcO
AcO
 
32h 
71 64 91 
O
AcO
AcO
OAc
OH
O
O
AcO
AcO
OAc
AcO
 
31i 
O
AcO
AcO
OAc
O
AcO
AcO
OAc
CN
CNO
O
O
O
O
AcO
AcO
OAc
AcO
O
AcO
AcO
AcO
AcO
 
32i 
62 68 85 
 
Finally in DMAC, K2CO3 was used as the base at 35-40 oC under which conditions 
the diglucosylated phthalonitrile 32a was formed in good yield (table 3), 
exclusively as the α-linked product (figure 38) beside small amounts of the 
monoglucosylated phthalonitrile. Purification of 32a was done by column 
chromatography (scheme 26). 
O
XHAcO
CN
CN
R1
R2
+
CN
CN
O
XAcO
O
XAcO26 32a-32i
i or ii
31a-31i
26a= R1=Br, R2= NO2
26b= R1=R2= F
X= O, S
 
Scheme 26: Synthesis of octaglycosylated zinc(II) phhthalocyanines. Reagents and 
conditions: (i) K2CO3, DMAC, 35-40 oC, 48h (ii) TBAH, DCM, rt, 48h. 
 
For the reaction of 4,5-difluorophthalonitrile (26b) with anomerically deprotected 
thioglucose 31b in presence of K2CO3 at 35-40 oC in DMAC the results were quite 
different. As the major product the monosubstituted phthalonitrile was formed. 
Replacing K2CO3 with NaH, using a variety of different solvents like DMF or DMSO 
also did not change the product composition. Only the use of 
tetrabutylammoniumhydroxide (TBAH) in dichloromethane at room temperature 
proved to be a successful route to obtain the diglucosylated phthalonitrile 32b in 
good yield (table 3). 31b was obtained as the β-anomer (figure 39). 
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After establishing the optimized reaction conditions also the sugar molecules 31c, 
31e, 31g and 31i containing an anomerically deprotected OH group were reacted 
as described above with 4,5-difluorophthalonitril (26b) using K2CO3 as base at 35-
40 oC in DMAC as solvent. The 4,5-diglycosylated phthalonitriles 32c, 32e, 32g 
and 32i respectively were obtained in moderate to good yields (table 1). The 
sugars 31d, 31f, and 31h respectively containing SH groups were reacted with 
4,5-difluorophthalonitrile (26b) under the described conditions for 32b using 
tetrabutylammonium hydroxide in dichloromethane to give the 4,5-diglycosylated 
phthalonitriles 32d, 32f, and 32h respectively (scheme 26). All phthalonitriles were 
purified by column chromatography. 
The O-glycosides 32a, 32c, 32e, 32g and 32i respectively were obtained as α-
glycosides (figure 39) whereas the S-glycosides 32b, 32d, 32f and 32h were 
formed as β-anomers (figure 40). This was clearly evident from the NMR spectra 
of glycosides 32 which showed vicinal coupling constants J1,2 of 3.3-3.8 Hz for the 
α-linked glycosides and 10.2 Hz for the β-linked compounds. 
 
(ppm)
12345678
456
 
Figure 39: 1H NMR spectrum of 4,5-diglycosylated phthalonitrile 32a. 
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Figure 40: 1H NMR spectrum of 4,5-diglycosylated phthalonitrile 32b. 
 
3.3.3 Syntheses of the protected octaglycosylated phthalocyanines 33a–
33i and the deprotected octaglycosylated phthalocyanines 34a–34i  
 
The syntheses of the octaglycosylated phthalocyanines 33a–33i and 34a–34i 
respectively turned out to be rather difficult; quite a few methods had to be applied 
before a successful route could be found. 
First the protected 4,5-diglucosylated phthalonitrile 32a was taken as starting 
material which was heated for 12h in a mixture of DMAE/n-butanol and 
Zn(OAc)2.2H2O. No indication for the formation of phthalocyanine was found only 
a black jelly tar was formed. In the next attempt phthalonitrile 32a was deprotected 
with MeONa/MeOH using our previously described method[154] and then subjected 
to the same reaction condition as described before to convert it into the 
corresponding octaglucosylated zinc phthalocyanine 34a. However also this 
reaction was unsuccessful, no phthalocyanine was formed. 
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32a= Glucose        O
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32g= Cellobiose    O
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Scheme 27: Synthesis of octaglycosylated zinc(II) phthalocyanines. Reagents and 
conditions: (i) p-TsOH, HMDS, DMF, Zn(OAc)2.2H2O, 125-130 oC, 15h (ii) MeOH, DMSO, 
Na, rt, 15h. 
 
To increase the reactivity of phthalonitrile 32a it was converted first into its 
corresponding isoindoline in MeONa/MeOH while passing gaseous NH3 through 
the solution. This process leads to deprotection of the acetyl groups in the sugar 
part of the phthalonitrile 32a. The isoindoline was heated with ZnCl2 or 
Zn(OAc)2.2H2O in various solvents like DMAE, DMF, pentanol, butanol, hexanol 
as well as in mixtures of these solvents with DMAE. In all cases the isoindoline 
could not be converted into the zinc phthalocyanine 34a. 
Now instead of phthalonitrile 32a phthalonitrile 32b in which the glucose parts are 
connected via sulfur to the aromatic ring was taken considering its higher reactivity 
as compared with phthalonitrile 32a. Also 32b did not react with formation of the 
phthalocyanine 33b using similar reaction conditions as described above in a 
variety of experiments. It forms phthalocyanine 34b in 19% yield when 32b was 
  
 69 
refluxed in MeOH/THF (1:1) containing traces of conc. HCl while Zn dust was 
used as metal source. Advantage of this method was that it led to deprotection of 
the acetyl groups in sugar in one step reaction however the yield obtained was 
poor. When this method was applied on phthalonitrile 32a, it failed to indicate any 
formation of phthalocyanine 34a. 
Finally the following route for the syntheses of the phthalocyanines was successful 
using phthalonitrile 32a for the first trial: 32a was heated in DMF with 30 mol% 
hexamethyldisilazane (HMDS)[179], p-toluenesulfonic acid and Zn(OAc)2.2H2O at 
125-130 °C overnight (p. 57). Using this procedure the protected octaglucosylated 
phthalocyanine 33a was formed in 75 % yield. As shown by MALDI-TOF the acetyl 
groups were not affected. The octaglycosylated phthalocyanines 33c-33i were 
obtained in yields between 55 and 78% (table 1). The phthalocyanines were 
purified by column chromatography. 
For deprotection of the acetyl groups phthalocyanine 33a was treated with MeONa 
in methanol at room temperature. As shown by Maldi TOF only partial 
deprotection took place, at least eight acetyl groups were still intact. The only 
partial deprotection of the acetyl groups might have been due to the low solubility 
of the deprotected phthalocycanine 34a in methanol. To overcome this problem 
DMSO was used as cosolvent together with methanol and a catalytic amount of 
Na metal. By applying this procedure all acetyl groups in phthalocyanines 33a–33i 
could be removed with formation of the phthalocyanines 34a–34i. 
The purity of the deprotected phthalocyanines 34a-34i was shown by reverse 
phase HPLC and for all the Pc’s 33a-33i and 34a-34i by MALDI-TOF (figure 42) 
which showed the calculated compositions. 
1H NMR spectra of the acetyl protected Pc’s 33a-33i in CDCl3 due to rather higher 
concentration lead to partial aggregation and thereby to broad peaks. This is also 
due for the deprotected systems 34a-34i measured in DMSO-d6. As an example 
1H NMR spectrum of PcZn 34c is shown in figure 41. 
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Figure 41: 1H NMR spectrum of PcZn 34c measured in DMSO-d6. 
 
Figure 42: MALDI-TOF spectrum of PcZn 34c. 
 
3.4 Aggregation behavior of acetyl protected phthalocyanines 33a-33i 
 
The aggregation behaviour of the acetyl protected 33a-33i and deprotected 
octaglycosylated PcZn’s 34a-34i was investigated by their UV/Vis spectra in 
different solvents. 
The data of the acetyl protected octaglycosylated PcZn’s dissolved in DCM are 
given in table 4. The PcZn’s 33a-33i show almost no aggregation, as an example 
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UV/Vis spectrum of 33a is given in figure 43. This is in contrast to the aggregation 
behaviour of acetyl protected tetraglucosylated naphthalocyaninato zinc 46: Its 
UV/Vis spectrum in DCM shows a strong broad Q2-band with the maximum at 696 
nm typical for strong aggregation. The Q1-band only appears as shoulder at 769 
nm. Traces of pyridine added to the DCM solution lead to an interruption of the 
aggregation shown in the UV/Vis spectrum by a now strong narrow Q1-band with 
the maximum at 763 nm and a broad Q2-band of low intensity at 704 nm. 
All data given in table 4 have been measured in concentration range of 0.35 × 10-5 
M – 0.86 × 10-5 M for acetyl protected PcZn’s 33a-33i. 
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Figure 43: UV/Vis spectrum of PcZn 33a in 
DCM (c = 0.60 × 10-5 M). 
Table 4: UV/Vis data of acetyl PcZn’s 33a-
33i in DCM. 
Pc Q1-band, 
λ(logε) 
Pc Q1-band, 
λ(logε) 
33a 673 (5.50) 33d 700 (5.63) 
33c 673 (5.38) 33f 700 (5.11) 
33e 674 (5.29) 33h 700 (5.30) 
33g 673 (5.59)   
33i 673 (5.49)   
 
 
3.5 Aggregation behavior of deprotected phthalocyanines 34a-34i 
 
In DMSO as solvent the deprotected glycosylated PcZn’s 34a-34i show almost no 
aggregation as demonstrated by the strong narrow Q1-bands between 678-710 
nm (table 5) and bands of low intensity between 612-635 nm indicating very little 
aggregation. As can be seen from table 5 the anomerically oxygen bound sugar 
Pc’s dissolved in DMSO show the Q1-band at 678-680 nm, whereas a red shift of 
Q1-band is observed for the corresponding S-bound sugar Pc’s to 708-710 nm. 
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Figure 44: UV/Vis spectrum of 34a in H2O 
 (c = 1.25 × 10-5 M). 
Table 5: UV/Vis data of PcZn’s 34a-34i in 
DMSO. 
Pc Q1-band, 
λ(logε)  
Pc Q1-band, 
λ(logε)  
34a 678 (4.89) 34b 710 (5.38) 
34c 680 (5.34) 34d 708 (5.06) 
34e 679 (4.99) 34f 708 (5.01) 
34g 679 (5.31) 34h 709 (5.32) 
34i 679 (4.68)   
 
 
In water as the solvent all deprotected PcZn’s 34a-34i are highly aggregated as 
shown with one example (glucose) in figure 44. The UV/Vis spectrum of 34a 
shows a broad Q2-band with the maximum at 635 nm, the Q1-band only appears 
as a small shoulder at ∼ 670 nm. Addition of pyridine did not interrupt the strong 
aggregation of Pc’s 34a-34i in water. 
Figure 45 shows the UV/Vis spectrum of the deprotected octaglucosylated PcZn 
34a in pure DMSO and the UV/Vis spectra of 34a in different DMSO/water 
mixtures with an increasing amount of water. It can be seen that increasing the 
amount of water leads to an increase of the aggregation band Q2 at 612 nm and a 
decrease of the Q1-band at 678 nm. In mixtures of DMSO/water (2:1) the Q1-band 
as in case of pure water almost vanished and the main absorption occurs at 637 
nm indicating strong aggregation. 
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Figure 45: UV/Vis spectrum of octaglucosylated PcZn 34a in DMSO with different amounts 
of H2O. 
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The ratios of the two Q-bands, Q1 (nonaggregated) and Q2 (aggregated) for 34a-
34i in a DMSO/water mixture of 1:1 (volume) are given in table 6. Figure 46 shows 
the UV/Vis spectra of the deprotected systems 34c, 34e, 34g, 34h and 34i. From 
table 6 and figurte 46 it is evident that in DMSO/water 1:1 the anomerically oxygen 
bound octaglycosylated PcZn’s 34a, 34c, 34g and 34i are less aggregated than 
the anomerically sulphur bound systems 34b, 34d, 34f and 34h. 
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Figure 46: UV/Vis spectra of PcZn’s 34a-34i in 
DMSO:H2O (1:1) mixture. 
Table 6: Absorption and AQ1/AQ2 band 
ratios of PcZn’s 34a-34i in 
DMSO:H2O mixture (1:1). 
Pcs AQ1 AQ2 AQ1/AQ2 
34a 0.38 0.49 0.78 
34b 0.34 0.38 0.89 
34c 0.28 0.40 0.70 
34d 0.27 0.20 1.35 
34e 0.37 0.23 1.61 
34f 0.15 0.12 1.25 
34g 0.36 0.23 1.57 
34h 0.28 0.33 0.85 
34i 0.12 0.00 ∝ 
 
 
The Q1-band of the oxygen bound octaglycosylated PcZn’s appear at 678 nm, 
whereas the Q1-band of sulphur bound PcZn’s appears somewhat higher at ~ 710 
nm indicating a red shift ~ 30 nm for the sulphur bound systems. 
Aggregation of Pc’s 34a-34i in DMSO/H2O mixture (1:1) as solvent, also depends 
upon the size of sugar substituents. Pc’s 34e-34i with bulky sugar substituents are 
less aggregated in comparison with those containing less bulky sugar 
substituents, i.e. Pc’s 34a-34d. Pc’s with sulfur atoms at anomeric position show 
more aggregation as compared to the Pc’s with oxygen atoms at anomeric 
position of sugar part, while Pc 34i with maltose as sugar part is almost non 
aggregated in this mixture of solvents. All data given in table 5 and 6 have been 
measured for the deprotected PcZn’s 34a-34i in the concentration ranges from 
0.70 × 10-5 M to 1.29 × 10-5 M. 
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3.6 Synthesis of tetraglucosylated zinc(II) naphthalocyanines 45 and 46 
(scheme 28) 
 
Our synthesis of the tetraglucose NcZn’s 45 and 46 (scheme 29) in high yield via 
template reaction of the glucosylated naphthalonitrile 39 (scheme 28) is based on 
the possibility to obtain glucosyloxyphthalonitriles, in high yields by nucleophilic 
substitution of 4-nitrophthalonitrile with protected glycopyranoses.[155] 
To synthesize the glucosylated naphthalodinitrile 39 (scheme 28) the same SNAr 
displacement of nitrite in 6-nitronaphthalodinitrile 40a by anomerically deprotected 
glucose 41 in various polar aprotic solvents such as DMF, DMSO and HMPA at 
room temperature, with NaH and K2CO3 as bases was followed. In spite of 
different conditions which were applied, no sugar nitrite exchange was observed. 
Increasing the temperature mostly led to the degradation of the sugar part. To 
increase the reactivity of the leaving group X in the naphthalodinitrile 40, instead of 
the nitro- the corresponding fluoronaphthalodinitrile 40b was reacted with sugar 
41. However also the fluoronaphthalodinitrile 40b using different conditions did not 
react with sugar 41 to form the expected substitution product 39. 
A more detailed investigation concerning the reactivity of both the 6-nitro and the 
6-fluoronaphthalodinitriles 40a,b not only with sugar 41 but e.g. with n-hexanol as 
the alcohol part in solvents like DMF, DMSO and HMPA respectively and K2CO3 
or NaH as bases gave no indication for a substitution reaction at room 
temperature or slightly elevated temperatures. At higher temperatures (80-100oC) 
only degradation products were found. 
Nucleophilic substitution of 40a has only been reported with sterically hindered 
phenols.[183] Even in these cases the yields of substitution products are low and 
side products of unknown structure are formed. These and our own experiments 
also demonstrate that the nuleophilic reactivity of the nitro and fluoro substituted 
naphthalonnitriles 40 are much lower and less clear than the well investigated 
reactivity of the 4-substituted phthalonitriles. 
Therefore the synthesis of glucosylated naphthalodinitrile 39 was carried out using 
the well known route for the preparation of substituted naphthalonitriles[184] 
(scheme 28): first the glucose part was introduced by a Koenigs-Knorr type 
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glycosidation reaction of 3,4-dimethylphenol 36 with penta-O-acetyl-β-D-glucose 
35 under activation with BF3:etherate leading to compound 37.[185] 
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Scheme 28: Synthesis of glucosylated naphthalonitrile 39. Reagents and conditions: (i) 
BF3:etherate, benzene, rt, 48 h, 94% (ii) NBS, benzoyl peroxide, CCl4, reflux, 48h, 91% (iii) 
fumaronitrile, NaI, DMF, 75-80°C, 24 h, 65% (iv) Ag2O, CH3CN, 50°C, 24h, 71%. 
 
37 could be brominated with NBS in CCl4 to form tetrabromide 38 in good yield 
which was reacted with fumaronitrile and NaI in DMF in a Diels-Alder process to 
obtain the glucosylated naphthalonitrile 39 (scheme 28). Naphthalonitrile 39 was 
also obtained by reacting 6-hydroxy naphthalonitrile[186] (42) with the acetylated 
bromoglucose 43. 
The sugar part of naphthalonitrile 39 was deprotected with Na in methanol while 
passing gaseous NH3 through the solution to form the corresponding 
diiminoisoindoline 44 which was subsequently reacted with Zn(OAc)2.2H2O in 
DMAE as the solvent, after which the tetraglucosylated NcZn 46 was obtained as 
a mixture of structural isomers. 
Naphthalocycanine 45 was formed by direct tetramerisation of naphthalonitrile 39 
with hexamethyldisilazan, p-toluensulfonic acid (p-TsOH) and Zn(OAc)2 2H2O in 
refluxing DMF.[179] Treating 45 with CH3ONa in a DMSO/methanol mixture (2:1) 
the acetyl groups were removed and the deprotected NcZn 46 was formed. 
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Scheme 29: Synthesis of tetraglucosylated zinc(II) naphthalocyanines 45 and 46. Reagents 
and conditions: (i) Na, NH3, methanol, rt-reflux, 2h, 99% (ii) Zn(OAc)2.2H2O,DBU, DMAE, 
reflux, 24h, 29% (iii) Zn(OAc)2.2H2O, HMDS, p-TsOH, DMF, reflux, 15h, 45% (iv) CH3ONa, 
MeOH, DMSO, rt, 12h, 93%. 
 
Contrary to the completely water soluble tetraglucose substituted PcZn[155] the 
corresponding NcZn 46 is much less soluble in water at room temperature, but 
soluble in DMF, DMSO and hot water. The lower solubility of 46 in water is a result 
of the larger hydrophobic Nc macrocycle for which the four hydrophilic substituents 
are not sufficient enough to allow water solubility. NcZn 45 is soluble in organic 
solvents like CHCl3, THF etc. 
The 1H NMR spectra of 45 and 46 were recorded in Methanol-d4 and DMSO-d6 
respectively. Both NMR spectra were very much depending upon the temperature 
of the solution which for both compounds have been increased from 20–100 oC. 
Only at higher temperatures clear very well resolved spectra were obtained 
indicating a strong aggregation of 45 and 46 even in coordinating solvents like 
DMSO-d6 and Methanol-d4. In non-coordinating solvents, e.g. CDCl3, the spectra 
especially in the aromatic region were of very low intensity. Even the addition of 
pyridine-d5 did not change the spectra very much at ambient temperature. 
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3.7 Aggregation behavior of zinc(II) naphthalocyanines 45 and 46 
 
In solution both Nc’s 45 and 46 depending upon the solvent are aggregated. This 
was directly demonstrated through the UV/Vis spectra of the acetyl protected 
tetraglucosylated NcZn 45: Its UV/Vis spectrum in DCM shows a strong broad 
band with the maximum at 696 nm typical for a strong aggregation. The Q-band of 
45 only appears as shoulder at 769 nm. Traces of pyridine added to the DCM 
solution of 45 lead to an interruption of the aggregation shown in the UV/Vis 
spectrum by a now strong narrow Q-band with the maximum 763 nm and a broad 
band of low intensity at 704 nm. In DMSO as the solvent 45 and 46 show less 
aggregation as shown by strong Q-bands at 769 and 773 nm respectively. 
300 400 500 600 700 800 900 1000
0,0
0,2
0,4
0,6
0,8
1,0
1,2
1,4
1,6
1,8
2,0
2,2
2,4 A
λ, nm
1
2
3
4
 
Figure 47: UV/Vis spectra of NcZn’s 45 and 46. (1) NcZn 45 in DCM (c = 0.16x10-7 M) (2) 
NcZn 45 in DCM with traces of. Pyridine (3) NcZn 45 in DMSO (c = 0.14x10-7 M) (4) NcZn 46 
in DMSO (c = 0.6x10-7 M). 
 
3.8 Glycosylated zinc phthalo/naphthalocyanines and PDT studies 
 
Samples of tetra-(24a-24e) and octaglycosylated (30,34a-34i) PcZn’s as well as 
tetraglucosylated NcZn 46 have been sent to various research groups for PDT 
investigations. Studies for the efficiency of these compounds for the generation of 
singlet oxygen molecules is also underway and the results will be published in due 
course of time. 
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4 Experimental section 
 
4.1 General informations 
 
All commercially available reagents were purchased and used as acquired. 
Solvents were dried according to standard methods. The following equipment, 
methods and materials were used for the analysis and characterization of the 
compounds. 
 
NMR spectroscopy 
 
1H NMR spectra were measured with either Bruker ARX 250 (250 MHz) or Bruker 
Avance 400 (400 MHz) spectrometer. 13C NMR spectra were measured by using 
either Bruker ARX 250 (62 MHz) or Bruker Avance 400 (100 MHz) spectrometer. 
The deuterated solvent was used as internal standard and the chemical shift 
values (δ) are given in parts per million (ppm) units in relation with known values 
of internal standards. 
 
Mass spectroscopy 
 
EI: Finnigen MAT TSQ 70 with direct inlet, temperature of ion source 200 oC and 
electron energy 70 ev. 
FT-ICR: Bruker Daltronic APEX 2 specrtometer with electron spray ionization 
(ESI) mode of ionization technique. 
MALDI-TOF: Buker Autoflex, 2,5-dihydroxybenzoic acid or α-cyano-4-
hydroxycinnamic acid was used as matrix. 
 
IR spectroscopy 
 
Bruker Tensor 27 spectrometer was used. Solid substances were grounded with 
KBr and pressed to pelltets whereas liquid compounds were measured directly in 
the instrument. 
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UV/Vis spectroscopy 
 
The absorption spectra of the compounds were recorded as solutions in CH2Cl2 
(otherwise stated) contained in quartz cuvett of 1 cm path length, by using Perkin 
Elmer lamda25 spectrometer. 
 
Elemental analysis 
 
Euro EA 3000 instrument from HEKAtech GmbH. 
 
Optical rotation 
 
Perkin-Elmer 341 polarimeter. The measurements were recorded as CHCl3 
solutions of the compounds taken in 10 cm glass cell at 20 oC. 
 
Preparative chromatography 
 
Preparative RP-HPLC was performed on an aqueous system using a GROM SIL 
120 ODS-4HE;10 mm; 250 × 20 mm (C-18 column). The eluents used were H2O 
and acetonitrile. Silica gel 60 (particle size 0.040–0.063 mm) from Macherey-
Nagel, was used for column chromatography. 
 
Analytical chromatography 
 
Thin layer chromatography (TLC) was performed on Macherey-Nagel Polygram 
SIL G/UV254 plastic plates, precoated with 0.2 mm thickness of silica gel 
containing fluorescent indicator. Detection of spots on TLC was carried out by UV 
light whereas sugar containing compounds were visualized by spraying the TLC 
with 5% H2SO4 solution in EtOH and heating the plate. 
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Melting points 
 
Melting points were taken on a Büchi B-540 and are uncorrected. 
 
4.2 Synthesis of substituted phthalonitrile precursors  
 
4.2.1 1,2-Dibromo-4-tert-butylbenzene (2a) 
 
To a solution of 1-bromo-4-tert-butylbenzene (8 g, 0.04 mol) in 
CCl4 (5 ml) in the presence of a small amount of iron powder was 
added a solution of bromine (9.5 g, 0.12 mol) in CCl4 (4 ml) at 5 
°C over 10 min. The mixture was stirred at 15 °C for 2h. Solvent was evaporated 
and product was purified by column chromatography using CH2Cl2/hexane (1:1) as 
eluent; yield 11 g (92%). 
1H NMR (400MHz, CDCl3): δ = 7.59 (d, 4J = 2.3 Hz, 1 H), 7.50 (d, 3J = 8.4 Hz, 1 
H), 7.16 (dd, 3J = 8.4 Hz, 4J = 2.3 Hz, 1 H), 1.27 (s, 9 H). 
MS (EI): m/z (%) = 291.8 (45) [M]+, 276.8 (100). 
 
4.2.2 1,2-Dibromo-4-acetanilide (8a) 
 
To a solution of 3-bromoacetanilide (2.10 g, 10 mmol) and NBS 
(1.95 g, 11mmol) in acetone (20 ml), 100 μl of 1 M HCI was 
added at room temperature. The resulting yellow solution was 
stirred until the solution became colorless .The acetone was removed in vacuo 
and 5 ml of hexanes were added. After cooling the mixture in an ice bath, the 
succinimide was removed by filtration. Removal of the hexanes in vacuo yielded 
the crude product. After purification by column chromatography with silica gel 
eluted by CH2Cl2, the compound 8a was obtained as white solid. Yield 2.63 g 
(90%). 
1H NMR (400 MHz, CDCl3): δ = 7.84 (s, 1 H), 7.50 (d, 3J = 8.8 Hz, 1 H), 7.38 (br s, 
1 H), 7.30 (d, 3J = 8.8 Hz, 1 H), 2.15 (s, 3 H). 
MS (EI): m/z (%) = 293.0 (100) [M]+. 
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4.2.3 tert-Butyl-(3,4-dibromophenoxy)dimethylsilane (9a)  
 
tert-Butyldimethylsilyl chloride (1.5 g, 10 mmol) and imidazole 
(0.68 g, 10 mmol) were dissolved in 30 ml of CH2Cl2 under N2. 
3-Bromophenol (1.72 g, 10 mmol) was added, and the solution 
stirred overnight. The solution was diluted with H2O and washed twice with 1 N 
HCl, followed by saturated aqueous NaHCO3. The organic layer was collected, 
dried, filtered, and condensed by rotatory evaporation. Chromatography through a 
short column using CH2Cl2/hexanes (1:1), afforded tert-butyl(3-
bromophenoxy)dimethylsilane quantitatively as a slightly golden oil. tert-Butyl(3-
bromophenoxy)dimethylsilane was then brominated following the procedure 
described for compound 8a to afford 9a as white solid. Yield 2.85g (78%). 
1H NMR (400 MHz, CDCl3): δ = 7.41 (d, 3J = 7.5 Hz, 1 H), 7.10 (d, 4J = 2.5 Hz, 1 
H), 6.64 (dd, 3J = 7.5 Hz, 4J = 2.5 Hz, 1 H), 0.95 (s, 9 H), 0.18 (s, 6 H). 
MS (EI): m/z (%) = 365.9 (40) [M]+, 308.9 (100). 
 
4.2.4 3,4-Dibromophenol (10a) 
 
The tert-butyldimethylsilyl protected compound 9a (1.83 g, 5 
mmol) was taken in THF (20ml) and cooled to -78 °C. TBAF (5 
ml, 5 mmol 1.0 M in THF) was added via syringe in two 
portions. Three quarters of the TBAF were added and the reaction was stirred for 
3 h at -78 °C, then the remaining TBAF was added followed by stirring for 1 h at -
78 °C. The reaction was quenched with 3 ml of 10% AcOH/THF. The reaction 
mixture was diluted with CH2Cl2 and washed with H2O. The organic layer was 
collected, dried, filtered, and concentrated in vacuo. Column chromatography 
using CH2Cl2 as the eluent afforded 10a as white solid. Yield 1.6 g (92%). 
1H NMR (400 MHz, CDCl3): δ = 7.28 (d, 3J = 8.6 Hz, 1 H), 7.02 (s, 1 H), 6.55 (d, 3J 
= 8.6 Hz, 1 H). 
MS (EI): m/z (%) = 252.0 (100) [M]+. 
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4.2.5 6,7-Dibromo-2,2-dimethylnaphtho[2,3-d][1,3]dioxole (19a) 
 
To 5.6 g (17.6 mmol) of 2,3-dibromo-6,7-
dihydroxynaphthalene dissolved in toluene (40 ml) and 
anhydrous acetone (5 ml) was added P2O5 in three portions during 48 h while the 
reaction mixture was heated at 50 °C. The solution was diluted with toluene (50 
ml), washed with H2O, 10% NaOH solution, H2O and brine. Combined organic 
phase was concentrated with a rotary evaporator. Purification of the crude product 
was carried out by column chromatography using dichloromethane as eluent. 
Yield 3.42 g (57%). 
1H NMR (400 MHz, CDCl3): δ = 7.88 (s, 2 H), 6.87 (s, 2 H), 1.71 (s, 6 H). 
MS (EI): m/z (%) = 357.9 (60) [M]+, 342.8 (100). 
 
4.3 General procedure for the synthesis of phthalonitriles 
 
A 25 ml two-neck round-bottom flask was charged with 1 
mmol of o-dibromobenzene in DMAC (2 ml) and PMHS (20 
mg) was added at r.t. The reaction mixture was heated to the 
required temperature (Table 2) and Pd2 (dba)3 (20 mg, 2 mol%) and DPPF (15 
mg, 2.7 mol%) were added. Afterwards, Zn(CN)2 (117 mg, 1 mmol) was added in 
4–5 portions during the time mentioned in Table 2 till TLC indicated completion of 
the reaction. The reaction mixture was cooled, diluted with EtOAc and filtered. 
Filtrate was washed with H2O, dried with MgSO4, and concentrated in vacuo. The 
crude product was purified by column chromatography using CH2Cl2 as eluent. 
Compound 19b: 1H NMR (400 MHz, CDCl3): δ = 8.05 (s, 2 H), 7.10 (s, 2 H), 1.77 
(s, 6 H). 
MS (EI): m/z (%) = 250.0 (40) [M]+, 235.0 (100), 210.0 (50). 
 
4.4 Syntheses of 1,8(11),15(18),22(25)-tetraglycosylated 
phthalocyaninato zinc (II) 24a-24e 
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4.4.1 Synthesis of 3-glycosylated phthalonitriles 22a-22e 
4.4.1.1 3-(2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl)-phthalonitrile (22a) 
 
K2CO3 (5.80g, 42 mmol) was added to a mixture of 3-
nitrophthalonitrile (20) (1.0 g, 5.78 mmol) and 2,3,4,6-tetra-
O-acetyl-α/β-D-glucopyranose (21a) (2.44 g, 7 mmol) in 
dimethylformamide (DMF) (50ml). The reaction mixture was 
stirred at room temperature for 12h. After completion the reaction mixture was 
poured into water. Precipitates formed were filtered washed with water, dried and 
purified by column chromatography on silica gel using toluene acetone (5:1) as 
eluent to afford 2.10 g of 22a in 77% yield. 
Mp: 142-144 °C. [α]D20 = +13.9 (c 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.68-7.63 (m, 1H, HAr), 7.53-7.48 (m, 2H, HAr), 
5.83 (d, J1,2 = 3.8 Hz, 1H, H-1), 5.66 (t, J2,3 = J3,4 = 9.8 Hz, 1H, H-3), 5.17 (t, J4,3 = 
J4,5 = 9.8 Hz,1H, H-4), 5.03 (dd, J2,1 = 3.8 Hz, J2,3 = 9.8Hz, 1H, H-2), 4.23 (dd, J5,6a 
= 4.6 Hz, J6a,6b = 12.2Hz, 1H, H-6a), 4.16-4.12 (m, 1H, H-5), 4.10 (dd, J5,6b = 2.0 
Hz, J6a,6b = 12.2Hz, 1H, H-6b), 2.09 (s, 3H, CH3), 2.02 (s, 9H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 170.7, 170.5, 170.0, 169.7 (4C,C=O), 159.1 (1C, 
O-CAr), 135.1 (1C, H-CAr), 128.3 (1C, H-CAr), 121.2 (1C, H-CAr), 117.7 (1C, H-CAr), 
115.2 (1C, CN), 112.4 (1C, NC-CAr), 107.6 (1C, NC-CAr), 96.9 (1C, C-1), 70.5 (1C, 
C-2), 69.9 (1C, C-3), 69.6 (1C, C-5), 68.2 (1C, C-4), 61.7 (1C, C-6), 21.1, 21.0, 
21.0, 20.9 (4C, CH3). 
HRMS (FT-ICR): m/z calcd for [M+Na]+ 497.1166, found 497.1169. 
Anal. calcd. for C22H22N2O10: C 55.70, H 4.67, N 5.90. Found: C 55.34, H 4.94, N 
5.80. 
 
4.4.1.2 3-(2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl)-phthalonitrile (22b) 
 
Prepared from 2,3,4,6-tetra-O-acetyl-α/β -D-galactopyranose 
(21b, 2.44 g, 7 mmol) and 3-nitrophthalonitrile (20, 1 g, 5.78 
mmol.) as described for compound 22a. Purification was 
carried out by column chromatography using toluene 
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acetone mixture (5:1) as eluent to afford 2.29 g product as white solid. Yield 
(84%).  
Mp: 192-194 °C. [α]D20 = +14.7 (c 0.3, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.67-7.63 (m, 1H, HAr), 7.55-7.48 (m, 2H, HAr), 
5.88 (d, J1,2 = 3.8 Hz, 1H, H-1), 5.58 (d, J4,5 = 2.8 Hz, 1H, H-4), 5.51 (dd, J3,4 = 
3.3Hz, J3,2 = 10.9 Hz,1H, H-3), 5.27 (dd, J2,1 = 3.8 Hz, J2,3 = 10.9 Hz, 1H, H-2), 
4.37 (t, J5,6a = J5,6b = 6.6 Hz, 1H, H-5), 4.10 (d, J6,5 = 6.6 Hz, 2H, H-6), 2.15, 2,12, 
2.01, 1.96 (4s, 4x3H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 170.4, 170.3, 170.2, 169.9 (4C,C=O), 159.4 (1C, 
O-CAr), 135.1 (1C, H-CAr), 128.2 (1C, H-CAr), 121.3 (1C, H-CAr), 117.7 (1C, H-CAr), 
115.3 (1C, CN), 112.5 (1C, NC-CAr), 107.6 (1C, NC-CAr), 97.6 (1C, C-1), 70.7 (2C, 
C-2,3), 67.7 (2C, C-4,5), 61.7 (1C, C-6), 21.2, 21.0 (4C, CH3). 
HRMS(FT-ICR): m/z calcd for [M+Na]+ 497.1166, found 497.1170. 
Anal. calcd. for C22H22N2O10: C 55.70, H 4.67, N 5.90. Found: C 55.98, H 5.04, N 
5.74. 
 
4.4.1.3 3-(2,3,6,2’,3’,4’,6’-Hepta-O-acetyl-α-D-maltose)-phthalonitrile (22c) 
 
Prepared from 2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α/β-D-
maltose (21c, 4.45 g, 7 mmol) and 3-nitrophthalonitrile 
(20, 1 g, 5.78 mmol.) as described for compound 22a. 
Purification was carried out by column chromatography 
using toluenen acetone (4:1) mixture to form 3.80 g white solid. Yield (86%). 
Mp: 188-190 °C. [α]D20 = +12.2 (c 0.6, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.68-7.63 (m, 1H, HAr), 7.53-7.49 (m, 2H, HAr), 
5.74-5.69 (m, 2H, H-1,1’), 5.42 (d, J = 4.1, 1H, H-2’), 5.35-5.26 (m, 1H, H-5’), 5.03 
(t, J3,2 = J3,4 = 9.9 Hz, 1H, H-3), 4.92 (dd, J2,3 = 9.9 Hz, J2,1 = 3.8 Hz, 1H, H-2), 4.85 
(dd, J = 10.4Hz, 1H, H-3’), 4.48 (dd, J = 2.6 Hz, J = 12.4Hz, 1H, H-6b), 4.22 (dd, J 
= 3.6 Hz, J = 12.4Hz, 2H, H-6a’,b’), 4.14-3.94 (m, 4H, H6a, H-4, H-5) 2.08, 2.07, 
2.06, 2.03, 2.01, 1.98, 1.97 (7s, 7 x 3H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 171.2, 171.0, 170.9, 170.5, 170.2, 169.8, 169.7 
(7C,C=O), 159.1 (1C, O-CAr), 135.1 (1C, H-CAr), 128.6 (1C, H-CAr), 121.6 (1C, H-
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CAr), 117.7 (1C, H-CAr), 115.3 (1C, CN), 112.4 (1C, NC-CAr), 107.9 (1C, NC-CAr), 
96.9 (1C, C-1’), 96.0 (1C, C-1), 72.7 (1C, C-3), 71.9 (1C, C-5), 71.5 (1C, C-4), 
70.6 (1C, C-2), 70.3 (1C, C-2’), 69.6 (1C, C-3’), 69.0 (1C, C-5), 68.4 (1C, C-4’), 
62.6 (1C, C-6), 61.9 (1C, C-6’), 21.8, 21.2, 21.2, 21.1, 21.0, 21.0, 20.9 (7C, CH3). 
HRMS(FT-ICR): m/z calcd for [M+Na]+ 785.2011, found 785.2007. 
Anal. calcd. for C34H38N2O18: C 53.54, H 5.02, N 3.67. Found: C 53.48, H 5.14, N 
3.75. 
4.4.1.4 3-(2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyranosyl)-phthalonitrile 
(22d) 
 
Prepared from 2,3,4,6-tetra-O-acetyl-1-thio-β-D-
glucopyranose (21d, 2.54 g, 7 mmol) and 3-
nitrophthalonitrile (1, 1 g, 5.78 mmol) as described for 
compound 3a. Column chromatography was carried out by using toluene acetone 
mixture (5:1) to afford 2.27g of white solid. Yield (80%). 
Mp: 137-139 °C. [α]D20 = -3.0 (c 0.25, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 8.05 (dd, J = 1.0Hz, J = 8.1Hz, 1H, HAr), 7.78 (dd, 
J = 1.0Hz, J = 7.9Hz, 1H, HAr), 7.68 (t, J = 1.0 Hz, J = 7.9Hz, 1H, HAr), 5.22 (t, J3,4 
= J3,2 = 9.4 Hz, 1H, H-3), 4.99 (t, J4,3 = J 4,5 = 9.4 Hz, 1H, H-4), 4.87 (t, J2,1 = 9.9 
Hz, 1H, H-2), 4.786 (d, J1,2 = 9.9 Hz, 1H, H-1), 4.25 (dd, J6a,5 = 5.1 Hz, J6a,6b = 
12.5Hz, 1H, H-6a), 4.16 (dd, J6b,5 = 2.3 Hz, J6b,6a = 12.5 Hz, 1H, H-6b), 3.78-3.72 
(m, 1H, H-5), 2.11, 2.07, 2.00, 1.96 (4s, 4 x 3H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 170.8, 170.3, 169.7, 169.9, 169.8 (4C,C=O), 
139.0 (1C, O-CAr), 138.1 (1C, H-CAr), 133.5 (1C, H-CAr), 133.1 (1C, H-CAr), 121.1 
(1C, H-CAr), 117.9 (2C, CN), 115.3 (1C, NC-CAr), 114.1 (1C, NC-CAr), 84.8 (1C, C-
1), 76.7 (1C, C-2), 73.9 (1C, C-3), 69.6 (1C, C-4), 68.2 (1C, C-5), 62.2 (1C, C-6), 
21.1 21.1, 20.9 (4C, CH3). 
HRMS(FT-ICR): m/z calcd for [M+Na]+ 513.0938, found 513.0943. 
Anal. calcd. for C22H22N2O9S: C 53.87, H 4.52, N 5.71, S 6.54. Found: C 53.83, H 
4.65, N 5.69, S 6.47. 
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4.4.1.5 3-(2,3,4,6-Tetra-O-acetyl-1-thio-β-D-galactopyranosyl)-phthalonitrile 
(22e) 
 
Prepared from 2,3,4,6-tetra-O-acetyl-1-thio-β-D-
galactopyranose (21e, 2.54 g, 7 mmol) and 3-nitrophthalonitrile 
(20, 1 g, 5.78 mmol.) as described for compound 22a. 
Purification was carried out by column chromatography using toluene acetone 
(5:1) to produce 2.74 g of white solid. Yield (97%). 
Mp: 139-141 °C. [α]D20 = -0.23 (c 0.4, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 8.09 (dd, J = 1.0Hz, J = 7.9Hz, 1H, HAr), 7.75 (dd, 
J = 1.0Hz, J = 7.9Hz, 1H, HAr), 7.66 (t, J = 1.0 Hz, J = 7.9Hz, 1H, HAr), 5.42 (d, J4,5 
= 2.8 Hz, 1H, H-4), 5.15 (t, J2,1 = J2,3 = 9.9 Hz, 1H, H-2), 5.05 (dd, J3,4 = 3.3 Hz, J3,2 
= 9.9Hz, 1H, H-3), 4.78 (d, J1,2 = 9.9 Hz, 1H, H-1), 4.17 (dd, J6a,5 = 6.9 Hz, J6a,6b = 
11.4Hz, 1H, H-6a), 4.10 (dd, J6b,5 = 6.1 Hz, J6b,6a = 11.4 Hz, 1H, H-6b), 3.96 (t, 
J5,6a = 6.9, 1H, H-5), 2.11, 2.10, 2.02, 1.94 (4s, 4 x 3H, CH3). 
13C NMR (100 MHz, CDCl3): δ =170.8, 170.3, 170.2, 170.0, (4C,C=O), 139.4 (1C, 
O-CAr), 138.1 (1C, H-CAr), 133.2 (1C, H-CAr), 132.9 (1C, H-CAr), 120.2 (1C, H-CAr), 
117.8 (2C, CN), 115.4 (1C, NC-CAr), 114.1 (1C, NC-CAr), 85.7 (1C, C-1), 75.4 (1C, 
C-5), 72.0 (1C, C-3), 67.4 (1C, C-2), 66.7 (1C, C-4), 61.8 (1C, C-6), 21.1 21.1, 
21.0, 20.9 (4C, CH3). 
HRMS(FT-ICR): m/z calcd for [M+Na]+ 513.0938, found 513.0941.  
Anal. calcd. for C22H22N2O9S: C 53.87, H 4.52, N 5.71, S 6.54. Found: C 53.74, H 
4.69, N 5.63, S 6.37. 
 
4.4.2 Syntheses of acetyl protected phthalocyanines 23a-23e: General 
Procedure 
 
A mixture of phthalonitrile (2 mmol), Zn(OAc)2.2H2O (440 mg, 2 mmol), DMF (1.5 
ml), hexamethyldisilazane (HMDS) (65 mg, 0.40 mmol) and TMSOTf (77 mg, 0.35 
mmol) in a sealed glass tube was stirred and heated at 115-120 oC overnight. The 
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semisolid obtained was cooled and precipitated with methanol water (1:2) mixture. 
The precipitates obtained were dried and purified with column chromatography 
using ethylacetate containing 0-3% methanol. 
 
4.4.2.1 1,8(11),15(18),22(25)-Tetra(2,3,4,6-tetra-O-acetyl-α-D-
glucopyranosyl)phthalocyaninato zinc (II) 23a 
 
Prepared from 3-(2,3,4,6-tetra-O-acetyl-α-D-
glucopyranosyl)phthalonitrile (22a, 2.0 g, 4.2 
mmol.) to afford green solid. Yield 1.34 g (65%). 
1H NMR (400MHz, CDCl3): δ = 8.08-7.91 (m, 4H, 
HAr), 7.67-7.48 (m, 8H, HAr), 5.84 (d, J = 3.8Hz, 
4H, H-1), 5.65 (t, J =9.6, 4H), 5.42-5.37 (m, 8H), 5.18-5.00 (m, 4H), 4.26-4.00 (m, 
8H), 2.10-2.00 (m, 48H, CH3). 
UV/Vis (DCM): λmax (log ε) = 691 (5.11), 623 (4.40), 362 (4.50).  
HRMS (MALDI–TOF): m/z calcd for C88H88N8O40Zn 1960.4389; found, 1960.436 
[M]+. 
 
4.4.2.2 1,8(11),15(18),22(25)-Tetra(2,3,4,6-tetra-O-acetyl-α-D-
galactopyranosyl)phthalocyaninato zinc (II) 23b 
 
Prepared from 3-(2,3,4,6-tetra-O-acetyl-α-D-
galactopyranosyl)phthalonitrile (22b, 2.0 g, 4.2 
mmol.) to afford green solid. Yield 0.96 g (47%). 
1H NMR (400MHz, CDCl3): δ = 8.32-8.03 (m, 4H, 
HAr), 7.83-7.40 (m, 8H, HAr), 5.98-5.85 (m, 4H, H-
1), 5.68-5.23 (m, 8H), 5.15-4.97 (m, 2H), 4.59-4.49 (m, 2H), 4.40-4.26 (m, 2H), 
4.20-3.99 (m, 8H), 2.32-1.74 (m, 48H, CH3). 
UV/Vis (DCM): λmax (log ε) = 689 (4.90), 622 (4.24), 362 (4.33). 
HRMS (MALDI–TOF): m/z calcd for C88H88N8O40Zn 1960.4389; found, 1960.441 
[M]+. 
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4.4.2.3 1,8(11),15(18),22(25)-Tetra(2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α-D-
maltose)phthalocyaninato zinc (II) 23c 
 
Prepared from 3-(2,3,6,2’,3’,4’,6’-hepta-O-
acetyl-α-D-maltose)-phthalonitrile (22c, 
 3.0 g, 4. mmol.) to afford green solid. 
Yield 0.90 g (29%). 
1H NMR (400MHz, CDCl3): δ = 8.33-8.15 
(m, 4H, HAr), 8.09-7.93 (m, 4H, HAr), 7.70-7.42 (m, 4H, HAr), 6.72-6.49 (m, 4H), 
5.61-5.19 (m, 6H), 5.11-4.75 (m, 6H), 4.36-3.79 (m, 12H), 2.22-1.86 (m, 48H, 
CH3). 
UV/Vis (DCM): λmax (log ε) = 693 (4.92), 625 (4.14), 356 (4.27). 
HRMS (MALDI–TOF): m/z calcd for C136H155N8O72Zn [M+3H]+, 3115.8004; found, 
3115.808. 
 
4.4.2.4 1,8(11),15(18),22(25)-Tetra(2,3,4,6-tetra-O-acetyl-1-thio-β-D-
glucopyranosyl)phthalocyaninato zinc (II) 23d 
 
Prepared from 3-(2,3,4,6-tetra-O-acetyl-1-thio-
β-D-glucopyranosyl)phthalonitrile (22d, 2.5 g, 
4.2 mmol.) to afford green solid. Yield 0.84 g 
(39%). 
1H NMR (400MHz, DMSO-d6): δ = 9.35-9.05 
(m, 4H, HAr), 8.09-7.96 (m, 8H), 5.70-5.18 (m, 12H), 4.49-4.27 (m, 8H), 4.21- 4.01 
(m, 8H), 2.21-1.83 (m, 48H, CH3). 
UV/Vis (DCM). λmax (log ε) = 727 (4.73), 693 (5.09), 626 (4.47), 333 (4.65). 
HRMS (MALDI–TOF): m/z calcd for C88H88N8O36S4Zn [M]+, 2024.3476; found, 
2024.348. 
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4.4.2.5 1,8(11),15(18),22(25)-Tetra(2,3,4,6-Tetra-O-acetyl-1-thio-β-D-
galactopyranosyl)phthalocyaninato zinc (II) 23e 
 
Prepared from 3-(2,3,4,6-tetra-O-acetyl-1-thio-
β-D-galactopyranosyl)phthalonitrile (22e, 2.5 g, 
4.2 mmol.) to afford green solid. Yield 0.67 g 
(32%). 
1H NMR (400MHz, CDCl3): δ = 9.55-9.33 (m, 
4H, HAr),8.32-8.03 (m, 4H, HAr), 7.79-7.51 (m, 
4H, HAr), 5.75-5.50 (m, 8H), 5.30-4.96 (m, 6H), 4.47-4.20 (m, 12H), 4.09-4.00 (m, 
2H), 2.22-1.91 (m, 48H, CH3). 
UV/Vis (DCM): λmax (log ε) = 727 (4.97), 695 (5.17), 333 (4.67). 
HRMS (MALDI–TOF): m/z calcd for C88H88N8O36S4Zn [M]+, 2024.3476; found, 
2024.348. 
4.4.3 Syntheses of deprotected phthalocyanines 24a-24e: General 
procedure 
 
Acetylated phthalocyanines 23a-23e (400 mg) were dissolved in 2:1 mixture of 
DMSO/MeOH (15 ml). Catalytic amount of MeONa was added and the reaction 
mixture was stirred at room temperature overnight. Precipitation of the unprotected 
phthalocyanine was carried out by adding access of acetone. Precipitates formed 
were filtered and extensively washed with acetone to remove all of DMSO. The 
crude product was dissolved in small amount of water and repeatedly 
recrystallized with acetone. 
 
4.4.3.1 1,8(11),15(18),22(25)-Tetra-α-D-glucosephthalocyaninato zinc (II) 24a 
 
Prepared from phthalocyanine 23a 
(1.0 g, 0.5 mmol.) to afford bluish green solid. Yield 
630 mg (96%). 
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1H NMR (400MHz, DMSO-d6): δ = 9.51-9.48 (m, 4H, HAr), 8.19-8.06 (m, 8H, HAr), 
6.22 (bs, 4H, H1), 5.90 (bs, 4H), 5.47 (bs, 4H), 5.28 (bs, 4H), 4.69-4.64 (m, 8H), 
4.13 (bs, 4H), 3.82-3.74 (m, 8H), 3.64 (bs, 4H), 3.51-3.47 (m, 4H). 
UV/Vis (DMSO): λmax (log ε) = 702 (5.09), 633 (4.42), 352 (4.47). 
HRMS (MALDI–TOF): m/z calcd for C56H57N8O24Zn [M+H]+, 1289.2777; found, 
1289.287. 
 
4.4.3.2 1,8(11),15(18),22(25)-Tetra-α-D-galactosephthalocyaninato zinc (II) 
24b 
 
Synthesized from phthalocyanine 23b 
(800 mg, 0.4 mmol.) to afford bluish green solid. 
Yield 500 mg (95%). 
1H NMR (400MHz, DMSO-d6): δ = 9.44-9.42 (m, 
4H, HAr), 8.17-8.08 (m, 8H, HAr), 6.27 (bs, 4H, 
H1), 5.04-4.74 (m, 12H), 4.50-4.35 (m, 6H), 4.28-4.09 (m, 10H), 3.81-3.54 (m, 
16H). 
UV/Vis (DMSO): λmax (log ε) = 704 (5.17), 633 (4.48), 333 (4.55). 
HRMS (MALDI–TOF): m/z calcd for C56H57N8O24Zn [M+H]+, 1289.2777; found, 
1289.267. 
 
4.4.3.3 1,8(11),15(18),22(25)-Tetra-α-D-maltosephthalocyaninato zinc (II) 24c 
 
Prepared from phthalocyanine 23c 
(800 mg, 0.25 mmol.) to afford bluish green 
solid. Yield 440 mg (91%). 
1H NMR (400MHz, DMSO-d6): δ = 9.51-9.25 
(m, 4H, HAr), 8.18-8.03 (m, 8H, HAr), 6.28 
(bs, 4H, H1), 5.26 (bs, 4H), 5.10-4.87 (m, 12H), 4.23 (bs, 8H), 3.93-3.71 (m, 16H). 
UV/Vis (DMSO): λmax (log ε) = 703 (5.03), 633 (4.29), 329 (4.41). 
HRMS (MALDI–TOF): m/z calcd for C80H97N8O44Zn [M+H]+, 1937.4890; found, 
1937.482. 
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4.4.3.4 1,8(11),15(18),22(25)-Tetra(1-thio-β-D-glucose)phthalocyaninato zinc 
(II) 24d 
 
Prepared from phthalocyanine 23d 
(600 mg, 0.3 mmol.) to afford green solid. Yield 
381 mg (94%). 
1H NMR (400MHz, DMSO-d6): δ = 9.33-9.27 
(m, 4H, HAr), 8.27-8.12 (m, 8H, HAr), 5.47 (d, J 
= 10.2 Hz, 4H), 5.32 (bs, 4H), 5.15 (bs, 4H), 4.69 (bs, 4H), 3.85-3.74 (m, 6H), 
3.70-3.61 (m, 6H), 3.52-3.40 (m, 16H). 
UV/Vis (DMSO): λmax (log ε) = 710 (5.16), 639 (4.46), 336 (4.66), 260 (4.72). 
HRMS (MALDI–TOF): m/z calcd for C56H56N8O20S4Zn [M+H]+, 1353.1863; found, 
1353.181. 
4.4.3.5 1,8(11),15(18),22(25)-Tetra(1-thio-β-D-galactose)phthalocyaninato 
zinc (II) 24e 
 
Prepared from phthalocyanine 23e (500 mg, 0.35 
mmol.) to afford green solid. Yield 328 mg (94%). 
1H NMR (400MHz, DMSO-d6): δ = 9.33-9.26 (m, 
4H, HAr), 8.33-8.07 (m, 8H, HAr), 5.41 (d, J = 9.7 
Hz, 4H), 5.27 (bs, 4H), 5.10 (bs, 4H), 4.80 (bs, 
4H), 4.16-4.02 (m, 6H), 3.94-3.77 (m, 6H), 3.70-3.52 (m, 16H). 
UV/Vis (DMSO): λmax (log ε) = 712 (5.15), 639 (4.42), 336 (4.63), 261 (4.72). 
HRMS (MALDI–TOF): m/z calcd for C56H56N8O20S4Zn [M+H]+, 1353.1863; found, 
1353.187. 
 
4.5 Synthesis of 2,3,9,10,16,17,23,24-octa(α/ß-D-galactopyranos-6-
yl)phthalocyaninato zinc(II) 30 
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4.5.1 4,5-Di(1,2:3,4-di-O-isopropylidene-α-D-galactopyranos-6-
yl)phthalonitrile (27) 
 
NaH (800 mg, 20 mmol) was added to a mixture of 1,2:3,4-di-O-isopropylidene-α-
D-galactopyranose (25, 5.2 g, 20 mmol) and 4,5-difluorophthalonitrile (26b, 1.64 g, 
10 mmol) in 50 ml DMAC or DMF. The reaction mixture was heated at 35-40°C for 
2 days. After completion, the reaction mixture was cooled and 
poured in excess of water. Precipitates formed were collected 
by filtration and dried in vacuo. Purification of the crude product 
was carried out by column chromatography using toluene: 
acetone (5:1) mixture to yield 6.2 g of white solid: yield 96%.  
1H NMR (400MHz, CDCl3): δ = 7.16 (s, 2H, HAr), 5.5 (d, J = 5Hz, 2H, H-1 
anomeric), 4.61 (dd, J = 2.5Hz, J = 7.88Hz 2H, H-4), 4.36 (d, J = 7.88Hz 2H, H-3), 
4.32 (dd, J = 2.5Hz, J = 5.1Hz 6H, H-2), 4.20-4.12 (m, 6 H, H-5, H-6a,b), 1.49 (s, 
6H,CH3), 1.42 (s, 6H, CH3), 1.32 (s, 12H, CH3). 
IR (KBr): 2987, 2933, 2231, 1590, 1519, 1370, 1212, 1115, 1003, 920, 536 cm-1. 
HRMS(FT-ICR): m/z calcd for [M+Na]+ 644.2581; found, 644.249. 
 
4.5.2 4,5-Di(1,2:3,4-di-O-isopropylidene-α-D-galactopyranos-6-
yl)isoindoline (28) 
 
(502 mg, 9.3 mmol) NaOCH3 was added to 40 ml 1:1 mixture 
of dry THF and methanol at room temperature. The mixture 
was cooled to 0°C while passing gaseous NH3 through it. 
Phthalonitrile 27 (6g, 9.3 mmol) was added and the mixture 
was bubbled with NH3 for next half an hour. Afterwards the reaction mixture was 
allowed to stir at room temperature for  
1 hour followed by reflux for more 1 hour while passing gaseous NH3 through it. 
After the completion flow of gas was stopped and the reaction mixture was 
allowed to cool. Poured into water, precipitates formed filtered, washed with water, 
small portion of MeOH and DCM and dried in vacuo: yield 5.9 g (95%). 
LC-MS: (M+Na)+ 684. 
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4.5.3 2,3,9,10,16,17,23,24-octa(1,2:3,4-di-O-isopropylidene-α-D-
galactopyranos-6-yl)phthalocyaninato zinc(II) (29) 
 
Method A: Isoindoline 28 (661 mg, 1 mmol) and 
Zn(AcO)2.2H2O (110mg, 0.5 mmol) were refluxed in 1 
ml DMAE for 24 hr. Reaction mixture was cooled, 
poured in methanol water (1:1) mixture. Precipitates 
formed were filtered, dried and chromatographed first 
with n-hexan and ethylacetate (1:1) mixture to remove 
side products and then with ethylacetate. Yield 196 mg (29%). 
Method B: Isoindoline 28 (661 mg, 1 mmol) and Zn(AcO)2.2H2O (220mg, 1 mmol) 
were mixed well and taken in sealed tube. The tube was heated at 140-145 °C 
overnight. The solid material was then cooled and subjected to column 
chromatography as described in method A. Yield 198 mg (30%)  
1H NMR (400MHz, CDCl3): δ =7.16 (br. s, 8H, HAr), 5.6 (d, J = 4.84Hz, 8H, H-1 
anomeric), 4.76-4.43 (m,48H, H-Gal.), 1.53-1.36 (m, 96H, CH3). 
IR (KBr): 2987, 2936, 1609, 1492, 1456, 1383, 1281, 1211, 1070, 1005, 891, 748, 
511 cm-1. 
HRMS (MALDI–TOF): m/z calcd for C128H160N8O48Zn, [M]+,2644.0551; found, 
2644.053. 
UV/Vis (DMSO): λmax (log ε) = 669 (4.95), 604 (4.48), 352 (4.91), 289 (4.67). 
 
4.5.4 2,3,9,10,16,17,24,25-Octakis(α/ß-D-galactopyranos-6-
yl)phthalocyaninato zinc(II) (30) 
 
Phthalocyanine 29 (100 mg) was stirred in 10 ml 9:1 
mixture of trifluoroacetic acid (TFA) and water, for 4 hours 
at room temperature. The acid was neutralized by slow 
addition of aqueous Na2CO3. Resulting solution was 
concentrated in vacuo and crude product was purified by reverse phase HPLC 
using acetonitrile/H2O as eluent. Yield 60 mg (81%).  
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1H NMR (400MHz, DMSO-d6): δ =8.99 (br. s, 8H, HAr), 5.16-3.71 (3m, 56H, H-
Gal). 
IR (KBr): 3428, 2925, 1716, 1637, 1495, 1399, 1256, 1074, 744, 616, 580 cm-1. 
HRMS (MALDI–TOF): m/z calcd for C80H96N8O48Zn, [M]+,2000.4609; found, 
2000.899. 
UV/Vis (DMSO): λmax (log ε) = 679 (4.67), 613 (3.90), 360 (4.34), 291 (4.12). 
 
4.6 Synthesis of 2,3,9,10,16,17,23,24-octaglycosylated zinc(II) 
phthalocyanines 
 
4.6.1 Synthesis of 4,5-diglycosylated phthalonitrile precursors 32a-32i 
 
4.6.1.1 4,5-Di(2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)phthalonitrile (32a) 
 
K2CO3 (16.56 g, 120 mmol) was added to a mixture of 4,5-
difluorophthalonitrile (26b) (1.64 g, 10 mmol) and 2,3,4,6-
tetra-O-acetyl-α-D-glucopyranose (31a) (6.96 g, 20 mmol) 
in dimethylacetamide (DMAC, 50ml). The reaction mixture 
was heated at 35-40 oC for 48 hours. After completion the reaction mixture was 
cooled and poured into water. Precipitates formed were filtered washed with 
water, dried and purified by column chromatography on silica gel using toluene 
acetone (5:1) as solvent to afford 5.25 g of 32a in 64% yield.  
Mp: 145-150 °C. [α]D20 = +171 (c 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.53 (s, 2H, HAr), 5.78 (d, J1,2 = 3.3 Hz, 2H, H-1), 
5.61 (t, J2,3 = J3,4 = 9.8 Hz, 2H, H-3), 5.13 (dd, 2H, H-2), 5.10 (t, J4,5 = 9.8 Hz, 2H, 
H-4), 4.21 (dd, J5,6a = 5.4 Hz, J6a,6b = 12.4 Hz, 2H, H-6a),4.07 (dd, J5,6b = 2.0 Hz, 
2H, H-6b), 3.96-3.92 (m, 2H, H-5), 2.17, 2.06, 2.00, 1.93 (4s, 4 x 6H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 170.8, 170.7, 169.9, 169.6 (8C, C=O), 149.5 (2C, 
O-CAr), 119.7 (2C, H-CAr), 115.2 (2C, CN), 111.3 (2C, NC-CAr), 95.9 (2C, C-1), 
70.8 (2C, C-2), 69.9 (4C, C-3,5), 68.5 (2C, C-4), 61.9 (2C, C-6), 21.1, 21.0, 20.9, 
20.8 (8C, CH3). 
HRMS (FT-ICR): m/z 843.19498 [M+Na]+. 
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Anal. calcd. for C36H40N2O20: C 52.68, H 4.91, N 3.41. Found: C 52.60, H 4.83, N 
3.43. 
 
4.6.1.2 4,5-Di(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)phthalonitrile 
(32c) 
 
Prepared from 2,3,4,6-tetra-O-acetyl-α-D-galactopyranose 
(31c, 2 mmol) as described for compound 32a. Purification 
was carried out by column chromatography using toluene 
acetone mixture (5:1) to afford the product as white solid. 
Yield (72%).  
Mp: 113-115 °C. [α]D20 = +238 (c 0.5, CHCl3). 
1H NMR (400 MHz, DMSO-d6): δ = 7.99 (s, 2H, HAr), 6.24 (d, J1,2 = 3.3 Hz, 2H, H-
1), 5.47 (d, J4,3 = 3.0 Hz, 2H, H-4), 5.42 (dd, J3,2 = 10.7, J3,4 = 3.0 Hz, 2H, H-3), 
5.30 (dd, J2,3 = 10.76 Hz, J2,1 = 3.3 Hz, 2H, H-2), 4.21 (t, J5,6a = 6.4 Hz, 2H, H-
5),4.04 (d, J = 6.4 Hz, 4H, H-6a,b), 2.15, 2.06, 1.93, 1.86 (4s, 4 x 6H, CH3). 
13C NMR (100 MHz, DMSO-d6): δ = 167.9, 167.8, 167.7, 167.4 (8C, C=O), 146.7 
(2C, O-CAr), 118.7 (2C, H-CAr), 113.7 (2C, CN), 107.0 (2C, NC-CAr), 92.4 (2C, C-
1), 66.0 (2C, C-2), 65.5 (2C, C-3), 65.2 (2C, C-4), 64.2 (2C, C-5), 59.3 (2C, C-6), 
19.1, 18.4, 18.3, 18.2 (8C, CH3). 
HRMS (FT-ICR): m/z 843.20553 [M+Na]+. 
Anal. calcd. for C36H40N2O20: C 52.68, H 4.91, N 3.41. Found: C 52.76, H 4.38, N 
3.38. 
4.6.1.3 4,5-Di(2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α-D-lactose)phthalonitrile (32e) 
 
Prepared from 2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α-D-
lactose (31e, 2 mmol) as described for compound 
32a. Purification was carried out by column 
chromatography using toluene acetone mixture 
(4:1) to afford the product as white solid. Yield (56%).  
Mp: 138-140 °C. [α]D20 = +102.4 (c 0.5, CHCl3). 
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1H NMR (400 MHz, CDCl3): δ = 7.51 (s, 2H, HAr), 5.68 (d, J1,2 = 3.6 Hz, 2H, H-1), 
5.53 (t, J3,2 = J3,4 = 9.9 Hz, 2H, H-3), 5.28 (d, J4’,5’ = 2.8 Hz, 2H, H-4’), 4.99 (dd, J2,3 
= 9.9, J2,1 = 3.6 Hz, 2H, H-2), 4.89 (dd, J2’,1’ = 7.6, J2’,3’ = 3.0 Hz, 2H, H-2’), 4.35 (br, 
J1’,2’ = 7.6 Hz, 4H, H-6b, H-1’), 4.06-4.03 (m, 8H, H-6a, H-6a’,b’, H-3’), 3.85-3.72 
(m, 6H, H-4, H-5, H-5’), 2.09, 2.08, 2.04, 2.01, 1.98, 1.90, 1.87 (7s, 7 x 6H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 171.5, 170.7, 170.3, 169.9, 169.4, 169.1, 168.9 
(14C, C=O), 150.1 (2C, O-CAr), 119.9 (2C, H-CAr), 115.3 (2C, CN), 111.0 (2C, NC-
CAr), 101.5 (2C, C-1’), 95.9 (2C, C-1), 76.4 (2C, C-5), 71.2 (2C, C-4), 71.1 (2C, C-
3), 70.8 (2C, C-5’), 69.9 (2C, C-3’), 69.4 (2C, C-2), 69.3 (2C, C-2’), 69.2 (2C, C-4’), 
67.0 (2C, C-6), 61.2 (2C, C-6’), 21.2, 21.1, 21.0, 20.9, 20.8, 20.8, 20.7 (14C, CH3). 
HRMS (FT-ICR): m/z 1419.37678 [M+Na]+. 
Anal. calcd. for C60H72N2O36: C 51.58, H 5.19, N 2.00. Found: C 51.62, H 5.10, N 
1.95. 
 
4.6.1.4 4,5-Di(2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α-D-cellobiose)phthalonitrile 
(32g) 
 
Prepared from 2,3,6,2’,3’,4’,6’-hepta-O-acetyl-
α-D-cellobiose (31g, 2 mmol) as described for 
compound 32a. Purification was carried out by 
column chromatography using hexane 
ethylacetate mixture (2:5) to afford the product as white solid. Yield (74%). 
Mp: 150-155 °C. [α]D20 = +97.6 (c 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.47 (s, 2H, HAr), 5.65 (d, J1,2 = 3.3 Hz, 2H, H-1), 
5.51 (t, J3,2 = J3,4 = 10.2 Hz, 2H, H-3), 5.07 (t, J3’,2’ = 9.2, 4H, H-4’, H-3’), 4.98 (dd, 
J2,3 = 10.2, J2,1 = 3.3 Hz, 2H, H-2), 4.77 (t, J4,5 = 9.2 Hz, 2H, H-4), 4.39(bd, J1’,2’ = 
8.1 Hz, 2H, H-1’), 4.36-4.32 (m, 4H, H-2’, H6b’), 4.08-3.97 (m, 4H, H-6a, H-6a’), 
3.72-3.60 (m, 6H, H-6b, H-5, H-5’), 2.10, 2.06, 2.04, 1.96, 1.95, 1.90, 1.89 (7s, 7 x 
6H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 171.6, 170.7, 170.5, 169.9, 169.7, 169.4, 169.0 
(14C, C=O), 150.4 (2C, O-CAr), 119.4 (2C, H-CAr), 115.3 (2C, CN), 111.0 (2C, NC-
CAr), 101.2 (2C, C-1’), 95.9 (2C, C-1), 73.2 (2C, C-4), 72.3 (2C, C-5), 71.7 (2C, C-
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3’), 70.9 (2C, C-3), 70.6 (2C, C-5’), 69.7 (2C, C-2’), 68.9 (2C, C-2), 68.1 (2C, C-4’), 
62.0 (2C, C-6), 61.8 (2C, C-6’), 21.2, 21.1, 21.0, 20.9, 20.8, 20.8, 20.7 (14C, CH3). 
HRMS (FT-ICR): m/z 1419.42746 [M+Na]+. 
Anal. calcd. for C60H72N2O36: C 51.58, H 5.19, N 2.00. Found: C 51.46, H 5.29, N 
1.89. 
 
4.6.1.5 4,5-Di(2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α-D-maltose)phthalonitrile (32i) 
 
Prepared from 2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α-D-
maltose (31i, 2 mmol) as described for compound 
32a. Purification was carried out by column 
chromatography using hexane ethyl acetate mixture 
(2:5) to afford the product as white solid. Yield 
(62%).  
Mp: 128-131 °C. [α]D20 = +213.8 (c 0.8, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.62 (s, 2H, HAr), 5.79 (d, J1,2 = 3.8 Hz, 2H, H-1), 
5.61 (t, J3’,4’ = 9.9 Hz, 2H, H-3’), 5.32 (d, J1’,2’ = 4.0 Hz, 2H, H-1’), 5.26 (t, J3,2 = J3,4 
= 10.2 Hz, 2H, H-3), 5.05-5.01 (m, 4H, H-2’, H-4’), 4.86 (dd, J2,3 = 10.2 Hz, J2,1 = 
3.8 Hz, 2H, H-2), 4.43 (bd, J = 10.7, 2H, H-6a), 4.23-4.19 (m, 4H, H-5’, H-6b), 
4.05-3.94 (m, 8H, H-4, H-5, H-6a’,6b’), 2.11, 2.08, 2.07, 2.04, 2.01, 1.98, 1.96 (7s, 
7 x 6H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 171.5, 170.7, 170.3, 169.9, 169.4, 169.1, 168.9 
(14C, C=O), 150.1 (2C, O-CAr), 119.9 (2C, H-CAr), 115.3 (2C, CN), 111.0 (2C, NC-
CAr), 96.8 (2C, C-1’), 95.9 (2C, C-1), 77.1 (2C, C-3), 74.1 (2C, C-5), 71.9 (2C, C-
4), 70.4 (2C, C-2), 70.3 (2C, C-2’), 69.4 (2C, C-3’), 69.1 (2C, C-5), 68.3 (2C, C-4’), 
63.0 (2C, C-6), 61.8 (2C, C-6’), 21.2, 21.1, 21.0, 21.0, 21.0, 20.9, 20.8 (14C, CH3). 
HRMS (FT-ICR): m/z 1419.37527 [M+Na]+. 
Anal. calcd. for C60H72N2O36: C 51.58, H 5.19, N 2.00. Found: C 51.73, H 5.01, N 
2.04. 
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4.6.1.6 4,5-Di(2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranosyl)phthalonitrile 
(32b) 
 
Tetrabutylammonium hydroxide (14 ml, 20 mmol) was added 
to a mixture of 4,5-difluorophthalonitrile (26b) (1.64 g, 10 
mmol) and 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose 
(31b) (7.29 g, 20 mmol) in DCM (20ml). The reaction mixture was stirred at room 
temperature for 48 hours, diluted with water and extracted with DCM. Organic 
phase was washed with water, dried with MgSO4 and concentrated in vacuo. The 
obtained syrup purified by column chromatography over silica gel using toluene 
acetone (5:1) mixture as solvent to afford white solid in 65% yield. 
Mp: 226-230 °C. [α]D20 = -79.2 (c 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.87 (s, 2H, HAr), 5.24 (t, J4,3 = J4,5 9.9 Hz, 2H, H-
4), 5.07 (dd, J2,3 = 10.2 Hz, J3,4 = 9.9 Hz, 4H, H-2, H-3), 4.81 (d, J1,2 = 10.2 Hz 2H, 
H-1), 4.16 (d, J = 4.3 Hz, 4H, H-6a,b), 3.84-3.79 (m, 2H, H-5), 2.13, 2.06, 2.02, 
1.98 (4s, 4 x 6H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 171.0, 170.3, 169.7, 169.6 (8C, C=O), 142.9 (2C, 
O-CAr), 134.4 (2C, H-CAr), 115.3 (2C, CN), 114.6 (2C, NC-CAr), 84.1 (2C, C-1), 
76.7 (2C, C-5), 73.7 (2C, C-3), 69.7 (2C, C-2), 68.2 (2C, C-4), 62.5 (2C, C-6), 
21.2, 21.0, 20.9, 20.9 (8C, CH3). 
HRMS (FT-ICR): m/z 875.16136 [M+Na]+. 
Anal. calcd. for C36H40N2O18S2: C 50.70, H 4.73, N 3.28. Found: C 50.75, H 4.69, 
N 3.41. 
 
4.6.1.7 4,5-Di(2,3,4,6-tetra-O-acetyl-1-thio-β-D-
galactopyranosyl)phthalonitrile (32d) 
 
Prepared from 2,3,4,6-tetra-O-acetyl-1-thio-β-D-
galactopyranose (31d, 2 mmol) as described for compound 
32b. Column chromatography was carried out by using 
hexane ethylacetate mixture (1:1) to afford the product as 
white solid. Yield (80%). 
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Mp: 108-112 °C. [α]D20 = -18.8 (c 0.5, CHCl3).  
1H NMR (400 MHz, CDCl3): δ = 7.99 (s, 2H, HAr), 5.46 (d, J4,3 = 3.1 Hz, 2H, H-4), 
5.29 (t, J2,1 = J2,3 = 9.9 Hz, 2H, H-2), 5.08 (dd, J3,2 = 9.9 Hz, J3,4 = 3.1 Hz, 2H, H-3), 
4.78 (d, J1,2 = 9.9 Hz, 2H, H-1), 4.17-4.00 (m, 6H, H-5, H6a,b), 2.19, 2.08, 2.06, 
1.96 (4s, 4 x 6H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 170.9, 170.4, 170.2, 169.8 (8C, C=O), 142.8 (2C, 
O-CAr), 134.5 (2C, H-CAr), 115.5 (2C, CN), 114.2 (2C, NC-CAr), 84.5 (2C, C-1), 
75.8 (2C, C-5), 71.9 (2C, C-3), 67.5 (2C, C-4), 66.6 (2C, C-2), 62.5 (2C, C-6), 
21.4, 21.1, 21.0, 20.9 (8C, CH3). 
HRMS (FT-ICR): m/z 875.16055 [M+Na]+. 
Anal. calcd. for C36H40N2O18S2: C 50.70, H 4.73, N 3.28. Found: C 50.43, H 4.47, 
N 3.13. 
 
4.6.1.8 4,5-Di(2,3,6,2’,3’,4’,6’-hepta-O-acetyl-1-thio-β-D-lactose)phthalonitrile 
(32f) 
 
Prepared from 2,3,6,2’,3’,4’,6’-hepta-O-acetyl-1-
thio-β-D-lactose (31f, 2 mmol) as described for 
compound 32b. Purification was carried out by 
column chromatography using hexane ethyl acetate mixture (1:2) to afford the 
product as white solid. Yield (55%).  
Mp: 140-145 °C. [α]D20 = -47.2 (c 0.8, CHCl3).  
1H NMR (400 MHz, CDCl3): δ = 7.83 (s, 2H, HAr), 5.33 (d, J4’,3’ = 3.6 Hz, 2H, H-4’), 
5.21 (t, J3,2 = J3,4 = 8.9 Hz, 2H, H-3), 5.07 (dd, J2,1 = 10.2, J2,3 = 8.9 Hz 2H, H-2), 
4.92 (m, 4H, H-2’, H-3’), 4.75 (d, J1,2 = 10.2, Hz, 2H, H-1), 4.50 (bd, J6b,6a = 11.9 
Hz, 2H, H-6b), 4.47 (d, J1’,2’ = 7.9 Hz, 2H, H-1’), 4.09-4.05 (m, 6H, H-6a, H-6a’,b’), 
3.86 (t, J5’,6a’ = 6.6 Hz, 2H, H-5’), 3.78-3.71 (m, 4H, H-4, H-5), 2.15, 2.11, 2.04, 
2.03, 2.01, 1.93 (6s, 42H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 170.8, 170.7, 170.4, 170.4, 169.9, 169.8, 169.4 
(14C, C=O), 142.8 (2C, O-CAr), 134.4 (2C, H-CAr), 115.3 (2C, CN), 114.5 (2C, NC-
CAr), 101.5 (2C, C-1’), 83.9 (2C, C-1), 77.1 (2C, C-5), 76.1 (2C, C-4), 73.6 (2C, C-
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3), 71.3 (2C, C-5’), 71.2 (2C, C-3’), 70.8 (2C, C-2), 69.9 (2C, C-2’), 69.4 (2C, C-4’), 
62.5 (2C, C-6), 61.2 (2C, C-6’), 21.2, 21.1, 21.0, 21.0, 20.9, 20.9, 20.8 (14C, CH3). 
HRMS (FT-ICR): m/z 1451.32976 [M+Na]+. 
Anal. calcd. for C60H72N2O34S2: C 50.42, H 5.08, N 1.96. Found: C 50.41, H 5.12, 
N 1.85. 
 
4.6.1.9 4,5-Di(2,3,6,2’,3’,4’,6’-hepta-O-acetyl-1-thio-β-D-
cellobiose)phthalonitrile (32h) 
 
Prepared from 2,3,6,2’,3’,4’,6’-hepta-O-acetyl-1-
thio-β-D-cellobiose (31h, 2 mmol) as described for 
compound 32b. Purification was carried out by 
column chromatography using hexane ethylacetate mixture (1:3) to afford the 
product as white solid. Yield (71%).  
Mp: 275-280 °C. [α]D20 = -58.6 (c 0.5, CHCl3).  
1H NMR (400 MHz, CDCl3): δ = 7.83 (s, 2H, HAr), 5.19 (t, J4’,3’ = 5.1 Hz, 2H, H-4’), 
5.12 (t, J2,1 = 10.2 Hz, 2H, H-2), 5.10-4.96 (m, 4H, H-2’, H-3), 4.89 (t, J3’,4’ = 5.1 Hz, 
2H, H-3’), 4.75 (d, J1,2 = 10.2, Hz, 2H, H-1), 4.52 (bd, J6b,6a = 8.9 Hz, 2H, H-6b), 
4.48 (d, J1’,2’ = 6.4 Hz, 2H, H-1’), 4.36 (dd, J6b’,6a’ = 12.5 Hz, J6b’,5 = 4.1 Hz, 2H, H-
6b’), 4.07-4.01 (m, 4H, H-6a, H-6a’), 3.74-3.67 (m, 4H, H-4, H-5), 3.65-3.63 (m, 
2H, H-5’), 2.15, 2.05, 2.03, 1.99, 1.97, 1.94 (6s, 42H, CH3). 
13C NMR (100 MHz, CDCl3): δ = 170.8, 170.7, 170.5, 169.9, 169.8, 169.6, 169.4 
(14C, C=O), 142.8 (2C, O-CAr), 134.5 (2C, H-CAr), 115.3 (2C, CN), 114.5 (2C, NC-
CAr), 101.2 (2C, C-1’), 83.9 (2C, C-1), 77.1 (2C, C-5), 76.3 (2C, C-4), 73.3 (2C, C-
3), 73.2 (2C, C-4’), 72.4 (2C, C-5’), 71.9 (2C, C-2’), 69.8 (2C, C-2), 68.0 (2C, C-3’), 
62.4 (2C, C-6), 61.8 (2C, C-6’), 21.3, 21.1, 20.9, 20.8 (14C, CH3). 
HRMS (FT-ICR): m/z 1451.33138 [M+Na]+. 
Anal. calcd. for C60H72N2O34S2: C 50.42, H 5.08, N 1.96. Found: C 50.16, H 5.07, 
N 1.91. 
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4.6.2 Synthesis of acetyl protected octaglycosylated zinc(II) 
phthalocyanines 33a-33i: General Procedure 
 
A mixture of phthalonitrile (1 mmol), p-toluenesulfonic acid monohydrate (0.1 
mmol), hexamethyldisilazane (HMDS) (0.3 mmol), DMF (0.5 ml) and 
Zn(OAc)2.2H2O (0.5 mmol) in a sealed glass tube was stirred and heated at 125-
130 oC overnight. The semisolid obtained was cooled and precipitated with 
methanol water (1:2) mixture. The precipitates obtained were dried and column 
chromatographed with ethylacetate containing 0-5% methanol. 
 
4.6.2.1 2,3,9,10,16,17,23,24-Octa(2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)-
phthalocyaninato zinc(II) 33a 
 
Prepared from phthalonitrile 32a (5 g, 6.1 
mmol), using general procedure to furnish 
green solid. Yield: 3.8 g (75%).  
1H NMR (400MHz, CDCl3): δ = 9.16 (bs, 8H, 
HAr), 6.47 (bs, 8H, H-1), 5.92-5.88 (m, 8 H), 
5.41-5.25 (m, 16H), 4.35-4.18 (m, 24H), 2.28-
1.96 (m, 96 H, CH3). 
UV/Vis (DCM): λmax (log ε) = 673 (5.50), 607 
(4.68), 360 (5.10), 288 (4.76). 
HRMS (MALDI–TOF): m/z calcd for C144H161N8O80Zn, [M+H]+, 3345.8068; found, 
3345.942, calcd for [M+H-C2H2O]+,3303.7962; found 3303.941, calcd. for [M+H-
2(C2H2O)]+,3261.7856; found 3261.852. HRMS (FT-ICR): m/z calcd for [M+2Na]2+, 
1760.7989; found, 1760.7967. 
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4.6.2.2 2,3,9,10,16,17,23,24-Octa(2,3,4,6-tetra-O-acetyl-α-D-
galactopyranosyl)-phthalocyaninato zinc(II) 33c 
 
Prepared from phthalonitrile 32c (5 g, 6.1 
mmol), using general procedure to furnish 
green solid. Yield: 3.56 g (70%).  
1H NMR (400MHz, CDCl3): δ = 9.15 (bs, 8H, 
HAr), 6.67 (bs, 8H, H-1), 5.74- 5.58 (m, 20H), 
4.60-3.99 (m, 28H), 2.29-1.96 (m, 96H, CH3). 
UV/Vis (DCM): λmax (log ε) = 673 (5.38), 607 
(4.56), 359 (4.96), 288 (4.76). 
HRMS (MALDI–TOF): m/z calcd. for 
C144H160N8O80Zn, [M+H]+, 3345.8068; found, 3345.848, calcd. for [M+H-C2H2O]+, 
3303.7962; found 3303.869, calcd. for [M+H-2(C2H2O)]+,3261.7850;found 
3261.816. 
 
4.6.2.3 2,3,9,10,16,17,23,24-Octa(2,3,4,6-tetra-O-acetyl-1-thio-β-D-
galactopyranosyl)-phthalocyaninato zinc(II) 33d 
 
Synthesized from phthalonitrile 32d (2.56 
g, 3 mmol), using general procedure to 
furnish green solid. Yield: 2.0 g (78%).  
1H NMR (400MHz, CDCl3): δ = 9.35 (bs, 
8H, HAr), 5.54 (bs, 8H, H1), 5.40-5.09 (m, 
24H), 4.42 (bs, 8H), 4.06-3.99 (m, 16H), 
1.96-1.74 (m, 96H, CH3). 
UV/Vis (DCM): λmax (log ε) = 700 (5.63), 
629 (4.90), 369 (5.24), 302 (4.84). 
HRMS (MALDI–TOF): m/z calcd. for C144H160N8O72S8Zn, [M+H]+, 3473.6240; 
found, 3473.619, calcd. for [M+H-C2H2O]+, 3431.6212; found 3431.504. 
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4.6.2.4 2,3,9,10,16,17,23,24-Octa(2,2’,3,3’,4’,6,6’-hepta-O-acetyl-α-D-lactose)-
phthalocyaninato zinc(II) 33e 
 
Prepared from phthalonitrile 32e (4 g, 
2.87 mmol), using general procedure 
to afford green solid. Yield: 2.5 g 
(62%).  
1H NMR (400MHz, CDCl3): δ = 9.17 
(bs, 8H, HAr), 5.28-5.14 (m, 22H), 
4.89-4.71 (m, 22H), 4.31-3.95 (m, 
68H), 2.10-1.88 (m, 168H, CH3). 
UV/Vis (DCM): λmax (log ε) = 674 
(5.29), 611 (4.24), 359 (5.00). 
HRMS (MALDI–TOF): m/z calcd. for 
C240H288N8O144Zn, [M]+, 5654.2122; found, 5654.067, calcd. for [M-2(C2H2O)]+, 
5570.1389; found 5570.553,calcd. for [M-3(C2H2O)]+,5529.1104; found 
5529.569,calcd. for [M-4(C2H2O)]+, 5487.655; found 5487.782, calcd. for [M-
6(C2H2O)]+, 5403.5922; found 5403.651. 
 
4.6.2.5 2,3,9,10,16,17,23,24-Octa(2,2’,3,3’,4’,6,6’-hepta-O-acetyl-1-thio-β-D-
lactose)-phthalocyaninato zinc(II) 33f 
 
Prepared from phthalonitrile 32f 
(4.3 g, 3 mmol), using general 
procedure to furnish green solid. 
Yield: 3.0 g (70%).  
1H NMR (400MHz, CDCl3): δ = 9.17 
(bs, 8H, HAr), 6.40 (bs, 8H, H1), 
5.80-5.65 (m, 8H), 5.37- 5.21 (m, 
24H), 4.97-4.93 (m, 16H), 4.36-3.99 
(m, 56H), 2.10-1.91 (m, 168H, 
CH3). 
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UV/Vis (DCM): λmax (log ε) = 700 (5.11), 628 (4.91), 364 (4.80). 
HRMS (MALDI–TOF): m/z calcd. for C240H288N8O136S8Zn, [M+H]+, 5783.7530; 
found, 5783.981, calcd. for [M+H-2(C2H2O)]+,5700.1401; found 5700.190, calcd. 
for [M+H-8(C2H2O)]+,5447.4595; found 5447.484. 
 
4.6.2.6 2,3,9,10,16,17,23,24-Octa(2,2’,3,3’,4’,6,6’-hepta-O-acetyl-α-D-
cellobiose)-phthalocyaninato zinc(II) 33g 
 
Prepared from phthalonitrile 32g (4.2 g, 3 
mmol), using general procedure to furnish 
green solid. Yield: 2.3 g (55%).  
1H NMR (400MHz, CDCl3): δ = 9.07 (bs, 8H, 
HAr), 6.31 (bs, 8H, H1), 5.71 (bs, 8H), 5.26- 
5.21 (m, 22H), 4.87-4.74 (m, 22H), 4.29-3.86 
(m, 52H), 2.05-1.86 (m, 168 H, CH3). 
UV/Vis (DCM): λmax (log ε) = 673 (5.59), 612 
(4.42), 360 (4.84), 288 (4.70). 
HRMS (MALDI–TOF): m/z calcd. for C240H288N8O144Zn, [M+H]+, 5655.22; found, 
5655.085, calcd. for [M+H-C2H2O]+, 5613.1914; found 5613.067, calcd. for [M+H-
2(C2H2O)]+, 5571.1548; found 5571.093, calcd. for [M+H-3(C2H2O)]+, 5529.1181; 
found 5529.081, calcd. for [M+H-4(C2H2O)]+, 5487.0814; found 5486.953. 
 
4.6.2.7 2,3,9,10,16,17,23,24-
Octa(2,2’,3,3’,4’,6,6’-hepta-O-acetyl-1-
thio-β-D-cellobiose)-
phthalocyaninato zinc(II) 33h 
 
Prepared from phthalonitrile 32f (4.3 g, 
3 mmol), using general procedure to 
furnish green solid. Yield: 2.7 g (64%).  
1H NMR (400MHz, CDCl3): δ = 9.35 (bs, 
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8H, HAr), 5.50 (bs, 8H, H1), 5.17-4.99 (m, 8H), 4.76-4.64 (m, 24H), 4.08-3.68 (m, 
72H), 1.75-1.64 (m, 168H, CH3). 
UV/Vis (DCM): λmax (log ε) = 700 (5.30), 629 (4.61), 370 (4.96). 
HRMS (MALDI–TOF): m/z calcd. for C240H288N8O136S8Zn, [M+H]+, 5783.7530; 
found, 5783.823, calcd. for [M+H-C2H2O]+,5741.7242; found 5741.948, calcd. for 
[M+H-2(C2H2O)]+, 5699.6876; found 5699.947, calcd. for [M+H-3(C2H2O)]+, 
5657.6509; found 5657.670, calcd. for [M+H-4(C2H2O)]+, 5615.6142; found 
5615.502, calcd. for [M+H-5(C2H2O)]+, 5573.5775; found 5573.653. 
 
4.6.2.8 2,3,9,10,16,17,23,24-Octa(2,2’,3,3’,4’,6,6’-hepta-O-acetyl-α-D-
maltose)-phthalocyaninato zinc(II) 33i 
 
Prepared from phthalonitrile 32i (4.2 
g, 3 mmol), using general procedure 
to afford green solid. Yield: 2.8 g 
(68%).  
1H NMR (400MHz, CDCl3): δ = 9.17 
(bs, 8H, HAr), 6.40 (bs, 8H, H1), 5.80-
5.65 (m, 8H), 5.37-5.21 (m, 24H), 
4.97-4.93 (m, 16H), 4.36-3.99 (m, 
56H), 2.10-1.91 (m, 168 H, CH3). 
UV/Vis (DCM): λmax (log ε) = 673 
(5.49), 608 (4.69), 359 (5.06), 288 (4.84). 
HRMS (MALDI–TOF): m/z calcd. for C240H288N8O144Zn, [M+H]+, 5655.2202; found 
5655.261, calcd. for [M+H- C2H2O]+, 5613.1835; found 5613.593, calcd. for [M+H-
2(C2H2O)]+, 5571.1468; found 5571.489, calcd. for [M+H-7(C2H2O)]+, 5360.9634; 
found 5360.961. 
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4.6.3 Synthesis of octaglycosylated zinc(II) phthalocyanines 34a-34i 
 
4.6.3.1 2,3,9,10,16,17,23,24-Octa-α-D-glucopyranosyl phthalocyaninato 
zinc(II) 34b 
 
Zn dust (33 mg, 0.5 mmol) was added to 
phthalonitrile 33b (852 mg, 1 mmol) 
dissolved in THF/MeOH mixture (1:1) in a 
glass tube. Catalytic amount of conc. HCl 
was then added. The tube was sealed and 
the reaction mixture was refluxed overnight. 
The reaction mixture was diluted with small 
amount of water and filtered to remove 
unreacted metal. The filtrate was 
concentrated to obtain crude phthalocyanine, which was purified by reverse phase 
HPLC with water/acetonitrile as solvent; Yield: 100 mg (19%).  
1H NMR (400MHz, DMSO-d6): δ = 7.79 (bs, 8H, HAr), 5.60 (bs, 8H, H1), 5.39-4.95 
(m, 32H), 3.51-3.19 (m, 48H). 
UV/Vis (DMSO): λmax (log ε) = 710 (5.38), 636 (4.66), 371 (4.99). 
HRMS (MALDI–TOF): m/z calcd. for C80H96N8O40S8Zn, [M]+, 2128.2781; found, 
2128.258, calcd. for [M-C6H10O5]+, 1966.2253; found 1966.232. HRMS (FT-ICR): 
m/z calcd. for [M+2Na]2+, 1089.1278; found, 1089.1282. 
 
4.6.4 Deprotection of acetyl groups: General procedure 
 
Phthalocyanine (400 mg) was dissolved in 2:1 mixture of DMSO/MeOH (15 ml). 
Catalytic amount of Na metal was added and the reaction mixture was stirred at 
room temperature overnight. Ion exchange resin amberlite IR-120H was added to 
neutralize the solution. The solution was filtered to remove the resins. Precipitation 
of the product was carried out by excess of acetone. Precipitates formed were 
filtered and dissolved in small amount of water and reprecipitated with acetone. 
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The crude product was dried and purified with reverse phase HPLC using water 
acetonitrile as eluent. 
 
4.6.4.1 2,3,9,10,16,17,23,24-Octa-α-D-glucopyranosyl phthalocyaninato 
zinc(II) 34a  
 
Prepared from phthalocyanine 33a, using 
general procedure to afford bluish green solid. 
Yield: 225 mg (94%).  
1H NMR (400MHz, DMSO-d6): δ = 9.24 (bs, 
8H, HAr), 6.21 (bs, 8H, H1), 6.18-6.02 (m, 8H), 
5.46 (bs, 8H), 4.42-4.28 (m, 8H), 4.04-3.70 (m, 
56H). 
UV/Vis (DMSO): λmax (log ε) = 678 (4.89), 612 
(4.12), 360 (4.51), 288 (4.23). 
HRMS (MALDI–TOF): m/z calcd. for C80H96N8O48Zn, [M+], 2000.4608; found, 
2000.380, calcd. for [M-C6H10O5]+, 1838.4080; found 1838.319. 
HRMS (FT-ICR): m/z calcd. for [M+2Na]2+, 1023.7212; found, 1023.7214. 
 
4.6.4.2 2,3,9,10,16,17,23,24-Octa-α-D-galactopyranosyl phthalocyaninato 
zinc(II) 34c 
 
Prepared from phthalocyanine 33c, using 
general procedure to afford bluish green solid. 
Yield: 218 mg (91%).  
1H NMR (400MHz, DMSO-d6): δ = 9.26 (bs, 
8H, HAr), 6.16 (bs, 8H, H1), 5.21 (d, J = 6.32, 
8H), 4.94 (d, J = 4.6, 8H), 4.86-4.79 (m, 16H), 
4.38 (bs, 8H) 4.14-4.07 (m, 24H), 3.79-3.71 (m, 
18H). 
UV/Vis (DMSO): λmax (log ε) = 680 (5.34), 613 (4.58), 360 (4.97), 290 (4.67). 
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HRMS (MALDI–TOF): m/z calcd. for C80H96N8O48Zn, [M+], 2000.4608; found, 
2000.237,calcd. for [M-C6H10O5]+, 1838.4080; found 1838.217. 
 
4.6.4.3 2,3,9,10,16,17,23,24-Octa-1-thio-β-D-
galactopyranosylphthalocyaninato 
zinc(II) 34d 
 
Prepared from phthalocyanine 33d, using 
general procedure to afford green solid. 
Yield: 218 mg (89%).  
1H NMR (400MHz, DMSO-d6): δ = 9.49 
(bs, 8H, HAr), 5.52 (bs, 8H, H1), 5.37 (bs, 
8H), 5.06-4.70 (m, 24H), 3.95-3.63 (m, 
48H). 
UV/Vis (DMSO): λmax (log ε) = 708 (5.06), 635 (4.33), 371 (4.66), 314 (4.41). 
HRMS (MALDI–TOF): m/z calcd. for C80H95N8O40S8Zn, [M+H+], 2129.2859; found, 
2129.283, calcd. for [M+H-C6H10O5]+, 1967.2331; found 1967.225. 
 
4.6.4.4 2,3,9,10,16,17,23,24-Octa-α-D-lactosephthalocyaninato zinc(II) 34e 
 
Synthesized from phthalocyanine 33e, using 
general procedure to afford bluish green solid. 
Yield: 217 mg (93%).  
1H NMR (400MHz, DMSO-d6): δ = 9.18 (bs, 
8H, HAr), 6.12 (bs, 8H, H1), 5.21 (bs, 16H), 
4.82-4.11 (m, 56H), 3.87-3.68 (m, 88H). 
UV/Vis (DMSO): λmax (log ε) = 680 (4.99), 358 
(4.14). 
HRMS (MALDI–TOF): m/z calcd. for 
C128H177N8O88Zn, [M+H]+, 3297.8912; found, 3297.478, calcd. for [M+H-
2(C6H10O5)]+, 2973.7856; found 2973.426, calcd. for [M+H-3(C6H10O5)]+, 
2811.7328; found 2811.266. 
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4.6.4.5 2,3,9,10,16,17,23,24-Octa-1-thio-β-D-lactose phthalocyaninato 
zinc(II) 34f 
 
Prepared from phthalocyanine 33f, 
using general procedure to furnish 
green solid. Yield: 206 mg (87%).  
1H NMR (400MHz, DMSO-d6): δ = 9.41 
(bs, 8H, HAr), 5.11 (bs, 8H, H1), 4.78-
4.65 (m, 56H), 3.84-3.32 (m, 112H). 
UV/Vis (DMSO): λmax (log ε) = 708 
(5.01), 370 (4.76). 
HRMS (MALDI–TOF): m/z calcd. for 
C128H176N8O80S8Zn, [M]+, 3424.7007; found, 3424.352, calcd. for [M-2(C6H10O5)]+, 
3100.5951; found 3100.124. 
 
4.6.4.6 2,3,9,10,16,17,23,24-Octa-α-D-cellobiose phthalocyaninato zinc(II) 
34g 
 
Synthesized from phthalocyanine 
33g, using general procedure to 
afford bluish green solid. Yield: 210 
mg (90%).  
1H NMR (400MHz, DMSO-d6): δ = 
9.16 (bs, 8H, HAr), 6.13 (bs, 8H, H1), 
5.39-5.25 (m, 8H), 5.01 (bs, 16H), 
4.76-4.22 (m, 48H), 3.83-3.12 (m, 
80H). 
UV/Vis (DMSO): λmax (log ε) = 679 
(5.31), 612 (4.54), 361 (4.94), 289 (4.73). 
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HRMS (MALDI–TOF): m/z calcd. for C128H176N8O88Zn, [M]+, 3296.88; found, 
3297.023,calcd. for [M-C6H10O5]+, 3134.8306; found 3134.858, calcd. for [M-
2(C6H10O5)]+, 2972.7778; found 2972.752. 
 
4.6.4.7 2,3,9,10,16,17,23,24-Octa-1-thio-β-D-cellobiose phthalocyaninato 
zinc(II) 34h 
 
Prepared from phthalocyanine 33h, 
using general procedure to afford 
green solid. Yield: 216 mg (81%). 
1H NMR (400MHz, DMSO-d6): δ = 
9.46 (bs, 8H, HAr), 6.29 (bs, 8H, 
H1), 5.39-5.31 (m, 16H), 5.01 (bs, 
16H), 4.80-4.41 (m, 48H), 3.97-3.17 
(m, 80H). 
UV/Vis (DMSO): λmax (log ε) = 709 
(5.32), 636 (4.60), 372 (4.95). 
HRMS (MALDI–TOF): m/z calcd. for C128H176N8O80S8Zn, [M]+, 3424.7007; found, 
3424.646, calcd. for [M+H-2(C6H10O5)]+, 3101.6029; found 3101.486. 
 
4.6.4.8 2,3,9,10,16,17,23,24-Octa-α-D-maltose phthalocyaninato zinc(II) 34i 
 
Synthesized from phthalocyanine 
33i, using general procedure to 
furnish bluish green solid. Yield: 
198 mg (85%).  
1H NMR (400MHz, DMSO-d6): δ = 
9.23 (bs, 8H, HAr), 6.03 (bs, 8H, 
H1), 5.50-5.03 (m, 48H), 4.19 (bs, 
12H), 3.91-3.11 (m, 92H). 
UV/Vis (DMSO): λmax (log ε) = 679 
(4.68), 611 (4.43), 361 (4.35). 
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HRMS (MALDI–TOF): m/z calcd. for C128H176N8O88Zn, [M]+, 3296.8834; found, 
3296.746, calcd. for [M-C6H10O5]+, 3134.8306; found 3134.762, calcd. for [M-
2(C6H10O5)]+, 2972.7778; found 2972.718, calcd. for [M-3(C6H10O5)]+, 2810.725; 
found 2810.607, calcd. for [M-4(C6H10O5)]+, 2648.6722; found 2648.515. 
 
4.7 Synthesis of tetraglucosylated zinc(II) naphthalocyanines 45 and 46 
 
4.7.1 3,4-Dimethylphenyl-2,3,4,6-tetra-O-acetyl-D-glucopyranoside (37) 
 
To a solution of penta-O-acetyl-β-D-glucopyranose 
(35) (11.71 g, 30 mmol.) and 3,4-dimethylphenol (36) 
(4g, 33 mmol) in dry benzene (100 ml) was added 
boron trifluorideetherate (0.4 ml). The reaction mixture was stirred  
at room temperature for 48 hours. After completion, the reaction was terminated 
by dilution with of benzene (100 ml). The benzene solution was washed with 
water, sodium hydroxide (1N) and water to neutral washings, dried with sodium 
sulphate and evaporated in vacuo to obtain syrup like product which was 
recrystallised from hot ethanol to get white solid. Yield 12.76 g (94%). 
Mp: 113-115 °C. [α]D20 = -7.1 (c 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.00 (d, 3J = 8.1 Hz, 1H, H-5’), 6.76 (d, J = 2.3 Hz, 
1H, H-2’), 6.70 (dd, 3J = 8.1 Hz, J = 2.3 Hz, 1H, H-6’), 5.28 – 5.19 (m, 2H, H-1, H-
3), 5.12 (t, 1H, H-2), 5.01 (d, 3J = 7.4 Hz, 1H, H-4), 4.27 (dd, J6a,6b = 12.4, J6a,5 = 
5.4, 1H, H-6a), 4.15 (dd, J6b,6a = 12.4, J5,6b = 2.5, 1H, H-6b), 3.84 –3.78 (m, 1H, H-
5), 2.20, 2.17 (2s, 6H, H-CH3), 2.06, 2.03, 2.01, 2.00 (4s, 12H, H(Ac)). 
13C NMR (100 MHz, CDCl3): δ =171.0, 170.6, 169.8, 169.7 (4C,C=O), 155.4 (1C, 
C1’), 138.3 (1C, C-2’), 131.9 (1C, C-6’), 130.7 (1C, C-5’), 118.9 (1C, C-3’), 114.4 
(1C, C-4’), 99.8 (1C, C-1), 73.1 (1C, C-2), 72.3 (1C, C-3), 71.6 (1C, C-5), 68.7 
(1C, C-4), 62.4 (1C, C-6), 21.2, 21.0, 20.9, 20.8, 20.3, 10.3 (6C, CH3). 
HRMS (FT-ICR): m/z 475.15747 [M+Na]+. 
IR (KBr): 2957, 1755, 1607,1503, 1429, 1368, 1213, 1169, 1095, 1077, 1045, 908, 
817, 600 cm-1. 
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4.7.2 3,4-Bis(dibromomethyl)phenyl-2,3,4,6-tetra-O-acetyl-D-
glucopyranoside (38) 
 
3,4-Dimethylphenyl-2,3,4,6-tetra-O-acetyl-D-
glucopyranoside (37) (9 g, 20 mmol) , NBS 
(14.24 g, 80 mmol) and benzoyl peroxide (0.15 g) were stirred in dry CCl4 (100 ml) 
at reflux for 48 h, while illuminating the mixture with 250W tungsten lamp. The 
warm solution was filtered and the precipitate was washed with warm CCl4 (50 ml). 
After removal of bromine traces with NaHSO3, the filtrate was dried and 
concentrated to yield a white solid. Crude product was purified by column 
chromatography using n-hexane: ethylacetate (3:1) mixture. Yield 14 g (91%). 
1H NMR (400 MHz, CDCl3): δ = 7.58 (d, 3J = 8.1 Hz, 1H, H-5’), 7.05 (d, J = 2.3 Hz, 
1H, H-2’), 6.93 (dd, 3J = 8.1 Hz, J = 2.3 Hz, 1H, H-6’), 6.90 (s, 1H, H-CHBr2), 6.88 
(s, 1H, H-CHBr2), 5.31 – 5.01 (m, 2H, H-1, H-3), 4.54 (s, 1H, H-2), 4.40-4.29 (m, 
2H, H-4, H-6a), 4.05-3.80 (m, 2H, H-5, H-6b), 2.09-1.83 (m, 12H, H-CH3). 
IR (KBr): 3050, 2960, 1759, 1606, 1576, 1498, 1429, 1368, 1240, 1042, 907, 702, 
639, 599 cm-1. 
HRMS (FT-ICR): m/z: 788.794 [M + Na]+, 802.773 [M + K]+. 
 
4.7.3 6-(2,3,4,6-Tetra-O-acetyl-D-glucopyranosyl)naphthalodinitrile 39 
 
Method A: Compound 38 (7.68 g, 10 mmol) was 
stirred with fumaronitrile (780 mg, 10 mmol) and 
NaI (10 g) in dry DMF (100 ml) at 75-80 °C for 24 h. 
Afterwards additional fumaronitrile (780 mg, 10 mmol) was added, the reaction 
mixture was stirred for another 24 h. The cold solution was poured into a solution 
of NaHSO3 in water. Precipitates formed were filtered, dried and purified by 
column chromatography with acetonitrile: DCM (1:9). Yield 3.4 g (65%). 
Method B: 6-Hydroxynaphthalonitrile (42) (1.36 g, 7 mmol) and 
acetobromoglucose 43 (7 mmol) were suspended in acetonitrile (100 ml). Silver(I) 
oxide (2.32 g, 10 mmol) was added and the reaction mixture was heated at 50 oC 
for 24 h. The reaction mixture was cooled and filtered to remove inorganic salts 
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and solvent was evaporated by rotary evaporator. The solid obtained was purified 
by column chromatography using toluene aceton (4:1) mixture as solvent. Yield 
2.53 g (69%).  
Mp: 190-192 °C. [α]D20 = -19 (c 0.8, CHCl3). 
1H NMR (400 MHz, DMSO-d6): δ = 8.68 (s, 1H, H-1’), 8.59 (s, 1H, H-4’), 8.23 (d, J 
= 9.2 Hz, 1H, H-8’), 7.84 (d, J = 2.3, 1H, H-5’), 7.64 (dd, J = 9.2 Hz, J = 2.3 Hz, 
1H, H-7’), 5.79 (d, J = 7.9 Hz, 1H, H-1), 5.46 (t, J = 9.6 Hz, 1H, H-3), 5.31 (t, J = 
7.9 Hz, 1H, H-2), 5.21 (t, J = 9.6, 1H, H-4), 4.37-4.25 (m, 3H, H-5, H-6a,b), 2.03 –
2.01 (m, 12H, CH3). 
13C NMR (100 MHz, DMSO-d6): δ =170.1, 170.7, 170.4, 170.1 (4C,C=O), 159.3 
(1C, C6’), 137.3 (1C, C-7’), 137.2 (1C, C-5’), 135.6 (1C, C-8’), 131.0 (1C, C-4’), 
124.4 (1C, C-1’), 117.4 (1C, C-2’), 117.3 (1C, C-3’), 113.1 (1C, C-CN),111.6 (1C, 
C-CN), 99.1 (1C, C-1), 73.6 (1C, C-2), 73.3 (1C, C-3), 72.6 (1C, C-5), 72.0 (1C, C-
4), 68.9 (1C, C-6), 21.1, 21.0, 20.9, 20.8, 20.3 (4C, CH3). 
IR (KBr): 2958, 2234 (CN), 1755, 1623, 1597, 1500, 1465, 1369, 1233, 1040, 908, 
822, 700 cm-1. 
HRMS (FT-ICR): m/z: 547.132 [M + Na]+, 563.106 [M + K]+. 
 
4.7.4 6-Glucosyloxyisoindoline 44 
 
Naphthalonitrile 39 (1.0 g, 1.9 mmol) was 
suspended in dry methanol (10 ml), cooled in ice 
bath while bubbling the gaseous ammonia through the suspension. At 0°C Na 
metal (46 mg, 2 mmol) was added. 
After some time the solid dissolved in methanol indicating the deprotection of 
acetyl groups of sugar part. The reaction mixture now warmed slowly to room 
temperature during 2 h while bubbling the gaseous ammonia through the solution. 
After completion of the reaction, the solution was cooled, ammonia gas removed 
and mixture was bubbled with air to remove access of ammonia. Precipitates 
formed were separated and dried to get the crude product, which was used 
without further purification for the next step. Yield: 1.2 g (99%). 
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1H NMR (400 MHz, DMSO-d6): δ = 8.28 (s, 1H, H-1’), 8.23 (s, 1H, H-4’), 8.02 (d, J 
= 9.2 Hz, 1H, H-8’), 7.61 (s, 1H, H-5’), 7.40 (dd, J = 9.2 Hz, J = 2.3 Hz, 1H, H-7’), 
5.10 (d, J = 7.1 Hz, 1H, H-1), 3.80-3.72 (m, 2H), 3.55-3.41 (m, 4H), 3.37-3.28 (m, 
4H), 3.24-3.18 (m, 2H, H-5), 1.22 (s, 1H), 0.89-0.75 (m, 1H). 
13C NMR (100 MHz, DMSO-d6): δ = 156.9 (1C, C6’), 135.5 (1C, C-7’), 131.9 (1C, 
C-5’), 131.2 (1C, C-8’), 129.7 (1C, C-4’), 121.1 (1C, C-1’), 120.4 (1C, C-NH2), 
112.6 (1C, C-NH), 100.7 (1C, C-1), 77.5 (1C, C-2), 76.9 (1C, C-3), 73.6 (1C, C-5), 
70.0 (1C, C-4), 61.0 (1C, C-6). 
IR (KBr): 3381 (N-H, O-H), 2957, 1614, 1549, 1517, 1398, 1290, 1079, 1049 cm-1. 
HRMS (FT-ICR): m/z: 374.13466 [M + Na]+. 
 
4.7.5 3,12(13),21(22),30(31)-Tetra(2,3,4,6-tetra-O-acetyl-D-
glucopyranosyl)naphthalocyaninato zinc(II) 45 
 
A mixture of naphthalonitrile 39 (1.57 g, 3 
mmol), p-toluenesulfonic acid 
monohydrate (57 mg, 0.3 mmol), 
hexamethyldisilazane (HMDS) (0.21 ml, 1 
mmol), DMF (2 ml) and Zn(OAc)2.2H2O 
(330 mg, 1.5 mmol) in a sealed glass tube 
was stirred and heated at 150 oC overnight. The semisolid obtained was cooled 
and precipitated with methanol water (1:2) mixture. The precipitates obtained were 
dried and chromatographed first with ethylacetate to remove unreacted 
naphthalodinitrile 39 and side products then with ethylacetate containing 2-5% 
methanol. Yield 730 mg (45%). 
1H NMR (250MHz, CD3OD-d4): δ =9.38 (bs, 8H), 8.38 (bs, 4H), 8.11 (bs, 4H), 7.45 
(bs, 4H), 5.91-5.68 (m, 4H), 5.39-5.29 (m, 4H), 5.23-5.06 (m, 12H), 4.85-4.48 (m, 
8H), 2.25-2.06 (m, 48H). 
UV/Vis (DMSO): λmax (log ε) = 769 (5.46), 336 (5.05). 
HRMS (MALDI–TOF): m/z calcd. for C104H96N8O40Zn, [M]+, 2160.5281; found 
2160.475 [M]+. 
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4.7.6 3,12(13),21(22),30(31)-Tetra-D-glucosenaphthalocyaninato zinc(II) 46 
 
Method A: Isoindoline 44 (373 mg, 1 mmol) and DBU 2-3 drops were refluxed in 
DMAE (1 ml) for 24 h. Reaction mixture was cooled to room temperature and 
washed with methanol. Precipitates formed were separated by centrifugation. 
Crude product was extracted with methanol in Soxhlet apparatus. Yield 108 mg 
(29%). 
Method B: Naphthalocyanine 45 (400 
mg) was dissolved in 2:1 mixture of 
DMSO/MeOH (15 ml). Catalytic amount 
of CH3ONa was added and the reaction 
mixture was stirred at room temperature 
overnight. Ion exchange resin amberlite 
IR-120H was added to neutralize the 
solution. The solution was filtered to 
remove the resins. Precipitation of the product was carried out by excess of 
acetone. Precipitates formed were filtered and dissolved in small amount of water 
and reprecipitated with acetone. The crude product was dried and purified with 
reverse phase HPLC using water acetonitrile as eluent. Yield 257 mg (93%). 
1H NMR (250MHz, DMSO-d6): δ =9.75 (s, 4H), 8.70 (s, 4H), 8.61 (d, J = 9.2, 4H), 
8.24 (s, 4H), 7.68 (d, J = 9.2, 4H), 5.38 (s, 4H), 3.98-3.94 (m, 12H), 3.77-3.42 (m, 
28H). 
UV/Vis (DMSO): λmax (log ε) = 773 (7.55), 688 (6.85), 344 (7.13). 
HRMS (MALDI–TOF): m/z calcd. for C72H64N8O24Zn, [M]+, 1488.3241; found 
1488.325 [M]+. 
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6 Summary 
 
Glycosylated phthalocyanines (Pc’s) despite their great potential for the generation 
of reactive oxygen species (singlet oxygen), are less common in literature. 
Reactive oxygen species are potent oxidant and are used for the destruction of 
cancer cells in a therapeutic technique called as photodynamic therapy (PDT). 
Objective of this work was to synthesize a structural variety of glycosylated zinc(II) 
phthalocyanines for PDT applications. We chose to prepare phthalocyanines, 
tetra- and octaglycosylated with different sugar moieties such as glucose, 
galactose, cellobiose, lactose and maltose. In tetraglycosylated zinc(II) 
phthalocyanines sugar moieties e.g. glucose, galactose and maltose were linked 
at 1,8(11),15(18),22(25) positions of the Pc macrocycle through anomeric oxygen 
or sulphur atoms (pages 55,86). Synthesis of these Pcs started from 3-
nitrophthalonitrile, in which NO2 group was substituted with anomerically 
deprotected sugar moieties through SNAr mechanism. Hence appropriate acetyl 
protected sugar molecules were reacted with 3-nitrophthalonitrile to furnish 3-
glycosylated phthalonitriles in good yields (page 53). Synthesis of acetylated sugar 
substituted phthalocyanines was accomplished when 3-glycosylated 
phthalonitriles were reacted with hexamethyledisilazane (HMDS) in DMF 
contaning trimethylsilyltriflate (TMSOTf) and zinc acetate, at 130 oC (pages 55,86). 
Deprotection of acetyl groups in sugar molecules was achieved by reacting the 
phthalocyanines with MeONa in DMSO/MeOH mixture to afford water soluble 
1,8(11),15(18),22(25)-tetraglycosylated zinc(II) phthalocyanines in excellent yields 
(pages 55,89). 
For the synthesis of 2,3,9,10,16,17,23,24-octaglycosylated zinc(II) 
phthalocyanines, corresponding 4,5-diglycosylated phthalonitriles were 
synthesized from 4,5-difluorophthalonitrile. Therefore 4,5-difluorophthalonitrile was 
reacted with acetyl protected sugar moieties such as glucose, galactose, lactose, 
cellobiose and maltose, containing OH or SH groups at anomeric positions (pages 
63,94). 4,5-Diglycosylated phthalonitriles were converted into their corresponding 
acetyl protected PcZn’s. Removel of the protecting groups of sugar molecules 
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afforded water soluble octaglycosylated phthalocyanine systems in good yields 
(pages 67,101). 
2,3,9,10,16,17,23,24-Octagalactosylated PcZn in which Pc macrocycle is attached 
via position 6 of galactose, was synthesized and characterized. Thus 1,2:3,4-
diisopropylidene-α-D-galactopyranose was reacted with 4,5-difluorophthalonitrile 
to obtain 4,5-(1,2:3,4-diisopropylidene-α-D-galactopyranosyl)phthalonitrile in good 
yield (pages 59,91). It was further converted to diisopropylidene protected 
octagalactosylated PcZn. Removal of isopropylidene groups in galactose units 
furnished water soluble octagalactosylated PcZn in good yield (pages 60,92). 
Aggregation behavior of tetra- and octaglycosylated PcZn’s was studied by UV/Vis 
spectroscopy (page 70). In DCM acetyl protected PcZn’s show almost no 
aggregation. In DMSO as solvent deacetylated Pc’s also exhibit no aggregation 
whereas in water these PcZn’s are highly aggregated. The aggregation of these 
Pc’s also depends on the size of the sugar substituents e.g. Pc’s with bulky sugar 
substituents in DMSO are less aggregated in comparison to Pc’s containing lower 
analogs. Comparing aggregation behaviour of these Pc’s it is evident that the 
PcZn’s in which sugar moieties are linked to the Pc macrocycle through anomeric 
sulphur atoms show higher aggregation tendency as compared to the Pc’s linked 
via anomeric oxygen atoms, in DMSO solutions. 
Naphthalocyanines (Nc’s) being higher analogs of Pc macrocycles are also 
promising candidates for PDT applications. A tetraglucosylated NcZn was 
synthesized and characterized during this study (page 74). For the synthesis of 6-
glucosylated naphthalonitrile two different approaches were adopted. In one 
methodology glucose pentaacetate was reacted with 3,4-dimethylphenol to furnish 
glucosylated-o-xylene, which was brominated to give tetrabrominated product. 
Conversion of tetrabrominated product with fumaronitrile in Diels-Alder process 
resulted into glucosylated naphthalonitrile (page 75). Alternatively 6-
hydroxynaphthalonitrile was converted in to 6-glucosyalted naphthalonitrile by its 
reaction with acetobromoglucose in the presence of Ag2O. Naphthalonitrile was 
tetramerized to form acetyl protected tetraglucosylated NcZn, which was further 
subjected to deacetylation process to yield tetraglucosylated zinc 
naphthalocyanine (pages 76,115). 
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The formed naphthalocyanine was soluble in DMF, DMSO and hot water but 
almost insoluble in cold water. Acetyl protected NcZn is aggregated in DCM 
solution as shown by UV/Vis spectroscopic data (page 77). Addition of traces of 
pyridine in DCM solution of acetyl protected Nc, however diminish this effect, 
which appears as an increase in the intensity of Q-band. Deacetyalted NcZn does 
not show any aggregation in DMSO solution as shown by intense Q-band in 
UV/Vis spectrum. 
One major objective of this work was to find a more productive and efficient 
method for the synthesis of substituted phthalonitriles, considering the importance 
of phthalonitriles as starting materials for phthalocyanines. In our new method 
substituted o-dibromobenzenes can be converted in to their corresponding 
phthalonitriles in good to excellent yields, using Pd(0) catalyst under moderate 
reaction conditions (pages 48,82).  
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6 Zusammenfassung 
 
Glycosylierte Phtalocyanine (Pc) sind trotz ihres großen Potentials für die 
Generierung von reaktiven Sauerstoffspezies (Singulett-Sauerstoff) selten in der 
Literatur zu finden. Reaktive Sauerstoffspezies sind starke Oxidationsmittel und 
werden in einer Behandlungsmethode, die als „Photodynamische Therapie (PDT)“ 
bekannt ist, zur Zerstörung von Krebszellen eingesetzt. Ziel dieser Arbeit war die 
Synthese von verschiedenen glycosylierten Zink(II) – Phtalocyanine für den 
Einsatz in der PDT. Wir entschieden uns dazu, tetra- und oktaglycosylierte 
Phtalocyanine mit verschiedenen Zuckerresten wie Glucose, Galactose, 
Cellobiose, Lactose und Maltose herzustellen. An tetraglycosylierten Zink(II) – 
Phtalocyanine wurden Zuckerreste wie z.B. Glucose, Galactose und Maltose an 
die Positionen 1,8(11), 15(18), 22(25) des Pc-Heterocyclus durch anomeren 
Sauerstoff oder Schwefel (Seiten 55, 86) gebunden. 
Die Synthese dieser Pcs begann mit 3-Nitrophtalonitril, an dem die Nitrogruppe 
mit anomer ungeschützten Zuckerresten in einer SNAr-Reaktion ersetzt wurden. 
So war es möglich, passend acetylgeschützte Kohlenhydrate mit 3-Nitrophtalonitril 
in guter Ausbeute zu 3-glycosylierten Phtalonitrilen umzusetzen (Seite 53). Die 
Synthese von Phtalocyanine, die mit acetylierten Kohlenhydraten substituiert sind, 
geschah durch Reaktion von 3-glycosylierten Phtalonitrilen, die mit 
Hexamethyldisilazan (HMDS) in DMF mit Trimethylsilyltriflat (TMSOTf) und 
Zinkacetat bei 130° C (Seiten 55, 86). Das Entfernen der Acetylschutzgruppen an 
den Kohlenhydratresten wurde durch Reaktion der Phtalocyanine mit NaOMe in 
DMSO und MeOH durchgeführt und ergab wasserlösliche 1,8(11), 15(18), 
22(25)tetraglycosylierte Zink(II) – Phtalocyanine in hoher Ausbeute (Seiten 55, 
89). Für die Synthese von 2,3,9,10,16,17,23,24-oktaglycosylierte Zink(II)- 
Phtalocyanine wurden entsprechende 4,5-diglycosylierte Phtalonitrile aus 4,5-
Difluorphtalonitril hergestellt. Dazu wurde 4,5-Difluorphtalonitril mit 
Acetylgeschützen Kohlenhydraten wie z.B. Glucose, Lactose, Cellobiose und 
Maltose mit Hydroxyl- bzw. Thiogruppen am anomeren Zentrum umgesetzt 
(Seiten 63, 94). Die 4,5-digylcosylierten Phtalonitrile wurden zu den 
korrespondierenden acetylgeschützten PcZns umgesetzt. Das Entfernen der 
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Acetylschutzgruppen der Kohlenhydratreste ergab wasserlösliche 
oktaglycosylierte Phtalocyninsysteme in hoher Ausbeute (Seiten 67, 101). 
2,3,9,10,16,17,23,24-Oktagalactosylierte PcZn, in denen der Pc-Makrozyklus an 
der Position 6 der Galactose angebunden ist, wurden hergestellt und 
charakterisiert. Dafür wurde 1,2:3,4-diisopropyliden-α-D-Galactopyranose mit 4,5-
Difluorphtalonitril umgesetzt, um 4,5-(1,2:3,4-Diisopropyliden- α-D-
galactopyranosyl)Phtalonitril in hoher Ausbeute zu erhalten (Seiten 59, 91). Es 
wurde weiterhin zum diisopropylidengeschützten oktaglycosylierten PcZn 
verarbeitet. Das Entfernen der Isopropylidengruppen an den Galactoseeinheiten 
führte zu wasserlöslichem oktaglycosylierten PcZn in guter Ausbeute (Seiten 60, 
92). 
Das Aggationsverhalten von tetra- und oktaglycosylierten PcZns wurde mit 
UV/Vis-Spektroskopie untersucht (Seite 70). In DCM zeigen acetylgeschützte 
PcZns fast keine Aggregation. In DMSO als Lösemittel weisen deacetylierte Pcs 
ebenfalls keine Aggregation auf, währen PcZns in Wasser stark aggregieren. Das 
Maß der Aggregation hängt auch von den Zuckersubstituenten ab, z.B. 
aggregieren Pcs mit sperrigen Zuckerrresten in DMSO weniger als Pcs mit 
kleineren Zuckerresten. Ein Vergleich des Aggregationsverhaltens dieser Pcs 
zeigt, dass die PcZns, in denen die Zuckerreste über eine Thiobrücke am 
anomeren Zentrum an den Pc-Makrozyklus gebunden sind, in DMSO eher zur 
Aggregation tendieren als Systeme, in denen Zuckerrest und Makrozyklus durch 
eine Sauerstoffbrücke verbunden sind.  
Napththalocyanine (Ncs), die höhere Analoge der Pc-Makrozyklen sind, sind 
ebenfalls vielversprechende Kandidaten für die Anwendung in der PDT. Ein 
tetraglycosyliertes NcZn wurde hergestellt und charakterisiert (Seite 74). Für die 
Darstellung von 6-glycosyliertem Napththalonitril wurden zwei verschiedene 
Syntheserouten gewählt. In einem Weg wurde Pentaacetylglucose mit 3,4-
dimethylphenol umgesetzt, um glycosyliertes o-Xylen zu ergeben, das durch 
Bromierung zum tetrabromierten Produkt umgesetzt wurde. Eine Diels-Alder-
Reaktion mit der tetrabromierten Verbindung und Fumaronitril ergab glycosyliertes 
Napththalonitril (Seite 75). Im zweiten Syntheseweg wurde 6-glycosylierten 
Naphthalonitril  durch Reaktion von 6-Hydroxynapththalonitril mit 
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Acetobromglucose in Gegenwart von Ag2O dargestellt. Naphthalonitril wurde 
tetramerisiert, um acetylgeschütztes tetraglycosyliertes NcZn zu ergeben, das 
durch Verseifung tetraglycosylierte Zink(II)-Naphthalocyanine zu ergeben (Seiten 
76, 115). 
Das entstandene Napththalocyanine war löslich in DMF, DMSO und heißem 
Wasser, jedoch in kaltem Wasser beinahe unlöslich. Wie mit UV/Vis-
Spektroskopie beobachtet werden kann, aggregiert acetylgeschütztes NcZn in 
DCM (Seite 77). In einer Lösung aus acetylgeschützem NcZn in DCM kann dieser 
Effekt durch die Zugabe von Spuren von Pyridin verringert werden, dies zeigt sich 
durch eine Intensitätssteigerung der Q-Banden. Deacetyliertes NcZn seigt in 
DMSO keinerlei Aggregation, wie aus der hohen Intensität der Q-Banden im 
UV/Vis-Spektrum ersichtlich ist. 
Ein Hauptziel der vorliegenden Arbeit war, in Anbetracht der Bedeutung von 
Phthalonitrilen als Ausgangsverbindungen für Phtalocyanine eine effizientere 
Methode zur Synthese von substituierten Phthalonitrilen zu finden. In unsere 
neuen Strategie können substituierte o-Dibrombenzole in ihre entsprechenden 
Phtalonitrile in hohen bis sehr hohen Ausbeuten umgesetzt werden, indem Pd(0)-
Katalysator unter milden Bedingungen eigesetzt wird (Seiten 48, 82). 
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Abbreviations 
δ  chemical shift 
λ  wavelength 
J  coupling constant 
ε  Extinction  
  coefficient 
c  concentration 
br  broad 
cm  centimeter 
oC  Degree Celsius 
DCM  dichloromethane 
DBU 1,8diazabicyclo[5.4.0]- 
 undec-7-ene 
DMAE Dimethylaminoethanol 
DMF  N,N’-
 dimethylformamide 
EI Electron  Ionization 
FAB  Fast Atom  
  Bombardement 
HOMO  Highest Occupied 
  Molecular Orbital 
HRMS  High Resolution 
Mass   Spectroscopy 
FT  Fourier Transform 
ICR  Ion Cyclotron  
  Resonance 
LUMO Lowest Unoccupied  
 Molecular Orbital 
IR  Infra Red 
MALDI Matrix Assisted Laser  
 Desorption Ionization 
TOF  Time of Flight 
UV/vis  Ultra-violet/Visible 
m  multiplet 
d  doublet 
dd  doublet of doublet 
DMSO  Dimethylsulfoxide 
EtOH  Ethanol 
h  hour 
M  Molar 
m/z  Mass/Charge 
ml  millilitre 
mmol  millimol 
nm  nanometer 
s  Singlet 
NBS  N-Bromosuccinimide 
HPLC High Performance  
 Liquid Chromatography 
MPLC Medium Pressure Liquid  
 Chromatography 
OL  Optical Limiting 
PDT  Photodynamic  
  Thereapy 
TMSOTf  Trimethylsilyltriflate 
rt  Room temperature 
NIS  N-Iodosuccinimide 
TfOH  Triflic acid 
A˚  Angstrom 
Tf2O  Triflic anhydride 
PPh3  Triphenylphosphene 
LD  Lethal Dose 
μ  micro 
M  Molar 
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MS Mass  Spectroscopy 
MeOH  methanol 
NMR  Nuclear Magnetic 
  Resonance 
ppm  parts per million 
THF  Tetrahydrofuran 
TLC  Thin Layer  
  Chromatography 
 
NMP  N-methylpyrrolidinone 
SNAr  Substitution 
 Nucleophilic  Aromatic 
HMPA Hexamethylphosphortriamide 
MHz  Megahertz 
TBAF  Tetrabutylammonium 
  fluoride 
AcOH  Acetic acid 
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